,Cluster,Biomarker,Relations
1853,0,HVA,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome: Increased dopamine levels in Alzheimer's Disease""}]"
1825,0,HF,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
1841,0,HR,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2395,0,Mer,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Microglia recognition and phagocytosis of amyloid plaques in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pathogenesis of AD'}]"
64,0,4-HNE,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
56,0,2HG,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1255,0,DA metabolite HVA,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}]"
1860,0,Hb,"[{'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Hospitalization'}, {'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Decreased hospitalization rates and improved nutritional status in older patients'}]"
1842,0,HRV,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathological states'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Autonomic dysfunction in dementia'}, {'article': 'PMC8154928.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Better cognitive performance and executive functions'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1852,0,HT7,"[{'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4180,0,hFABP,"[{'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Progression from mild cognitive impairment to AD'}, {'article': 'PMC6966425.txt', 'relationship': 'CORRELATES_WITH', 'object': 'Brain atrophy among individuals with low cerebral spinal fluid Aβ42'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]"
942,1,COI scores,"[{'article': 'PMC5226952.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher semantic organization and improved performance in Experiment 2'}]"
2142,1,KBIT-2 nonverbal raw score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal dementia'}]"
1843,1,HS score,"[{'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
1587,1,Five Time Sit-to-Stand test (FTSS) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Postural and physical impairments'}]"
2644,1,Omnibus Scores (Omn),"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease Progression""}]"
4338,1,omnibus scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3541,1,Test time score,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
108,1,ACE total score,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline associated with Alzheimer's Disease""}]"
1844,1,HS scores,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence via Aβ PET status correlation""}]"
2059,1,Imagined Timed 'Up & Go' (iTUG) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Motor imagery deficits'}]"
2703,1,PAL scores,"[{'article': 'PMC10916999.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Longitudinal decline predicts progression from mild cognitive impairment to Alzheimer's Disease""}]"
2241,1,Lumosity game scores,"[{'article': 'PMC7729136.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes due to MPH treatment in Alzheimer's Disease""}]"
3764,1,WMH (Fazekas score),"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Processing speed'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive ability'}]"
2143,1,KBIT-2 verbal raw score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Preclinical dementia'}]"
4209,1,inaccuracy score,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3565,2,Thioflavin T,"[{'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Amyloid deposits in Alzheimer's Disease""}]"
4567,2,thioflavin S,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3564,2,Thioflavin S,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1581,2,Fibrinogen,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Blood-brain barrier damage in Alzheimer's Disease""}]"
1580,2,Fibrin,"[{'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2520,3,NMDS criteria,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2511,3,NINCDS/ADRDA criteria,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1761,3,Global Deterioration Scale (GDS) score,"[{'article': 'PMC6794759.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of dementia in Alzheimer's Disease""}]"
1740,3,Gd-DOTA concentration,"[{'article': 'PMC8905724.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Blood-brain barrier disruption efficacy'}]"
10,3,129Xe retention parameter,"[{'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3532,3,Temporal Decline Percentage (TDP),"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
4135,4,florbenazine,"[{'article': 'PMC4027995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in Dementia with Lewy Bodies (DLB)'}]"
1599,4,Flortaucipir,"[{'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau tangles'}]"
1600,4,Flortaucipir SUVr,"[{'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4142,4,flortaucipir SUVr,"[{'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1590,4,Florbenazine,"[{'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
4136,4,florbenazine SUVr,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4141,4,flortaucipir,"[{'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology beyond the mesial temporal lobe'}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Longitudinal cognitive deterioration'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Age-related decrease in SUVr in Aβ+ subjects'}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive performance on MMSE and ADAS'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease-related tau deposition""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Monitoring effects of Alzheimer's Disease therapies""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Ptau burden'}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3839,5,[11C]PIB,"[{'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease by measuring Aβ load""}, {'article': 'PMC4877513.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Aβ deposition in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid load in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Liraglutide treatment in Alzheimer's Disease patients""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta'}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3841,5,[11C]PiB PET,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid deposition in AD'}]"
3873,5,[C11]PiB PET,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2731,5,PET,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2859,5,PiB load,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early AD marker'}]"
2745,5,PIB,"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease-related cognitive impairment""}, {'article': 'PMC4346122.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence of amyloid plaques""}]"
2746,5,PIB imaging,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2747,5,PIB-PET,"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid plaques associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict Pittsburgh compound B positivity'}]"
2752,5,PILRB,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
4,5,11C-PiB,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Aβ deposition in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Aβ plaque deposition in Alzheimer's Disease""}]"
2857,5,PiB,"[{'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid-beta (Aβ) burden'}, {'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuritic Plaques (NPs)'}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diffuse Plaques (DPs)'}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Amyloid Angiopathy (CAA)'}]"
2734,5,PET-PiB,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differential diagnosis of dementia'}]"
2860,5,PiB-PET,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid load in preclinical Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Amyloid Positivity in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid Accumulation in Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta pathology'}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early detection of amyloid-beta burden'}, {'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline associated with neuritic plaques'}]"
2861,5,PiB-positive individuals,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Risk for AD-type dementia'}]"
3762,6,WM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3769,6,WMH volume,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slow gait speed, large total WMH volume, and WMH volume in the frontal lobe'}]"
1274,6,DG volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'RI (hippocampal-dependent memory process)'}]"
4155,6,fusiform volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1686,6,GM volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}]"
3585,6,Total WMH volume,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
1817,6,HATA volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3584,6,Total WM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Simvastatin treatment in Alzheimer's Disease""}]"
3578,6,Total GM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1434,6,ERC volume,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]"
1435,6,ERC volume loss,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]"
1924,7,Hit rate,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]"
1925,7,Hit-rate,"[{'article': 'PMC4374455.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
4098,7,double support percentage,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'increased number of microbleeds'}]"
4099,7,double support time,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'silent infarcts and microbleeds'}]"
619,8,Aβ42 oligomers,"[{'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with ALZ-801'}]"
644,8,AβPP,"[{'article': 'PMC6015016.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
647,8,Aβo (oligomeric amyloid beta),"[{'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
651,8,Aβx–40 peptide levels,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
564,8,Aβ protein,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
652,8,Aβ−,"[{'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lower likelihood of Alzheimer's Disease""}]"
563,8,Aβ positivity,"[{'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
562,8,Aβ polymers,"[{'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in Aβ polymers in the hippocampus'}]"
375,8,Amyloid,"[{'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral amyloidosis'}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glymphatic clearance in Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decreased amyloid burden in tissue proximal to the implant'}, {'article': 'PMC8905724.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of amyloid burden in mild Alzheimer's Disease patients.""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease.""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Clinical benefit in early symptomatic Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Gantenerumab treatment'}, {'article': 'PMC6909550.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Clinical benefit in early symptomatic Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7074941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7074941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment to major neurocognitive disorder'}, {'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
376,8,Amyloid (Aβ oligomers),"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]"
323,8,Aggregated Aβ,"[{'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
4296,8,mitochondrial Aβ1–40 levels,"[{'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4431,8,plasma amyloid-β (Aβ) peptides,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in plasma Aβ peptides in response to semagacestat treatment'}]"
743,8,Beta-amyloid (Aβ),"[{'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
782,8,Brain Amyloid Burden,"[{'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}]"
974,8,CSF amyloid and tau biomarkers,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Distinguish AD from VaD with 80% specificity'}]"
1056,8,Cerebral amyloid angiopathy (CAA),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
377,8,Amyloid (D54D2),"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid clearance in deep cervical lymph nodes'}]"
378,8,Amyloid Beta (Aβ),"[{'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1206,8,Cortical Aβ,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1211,8,Cortical amyloid β (Aβ) deposition,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
379,8,Amyloid Beta Peptides Burden,"[{'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3991,8,cerebral amyloid,"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
528,8,AΒ1-42,"[{'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}]"
3963,8,brain amyloid plaque,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
380,8,Amyloid Beta Peptides and Phosphorylated Tau,"[{'article': 'PMC9373273.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Brain Pathologies""}]"
565,8,Aβ protein precursor (AβPP),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
591,8,Aβ1-42/1-40,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
614,8,Aβ40 peptide,"[{'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
606,8,Aβ1–42/Aβ1–40,"[{'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
590,8,Aβ1-42 expression,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
593,8,Aβ1-42/Aβ1-40,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}]"
589,8,Aβ1-42,"[{'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""No significant change during γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Rescue of cognitive deficits in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'p-Tau levels'}, {'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Autophagic clearance'}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Nilotinib treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Extracellular plaque deposition and dementia'}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Soluble Aβ Levels'}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early disease progression'}, {'article': 'PMC8416781.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Brain amyloid pathology'}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Intermediate to high Thal amyloid phases in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Lower levels associated with poor outcomes in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β (Aβ) deposition'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease in its prodromal stage""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Pre-clinical Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnostic of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposition'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation and neurodegeneration in AD'}]"
588,8,Aβ1-40,"[{'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""No significant change during γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Rescue of cognitive deficits in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'LY2811376 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Soluble Aβ Levels'}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
594,8,Aβ1-42/Aβ1-40 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposition'}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid'}]"
587,8,Aβ1-38,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from FTD or DLB'}]"
586,8,Aβ1-37,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from FTD or DLB'}]"
585,8,Aβ1-34,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'BACE inhibition in clinical trials'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibition in humans'}]"
596,8,Aβ1-43,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early disease progression'}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Greater propensity to aggregate and more neurotoxic'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'DIFFERENTIATE', 'object': 'Amnestic mild cognitive impairment patients who progress to AD'}]"
584,8,Aβ1-16,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Chronic semagacestat treatment'}]"
597,8,Aβ1-x,"[{'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
600,8,Aβ1–37,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]"
601,8,Aβ1–38,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]"
607,8,Aβ1–42/Aβ1–40 ratio,"[{'article': 'PMC8866346.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Nonpathological (A−/T−/N−) cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Non-pathological cerebral spinal fluid profiles'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid cerebral spinal fluid profiles'}]"
583,8,Aβ1-15,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Chronic semagacestat treatment'}]"
580,8,Aβ-specific antibody titers,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
575,8,Aβ-PET,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
573,8,Aβ+,"[{'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in preclinical Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Episodic memory decline in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
571,8,Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to crenezumab treatment in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma concentrations after crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild-to-moderate Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'MEASURED_IN', 'object': 'Plasma'}, {'article': 'PMC6977279.txt', 'relationship': 'INFLUENCED_BY', 'object': 'Baseline patient characteristics such as age and renal function'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_IN_MODEL', 'object': 'TMDD model to simulate free plasma Aβ concentrations'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Crenezumab Treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Crenezumab Treatment'}]"
570,8,Aβ(1–40),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma concentrations after crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Crenezumab treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild-to-moderate Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'MEASURED_IN', 'object': 'Plasma'}, {'article': 'PMC6977279.txt', 'relationship': 'INFLUENCED_BY', 'object': 'Baseline patient characteristics such as age and renal function'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_IN_MODEL', 'object': 'TMDD model to simulate free plasma Aβ concentrations'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Crenezumab Treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Crenezumab Treatment'}]"
569,8,Aβ(1-40),"[{'article': 'PMC4822297.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
602,8,Aβ1–40,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in soluble Aβ levels in the hippocampus'}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decreased levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nonpathological cerebral spinal fluid profile'}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposits in Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment monitoring in Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]"
568,8,Aβ seeding activity,"[{'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC8808989.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive performance and conventional AD biomarkers'}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
603,8,Aβ1–40 and Aβ1–42,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]"
604,8,Aβ1–40 and Aβ1–42 serum levels,"[{'article': 'PMC4731943.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}]"
567,8,Aβ protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Immunotherapy for Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'BAN2401 treatment'}, {'article': 'PMC4822297.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: BAN2401 dosing based on lowering of Aβ protofibrils'}]"
566,8,Aβ proteins,"[{'article': 'PMC5372260.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
605,8,Aβ1–42,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in soluble Aβ levels in the hippocampus'}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to GSK933776 treatment in Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrospinal fluid levels decreased following GSK933776 administration'}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent reductions in cerebrospinal fluid Aβ1–42 levels'}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increased levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta pathology in Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Anti-Aβ therapy'}, {'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in brain amyloid in apoe4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Biomarker for amyloid burden in Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to lecanemab'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nonpathological cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposits in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaque formation'}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral amyloid plaque deposition'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to P. gingivalis brain infection treatment'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7648990.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
582,8,Aβ1-14,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}]"
592,8,Aβ1-42/1-40 (blood-based),"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
3077,8,Retinal amyloid index,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
382,8,Amyloid PET,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid deposition in the brain, a hallmark of Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Disease-modifying therapies, specifically anti-amyloid drugs'}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid load in Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment subtypes'}, {'article': 'PMC4346122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Future diagnostic algorithms for CBS due to AD'}, {'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline risk'}, {'article': 'PMC8005243.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Anti-amyloid interventional trials'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Reduction in brain amyloid levels over 18 months'}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral amyloid burden'}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Behavioral changes in health'}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Disease progression in mild cognitive impairment'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced amyloid accumulation'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with amyloid plaques""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Detecting amyloid deposits in preclinical Alzheimer's Disease and monitoring progressive amyloid burden""}, {'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
556,8,Aβ pathology,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Memory performance and RI'}]"
4387,8,pGlu-Aβ,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Synaptic impairment and neurotoxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pGlu-Aβ levels associated with improved learning and memory deficits in AD-like mice.'}]"
557,8,Aβ peptide,"[{'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
450,8,Amyloid-β42,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
449,8,Amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
448,8,Amyloid-β protein,"[{'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in content in the visual cortex of mice after 40-Hz light stimulation'}]"
447,8,Amyloid-β plaques,"[{'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]"
446,8,Amyloid-β peptide (Aβ),"[{'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
445,8,Amyloid-β PET,"[{'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
555,8,Aβ oligomers (AβOs),"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia in Alzheimer's Disease""}]"
444,8,Amyloid-β 42,"[{'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
442,8,Amyloid-β (Aβ) plaques,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
441,8,Amyloid-β (Aβ),"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in executive/speed functions'}, {'article': 'PMC4519341.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Faster decline in executive/speed cognitive functions'}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's disease (AD) neuropathology in Down syndrome individuals""}, {'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz gamma oscillation therapy'}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Passive immunotherapy (crenezumab, gantenerumab, aducanumab)'}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
440,8,Amyloid-β,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurotoxic effects and memory inhibition'}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Reduction of amyloid levels through 40-Hz auditory stimulation'}, {'article': 'PMC9539040.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function in patients with AD'}]"
439,8,Amyloid-related imaging abnormalities with edema or effusions (ARIA-E),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Presence of edema or effusions in Alzheimer's Disease patients""}]"
438,8,Amyloid-beta plaques,"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]"
437,8,Amyloid-beta load (CL values),"[{'article': 'PMC9327167.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher tau deposition in Alzheimer's Disease""}]"
436,8,Amyloid-beta load,"[{'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
435,8,Amyloid-beta (Aβ42),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
434,8,Amyloid-beta (Aβ) plaques,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
443,8,Amyloid-β (Aβ) protofibrils,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
554,8,Aβ oligomers,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Synaptic plasticity impairment and neuronal death'}, {'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Early stages of Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress and mitochondrial dysfunction in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease changes""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic dysfunction and structural impairment'}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic impairment and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression'}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Aducanumab, gantenerumab, BAN2401, and ALZ-801'}, {'article': 'PMC7424995.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Clinical trials'}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
553,8,Aβ load,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction in Alzheimer's Disease""}]"
552,8,Aβ levels (Aβ1−40 and Aβ1−42),"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
529,8,Aβ,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Mild Cognitive Impairment/Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_RESPONSE', 'object': ""Response: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment: PLAS intervention'}, {'article': 'PMC11493878.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive decline mitigation'}, {'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Cognitive improvement'}, {'article': 'PMC11493878.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive function'}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid Plaques'}, {'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Cognitive benefit and reversal of brain Aβ deposition'}, {'article': 'PMC3338462.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""EMF treatment for Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater Aβ burdens in Tg mice'}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Prevention and reversal of brain Aβ aggregation/deposition'}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Vasoconstriction and reduced cerebral blood flow (CBF)'}, {'article': 'PMC3338462.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Enhanced Aβ removal/efflux from the brain'}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuronal loss and cognitive impairment'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic dysfunction and neuronal loss'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired insulin receptor function'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress and apoptosis'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive deficits and synaptic pathology'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses and neuronal death in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal death and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Disease progression and neurodegeneration'}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in neocortex and hippocampus'}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Near-infrared light treatment in Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring disease progression in Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathogenesis""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Immunotherapy for Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4095696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction in Aβ levels and amyloid plaques'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""SS treatment for Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE_TO_TREATMENT', 'object': 'Reduction in soluble Aβ levels after SS treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'GSK933776 treatment'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Changes in plasma and CSF levels during treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'CAD106 treatment'}, {'article': 'PMC4410460.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for CAD106 immunotherapy in Alzheimer's Disease treatment""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid-beta deposits in the brain'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster cognitive decline in APOE ε4 carriers'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster cognitive decline in African-Americans'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory decline'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster decline in executive/speed functions'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater hippocampal atrophy'}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Inverse relationship with regional glucose metabolism'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of Aβ amyloid angiopathy according to the Boston criteria'}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities, an indicator of the severity of white matter ischaemia'}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary pathology around Aβ-laden parenchymal arterioles in AD'}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Impaired blood–brain barrier (BBB) function'}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau deposition'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau hyperphosphorylation'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC4888851.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for Alzheimer's Disease therapies""}, {'article': 'PMC4918115.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Anti-Aβ therapies'}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloidosis'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid Plaque Burden'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid plaque deposition and soluble Aβ levels'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early detection of amyloid load using 18F-florbetaben PET'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Established Alzheimer's Disease pathology""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Progression to AD dementia'}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early detection of amyloid pathology'}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'Aβ plaque load predicts AD progression'}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better functional outcomes in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and AD pathogenesis in mice'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz light stimulation'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Personalized tACS stimulation based on individual Aβ accumulation maps'}, {'article': 'PMC8690894.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting cortical areas for tACS stimulation in Alzheimer's Disease treatment""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and diagnosis of cognitive impairment'}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4471648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Ultrasound therapy to remove Aβ and restore memory in AD mouse model'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta aggregates'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Amyloidosis'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Episodic memory impairment (r = -0.12)'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Executive function impairment (r = 0.08)'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Episodic memory impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Visuospatial function impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Semantic memory impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Global cognition impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: episodic memory'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: semantic memory'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: visuospatial function'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: global cognition'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Episodic memory decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Executive function decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Processing speed decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Visuospatial function decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Global cognition decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Semantic memory decline'}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-beta burden in cortex and hippocampus'}, {'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta deposits in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'LEVELS_ARE_NEGATIVELY_ASSOCIATED_WITH', 'object': 'Plasma leptin concentration'}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid Beta'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction of Aβ levels in the brain'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic interventions in Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Wnt-β-catenin signalling activity'}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Wnt-PCP signalling activity'}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced gait velocity'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased stance time variability, reduced cadence, and increased double support time'}, {'article': 'PMC6565843.txt', 'relationship': 'NOT_ASSOCIATED_WITH', 'object': 'Step length'}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral amyloid angiopathy'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis of: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of immunotherapy for Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Therapies targeting amyloid cascade'}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of combination treatments with cromolyn and ibuprofen'}, {'article': 'PMC6966425.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Clearance via albumin in plasma exchange'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of treatment: Aducanumab (BIIB037), BAN2401 (mAb158)'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response of crenezumab'}, {'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Antibiotic treatment (ABX)'}, {'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Microglial Aβ phagocytosis'}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Microglial Aβ phagocytosis'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: GV-971 (Sodium oligomannate)'}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of TEMT treatment to disaggregate toxic oligomers'}, {'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture treatment reduces Aβ deposition.'}, {'article': 'PMC9527145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Worse memory and decreased cerebral blood flow in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduces the levels of Aβ1-40 and Aβ1-42'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Slowed decline in cognitive, functional, and neuropsychological outcomes in AD patients'}, {'article': 'PMC9635167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid β deposition in the brain'}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced Aβ accumulation and improved cognitive impairment in Aβ1-42-infused mouse model'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Amyloid-clearing drugs'}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9768996.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
530,8,Aβ (Amyloid Beta),"[{'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
531,8,Aβ (amyloid beta peptides),"[{'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
532,8,Aβ (amyloid deposition),"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
533,8,Aβ (amyloid-beta),"[{'article': 'PMC7067577.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
534,8,Aβ 1-40,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
535,8,Aβ 1-42,"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
537,8,Aβ PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
538,8,Aβ Protein,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid Accumulation in Alzheimer's Disease""}]"
539,8,Aβ SUVR,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
540,8,Aβ accumulation,"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
541,8,Aβ amyloid angiopathy,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease, present in over 90% of patients""}]"
542,8,Aβ amyloid beta peptides,"[{'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
543,8,Aβ amyloid fibrils,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal damage associated with Neurofibrillary tangles and NT'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Promotion of neuronal damage'}]"
545,8,Aβ biomarkers,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
546,8,Aβ burden,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
547,8,Aβ deposition,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD symptoms'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tauopathy'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased risk of cognitive decline'}, {'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Preclinical Alzheimer's Disease intervention""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
548,8,Aβ deposition on PET,"[{'article': 'PMC4970664.txt', 'relationship': 'DIAGNOSITIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
549,8,Aβ depositions,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
550,8,Aβ deposits,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of AD-type dementia'}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
551,8,Aβ levels,"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive compromise in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased plasma Aβ levels with bapineuzumab treatment'}, {'article': 'PMC4866415.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics: Significant increases in plasma Aβ levels observed with bapineuzumab'}, {'article': 'PMC4875639.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring response to Aβ-targeting treatments'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
433,8,Amyloid-beta (Aβ) peptides,"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}]"
432,8,Amyloid-beta (Aβ) levels,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
431,8,Amyloid-beta (Aβ),"[{'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Amyloid-beta (Aβ) protofibrils in Alzheimer’s disease'}, {'article': 'PMC4095696.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying therapies in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology in cognitively normal older adults""}, {'article': 'PMC5315443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster cognitive decline and progression to mild cognitive impairment or Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
430,8,Amyloid-beta,"[{'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Beneficial changes in plasma amyloid levels'}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Central nervous system amyloid deposition'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Gantenerumab treatment'}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired fluid movement and decreased glymphatic clearance in Alzheimer's disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9327167.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Anti-amyloid therapies in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Genistein'}]"
404,8,Amyloid beta peptides42,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
403,8,Amyloid beta peptides40,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
402,8,Amyloid beta peptides (abeta 40 and 42),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
401,8,Amyloid beta peptides (Aβ) plaques,"[{'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
400,8,Amyloid beta peptides (Aβ),"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
399,8,Amyloid beta peptides,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC3389343.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced amyloid beta plaques in Alzheimer's Disease models""}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved spatial memory in Alzheimer's Disease models""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Gait velocity in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced amyloid burden in Alzheimer's Disease""}]"
398,8,Amyloid beta (Aβ) peptides,"[{'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor semagacestat treatment'}]"
397,8,Amyloid beta (Aβ),"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in brain amyloid levels'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
396,8,Amyloid and tau,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Motor performance in Alzheimer's Disease""}]"
559,8,Aβ plaque,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
560,8,Aβ plaque deposition,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced Aβ plaque deposition in Alzheimer's Disease mice treated with GV-971""}]"
392,8,Amyloid Precursor Protein (APP),"[{'article': 'PMC4890804.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
391,8,Amyloid Plaques (Aβ),"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of cerebral Aβ burden in Alzheimer's Disease""}]"
390,8,Amyloid PET-CT,"[{'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}]"
389,8,Amyloid PET testing,"[{'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Identify individuals at higher risk of developing Alzheimer's Disease or dementia""}]"
388,8,Amyloid PET scan,"[{'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical stage of Alzheimer's Disease""}]"
387,8,Amyloid PET positivity,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
386,8,Amyloid PET imaging with 18F–FDDNP,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease in individuals with Down Syndrome""}]"
385,8,Amyloid PET imaging,"[{'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of prodromal Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Target engagement and amyloid accumulation'}]"
384,8,Amyloid PET biomarkers,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early amyloid deposition in Alzheimer's Disease""}]"
561,8,Aβ plaques,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic stripping in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Disease progression in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'REDUCES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduced Aβ plaque formation in AD animal models'}]"
405,8,Amyloid biomarkers,"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Prodromal Alzheimer's Disease""}]"
381,8,Amyloid Centiloid,"[{'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
406,8,Amyloid burden,"[{'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in the brain'}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction in accumulation with high-dose IV crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target engagement in the central nervous system'}, {'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive reserve dysfunction'}]"
408,8,Amyloid deposition,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
429,8,Amyloid-PET,"[{'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
428,8,Amyloid β42,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
427,8,Amyloid β-protein (Aβ),"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
426,8,Amyloid β precursor protein,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory endothelial dysfunction and risk of cognitive decline'}]"
425,8,Amyloid β peptide (Aβ),"[{'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}]"
424,8,Amyloid β (Aβ) plaques,"[{'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
423,8,Amyloid β (Aβ),"[{'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to indomethacin treatment in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
422,8,Amyloid β,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
421,8,Amyloid tracer uptake,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
420,8,Amyloid status,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
419,8,Amyloid scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
418,8,Amyloid precursor protein (APP),"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
417,8,Amyloid positivity,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
416,8,Amyloid plaques (Aβ1–42),"[{'article': 'PMC4659639.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Increased amyloid plaques with age in transgenic mice'}]"
415,8,Amyloid plaques,"[{'article': 'PMC10704137.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD'}, {'article': 'PMC8043748.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reduction of amyloid plaques in AD'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
414,8,Amyloid plaque deposition,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
413,8,Amyloid peptide,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
412,8,Amyloid oligomers,"[{'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
411,8,Amyloid neuropathology,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
410,8,Amyloid levels,"[{'article': 'PMC6448216.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
409,8,Amyloid deposits,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
558,8,Aβ peptides,"[{'article': 'PMC3226277.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in plasma Aβ peptides associated with drug exposure'}, {'article': 'PMC4780148.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic interventions'}, {'article': 'PMC4875639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Amyloid-lowering therapies'}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotoxic effects leading to neuronal death'}]"
395,8,Amyloid accumulation,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
527,8,Aß amyloid deposits,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3909,8,amyloid-β (Aβ),"[{'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid accumulation'}]"
3912,8,amyloid-β plaques,"[{'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3901,8,amyloid peptides,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
2735,8,PET-quantified Aβ,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
220,8,APP and Aβ,"[{'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotoxicity in Alzheimer's Disease""}]"
3900,8,amyloid pathology,"[{'article': 'PMC6152871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
3920,8,anti-Aβ antibodies,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3899,8,amyloid deposition,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3898,8,amyloid beta peptides burden,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slower gait speed, increased stance time variability, less cadence, and increased double support time'}]"
3271,8,Soluble Aβ,"[{'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive deficits in Alzheimer's Disease""}]"
3272,8,Soluble Aβ protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early-onset Alzheimer's Disease""}]"
3902,8,amyloid plaque deposition,"[{'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3273,8,Soluble Aβ40,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3897,8,amyloid beta peptides accumulation,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3896,8,amyloid beta peptides,"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'preservation of neuroplasticity'}]"
3908,8,amyloid-β,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'interaction effects on tau-WM association patterns'}, {'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""preclinical Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'tau accumulation'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'spread of tau from hippocampus to cortex'}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3895,8,amyloid accumulation,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
3894,8,amyloid Positron Emission Tomography,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3893,8,amyloid PET imaging,"[{'article': 'PMC10013957.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Clinical decision-making in Alzheimer's Disease""}]"
3891,8,amyloid PET,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment planning for Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
3890,8,amyloid,"[{'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral amyloid levels in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3911,8,amyloid-β levels,"[{'article': 'PMC6909550.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to gantenerumab treatment'}]"
3552,8,Thal amyloid phase,"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3274,8,Soluble Aβ42,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3903,8,amyloid plaques,"[{'article': 'PMC4052448.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of Treatment: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Structural changes in the brain, including hippocampal volume loss and decreased glucose metabolism'}]"
3231,8,Serum amyloid A [SAA],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
38,8,18F-flutemetamol (amyloid-β),"[{'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid-β pathology in Alzheimer's Disease""}]"
3907,8,amyloid-beta deposits,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3073,8,Retinal Aβ,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}]"
4620,8,β-amyloid proteins,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4619,8,β-amyloid protein,"[{'article': 'PMC5372260.txt', 'relationship': 'REDUCES', 'object': 'β-amyloid protein or its toxicity'}]"
4618,8,β-amyloid plaques,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased β-amyloid plaques in Alzheimer's Disease""}]"
4617,8,β-amyloid aggregates,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased β-amyloid aggregates in Alzheimer's Disease""}]"
3906,8,amyloid-beta,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment with Lecanemab in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-beta positive subjects with mild cognitive impairment due to AD or mild AD dementia'}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
4616,8,β-amyloid (Aβ),"[{'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synapse loss and further Aβ production'}, {'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ production and synapse loss'}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4615,8,β-amyloid (1-42),"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3230,8,Serum amyloid A (SAA),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'greater preservation of function'}]"
2898,8,Plasma amyloid β,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4614,8,β-amyloid,"[{'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive deficits in Down Syndrome mice'}, {'article': 'PMC4526582.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Aducanumab'}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Hippocampal Atrophy in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hippocampal atrophy in Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Boosted clearance from the brain, potentially delaying neuropathological progression'}, {'article': 'PMC7995588.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Alzheimer's Disease""}]"
3954,8,beta-amyloid,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""reduced formation in Alzheimer's Disease treatment""}]"
3910,8,amyloid-β 42/40 ratio,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3951,8,beta amyloid,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
2868,8,Pittsburgh compound B (PiB) amyloid imaging,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
3904,8,amyloid precursor protein,"[{'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3956,8,beta-amyloid1–42 peptide,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2876,8,Plasma Amyloid-β (Aβ),"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Aβ burden in the brain'}]"
3913,8,amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3955,8,beta-amyloid levels,"[{'article': 'PMC9635167.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Treatment efficacy in Alzheimer's Disease""}]"
2879,8,Plasma Aβ seeding activity,"[{'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
3905,8,amyloid β,"[{'article': 'PMC4493418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4609,8,β amyloid,"[{'article': 'PMC4826954.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with better outcomes in Alzheimer's Disease through potential prevention, interruption, or elimination of β amyloid accumulation.""}]"
4161,9,gamma oscillations,"[{'article': 'PMC8690894.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'tACS treatment effects'}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}]"
4160,9,gamma activity,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Transcranial alternating current stimulation (tACS)'}]"
1729,9,Gamma oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved tactile sensations'}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Local network activity and learning and memory processes'}, {'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improvement in cognitive function in Alzheimer's Disease patients""}]"
1731,9,Gamma spectral power,"[{'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3284,9,Spectral power distribution,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
3962,10,brain MRI,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3328,10,Structural MRI,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}]"
2307,10,MRI,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Predicts: Future cognitive decline and conversion to AD'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and progression of Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Supports diagnostic assessment of CBS and other heterogeneous disorders'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Hippocampal atrophy in Down Syndrome'}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early diagnosis of pathological cognitive decline'}, {'article': 'PMC4822297.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Amyloid-related imaging abnormalities (ARIA)'}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Regional atrophy and disease progression'}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Typical AD (amnestic multidomain dementia)'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5642413.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Atrophy progression in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early functional changes in striatum and hippocampus'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Structural imaging and quantitative analysis of atrophy in mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain plasticity and structure in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Episodic memory impairment in mild cognitive impairment and AD'}, {'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring structural changes in the brain during PE treatment'}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Volume loss in subcortical structures'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Structural changes in Alzheimer's Disease such as cerebral atrophy and ventricular enlargement""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Hippocampus volume stabilization in Alzheimer's Disease patients""}, {'article': 'PMC9606044.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'response to PE treatment in AD patients'}]"
2330,10,MRI-derived structural measures,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]"
2329,10,MRI-derived measures,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No detectable structural brain changes'}]"
2327,10,MRI-based biomarkers,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
2324,10,MRI scans,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and staging of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}]"
2320,10,MRI measures,"[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}, {'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2319,10,MRI measurements,"[{'article': 'PMC7001626.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Alzheimer's Disease progression and treatment response""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]"
2351,10,Magnetic Resonance Imaging (MRI),"[{'article': 'PMC8733254.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring Alzheimer's Disease progression""}, {'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral atrophy in Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2315,10,MRI biomarkers,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2310,10,MRI Biomarkers,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}]"
2316,10,MRI findings,"[{'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced insular cortical thinning and more preserved hippocampi compared to prodromal Alzheimer's disease patients""}]"
1515,11,FCRT,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal episodic memory deficits in Alzheimer's Disease""}]"
1636,11,Fronto-Parietal Network (FPN),"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
1561,11,FYN,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neuronal Sensitivity to Excitotoxicity'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]"
1552,11,FPN,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
1551,11,FPG,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]"
1541,11,FFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1658,11,Fyn,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Saracatinib (AZD0530)'}]"
1540,11,FFA,"[{'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease patients""}]"
1516,11,FCSRT,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Decline in FCSRT scores indicates presence of Alzheimer's Disease.""}]"
1425,12,ELoc,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Changes in ELoc values are associated with brain network efficiency in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1456,12,Eloc,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Eloc values are associated with local efficiency in brain networks of Alzheimer's Disease patients""}]"
4108,12,eNOS,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3750,12,WASO,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4206,12,iNOS,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Not significantly reduced due to variability'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of toxic microglial enzyme in AD mice'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]"
1760,13,Glial fibrillary acidic protein (GFAP),"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4055,13,cerebrospinal fluid (CSF) GFAP levels,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of Alzheimer's Disease through association with p-tau181 levels""}]"
4429,13,plasma GFAP levels,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of Alzheimer's Disease through association with p-tau181 levels""}]"
2890,13,Plasma GFAP,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β (Aβ) pathology'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
1759,13,Glial activation biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1758,13,Glia-derived nexin (GDN),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]"
3987,14,cathepsin L,"[{'article': 'PMC5445077.txt', 'relationship': 'INCREASES_α-SECRETASE-MEDIATED_NON-AMYLOIDOGENIC_PATHWAY', 'object': 'In AD development'}]"
1020,14,Cathepsin L,"[{'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alpha-secretase activity and Aβ suppression in Alzheimer's Disease""}]"
1014,14,Catalase,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of catalase during osteogenesis in human MSCs'}]"
3985,14,catalase,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3986,14,cathepsin B,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_AMYLOID_PLAQUES_IN', 'object': 'AD brains'}]"
1019,14,Cathepsin B,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Amyloid plaques and Aβ levels in Alzheimer's Disease""}]"
1661,15,GABA,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Synaptic alteration in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
2526,15,NOSGER,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia screening'}]"
2525,15,NOS,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
3828,15,Yokukansan,"[{'article': 'PMC3097009.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1810,15,Guanfacine,"[{'article': 'PMC9340683.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}]"
1836,15,HOMA-B,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Beta-cell dysfunction in Alzheimer's Disease""}]"
325,15,Akkermansia,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced Aβ42 levels'}]"
1837,15,HOMA-IR,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Insulin resistance in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin resistance in Alzheimer's Disease patients""}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1694,16,GR/GPx ratio,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}]"
2615,16,Norton scale,"[{'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality'}]"
3297,16,Standardized Uptake Value (SUV),"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1808,16,Grober–Buschke scale,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Episodic memory in Alzheimer's Disease""}]"
2336,16,MTA-scale,"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2466,16,Motor Threshold (MT),"[{'article': 'PMC10439779.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""rTMS treatment intensity in Alzheimer's Disease""}]"
3196,16,SUVr (Standardized Uptake Value Ratio),"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}]"
1640,16,Frontotemporal behaviour scale,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dysexecutive behavioural syndrome in Alzheimer's Disease""}]"
3816,17,Word-finding difficulties,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild Cognitive Impairment and Alzheimer's Disease""}]"
3064,17,Repeated Words,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1387,17,Dubois’ five-word test,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
1204,17,Correct-word scores,"[{'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
3817,17,Words per clause,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4578,17,typical word usage,"[{'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}]"
3814,17,Word Typicality,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1588,17,Five-word test,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}]"
1041,18,Cereb,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
909,18,CES-D,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
457,18,Anti-dementia drugs,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Survival advantage in Alzheimer's Disease""}]"
905,18,CERAD Word List,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]"
907,18,CERAD neuritic plaque score,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
904,18,CERAD,"[{'article': 'PMC7001626.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
902,18,CE,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β associated with Alzheimer's Disease""}]"
116,18,AD pathology,"[{'article': 'PMC6110931.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
908,18,CERAD score,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1031,18,Ceftriaxone,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]"
362,18,Alzheimer’s disease,"[{'article': 'PMC8436545.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]"
360,18,Alzheimer’s Disease Co-operative Study – Activities of Daily Living Inventory,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in activities of daily living in participants with mild to moderate Alzheimer's disease""}]"
910,18,CES-D scale,"[{'article': 'PMC3978714.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Depression in Alzheimer's Disease""}]"
1567,18,Family history of dementia,"[{'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}]"
118,18,AD-GRS (Alzheimer's Disease Genetic Risk Score),"[{'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""dementia probability and memory functioning in Alzheimer's Disease""}]"
351,18,Alzheimer type neuropathologic change,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
349,18,Alzheimer Disease Cooperative Study–Activities of Daily Living (ADCS-ADL),"[{'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Functional impairment reduction'}]"
361,18,Alzheimer’s Disease Cooperative Study—Activity of Daily Living total score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improvement in daily living activities in Alzheimer's Disease""}]"
774,19,Body Mass (BM),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
706,19,BMI,"[{'article': 'PMC10306194.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""No significant reduction in BMI-related risk for Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain Atrophy and Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavior change and improved clinical outcomes in Alzheimer's Disease risk reduction""}, {'article': 'PMC4987494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Reducing BMI can lower the risk of Alzheimer's Disease and other chronic diseases such as diabetes, heart disease, and stroke.""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Addressing BMI as part of a multifactorial intervention improves overall health and reduces the risk of Alzheimer's Disease.""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'BMI reduction during the study'}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Desirable lowering of BMI'}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Physical health indicators in Alzheimer's Disease""}, {'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher BMI in the AHF group compared to the NGF group (22.7 ± 3.3 vs. 21.4 ± 3.6, p = 0.042)'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline and dementia'}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3781,19,Weight,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3782,19,Weight loss,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Deep brain stimulation (DBS)'}]"
2636,19,Obesity,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]"
775,19,Body weight,"[{'article': 'PMC4353453.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment response prediction in Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}]"
3593,19,Total fat mass,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2819,19,Peripheral adiposity,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4595,19,weight loss,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD-related cognitive decline'}]"
3120,20,SBD,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3494,20,TYROBP,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune module""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3121,20,SBP,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in systolic blood pressure'}]"
3649,20,Tyrobp,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2161,20,LAL,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Autophagy-lysosomal cascade functionality'}]"
2360,21,Mattis dementia Rating Scale (DRS),"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognition in Alzheimer's Disease""}]"
730,21,Behavior Rating Scale for dementia,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Behavioral disturbances in Alzheimer's Disease""}]"
1328,21,Dementia Mood Assessment Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression severity in Alzheimer's Disease""}]"
2991,21,Quick dementia Rating Scale (QDRS),"[{'article': 'PMC9552361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and staging of Alzheimer’s disease and related disorders (ADRD)'}]"
1138,21,Clinical Dementia Rating scale,"[{'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Dementia severity in Alzheimer's Disease""}]"
1365,21,Discomfort Scale - dementia of Alzheimer Type,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Discomfort in Alzheimer's Disease patients""}]"
1364,21,Disability Assessment dementia (DAD) scale,"[{'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dependency levels in Persons with Dementia (PwD)'}]"
1203,21,Cornell Scale for Depression in dementia,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease patients""}]"
356,21,Alzheimer’s Disease Assessment Scale,"[{'article': 'PMC3407718.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
355,21,Alzheimer's Mood Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Mood changes in Alzheimer's Disease""}]"
1363,21,Disability Assessment dementia (DAD),"[{'article': 'PMC7413274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Functional status in dementia'}]"
1259,21,DAD scores,"[{'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Functional decline: Slower progression in galantamine-treated patients'}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality: Lower rates in galantamine-treated patients'}]"
2247,22,MADRS,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
158,22,AIS,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Insomnia Disorder in Alzheimer's Disease""}]"
1440,22,ESS,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Excessive Daytime Sleepiness in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3385,22,TBARS,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in mTBI'}]"
3387,22,TBV,"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in stroke survivors'}]"
3028,22,ROS,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses and oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: High ROS levels inhibit MSC self-renewal, differentiation, and proliferation'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1560,22,FUS,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative diseases'}]"
3804,23,"White matter microstructure metrics (FA, MD, Da, Dr, ICVF, OD)","[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3332,23,Subcortical white-matter hyperintensities,"[{'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Associated with functional impairments in Alzheimer's Disease""}]"
4178,23,grey matter atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3802,23,White matter integrity,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1803,23,Grey matter atrophy,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]"
3798,23,White matter hyperintensity lesions,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]"
3773,23,WML (White Matter Lesions),"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower cerebral spinal fluid Aβ38 and Aβ40 levels in Alzheimer's Disease""}]"
3801,23,White matter imaging markers,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Gait velocity decline'}]"
1347,23,Diffusion tensor imaging measures of white matter integrity,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]"
3791,23,White matter atrophy,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Executive function deficits'}]"
1371,23,Disruption of limbic white matter pathways,"[{'article': 'PMC7477392.txt', 'relationship': 'CAUSES', 'object': 'Decreased glucose metabolism in parietal and temporal cortices'}]"
2213,23,Lesions Load,"[{'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3795,23,White matter hyperintensities (WMH) in the splenium of the corpus callosum,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Greater Aβ deposition'}]"
3794,23,"White matter hyperintensities (WMH) in the posterior corpus callosum, parietal, occipital, and frontal areas","[{'article': 'PMC7814451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower temporo-parietal glucose metabolism'}, {'article': 'PMC7814451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower medial-temporal gray matter volume (GMV)'}]"
4274,24,miR-301a-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4287,24,miRNAs,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aging and Alzheimer's Disease""}]"
4269,24,miR-16,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]"
4272,24,miR-2467-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4271,24,miR-19a-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4286,24,miRNA-33,"[{'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ metabolism in AD'}]"
4285,24,miRNA-146a,"[{'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Immune responses in AD'}]"
4270,24,miR-16-5p,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4275,24,miR-3132,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4273,24,miR-25802,"[{'article': 'PMC11274940.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Survival: AD-related pathology'}]"
4268,24,miR-155,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Limiting AD pathology and maintaining cognitive function'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'MGnD-induced phenotypic reversion and cognitive function'}]"
4284,24,miR-623,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2439,24,Mir107,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Amild cognitive impairment (aMCI) associated with Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early biomarker for Alzheimer's Disease""}]"
4279,24,miR-4649-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4280,24,miR-4761-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4281,24,miR-495-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4267,24,miR-124,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4283,24,miR-5682,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4282,24,miR-543,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4276,24,miR-411-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4278,24,miR-4513,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4277,24,miR-4303,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1267,25,DC8E8 antibody,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treat: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treat: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for: Alzheimer's Disease treatment""}]"
1453,25,Elecsys® immunoassay,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1424,25,ELISA Anti-HIV Test,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2044,25,IgG Antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
69,25,4G8 antibody,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid-beta plaques'}]"
2046,25,IgG antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathological tau protein in Alzheimer's Disease""}]"
2047,25,IgG antibody levels,"[{'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to AADvac1'}]"
2051,25,IgG1 and IgG3 antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Alzheimer's Disease""}]"
2019,26,INFγ,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
1970,26,IFN-γ secretion,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2106,26,"Interferon gamma induced protein 10 [IP-10, CXCL10]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1969,26,IFN-γ,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Immune response in Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced IFN-γ levels in peripheral plasma and improved cognition defects'}]"
2107,26,Interferon-gamma [IFN-γ],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2108,26,Interferon-γ,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]"
4630,26,γH2AX,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No DNA damage after TI stimulation'}]"
2018,26,INF-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1972,26,IFNγ,"[{'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in Alzheimer's Disease risk through anti-inflammatory effects in the brain""}]"
2708,27,PCC metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4243,27,lower resting cortical metabolism,"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4266,27,metabolism intensity,"[{'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'PE treatment in AD patients'}]"
1235,27,Ctrough (Plasma drug concentration),"[{'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}]"
2396,27,"MetS components (waist circumference, triglyceride, HDL, hypertension, fasting glucose)","[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain aging and neurodegenerative disorders, including Alzheimer's disease""}]"
2397,27,Metabolic Syndrome (MetS),"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1743,27,Generalized low uptake on SPECT/PET perfusion/metabolism scan,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
3021,27,RMR (Resting Metabolic Rate),"[{'article': 'PMC4922661.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Energy expenditure in Alzheimer's Disease patients""}]"
4117,27,energy expenditure,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2712,27,PCUN metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3002,28,RAVLT Del,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]"
3038,28,Rab7,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3037,28,Rab3,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3039,28,Rac1,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4293,28,mid temporal volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3000,28,RAVL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2996,28,RAK1,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2994,28,RAB27A,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2418,28,Mid temporal (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4427,28,planum temporale in STG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4561,28,temporal pole,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3001,28,RAVLT,"[{'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive function related to Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Disease progression in amild cognitive impairment group'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
2744,29,PI3K,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2163,29,LAMP2,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2162,29,LAMP1,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2220,29,Lgals3,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]"
4635,29,λk3,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4414,29,phospho-PI3K,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3765,30,WMH accumulation,"[{'article': 'PMC6521224.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3758,30,WM,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3759,30,WM alterations,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3760,30,WM degeneration,"[{'article': 'PMC8364310.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3763,30,WMH,"[{'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and dementia risk'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive dysfunction and cognitive flexibility impairment'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}, {'article': 'PMC8351379.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrovascular disease'}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive Decline'}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Greater cognitive deficits in African Americans'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Vascular cognitive impairment'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Poor cognitive outcomes'}, {'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Poor cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Aβ burden and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'AD-typical neurodegeneration'}]"
3749,30,WAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3767,30,WMH presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decline in gait velocity over time in Alzheimer's Disease""}]"
3768,30,WMH progression,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3770,30,WMHV,"[{'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Amyloid-beta (Aβ) burden'}, {'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cortical tau load in AD'}, {'article': 'PMC10233712.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Intranasal insulin treatment'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsened cognitive scores (ADAS-Cog, ADCS-ADL, CDR-SOB)'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Decreased cerebral spinal fluid Aβ42 levels and Aβ42/Aβ40 ratio'}, {'article': 'PMC10233712.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Insulin treatment'}]"
3771,30,WMHs,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'PREDICTS_INCIDENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cerebral Aβ burden'}, {'article': 'PMC7477392.txt', 'relationship': 'NOT_ASSOCIATED_WITH', 'object': 'Increased p-tau burden'}, {'article': 'PMC7477392.txt', 'relationship': 'CONTRIBUTES_TO', 'object': 'Brain atrophy patterns in AD'}, {'article': 'PMC7477392.txt', 'relationship': 'CAUSE', 'object': 'Disruption of functional connectivity and lower glucose metabolism'}]"
1302,30,DWMH,"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease based on white matter hyperintensity severity""}]"
3766,30,WMH burden,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Development of AD'}, {'article': 'PMC7477392.txt', 'relationship': 'NEGATIVELY_CORRELATED_WITH', 'object': 'Regional glucose metabolism in frontal, temporal, and parietal cortices'}]"
3812,30,Wnt3,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3775,30,WMS-III,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3811,30,Wnt signaling,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Modulation in Alzheimer's Disease""}]"
3776,30,WMS-VR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3777,30,WST,"[{'article': 'PMC5016950.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline related to Alzheimer's Disease""}]"
2791,30,PWMH,"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease based on white matter hyperintensity severity""}]"
1937,31,Huperzine A,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]"
4250,31,mSOA,"[{'article': 'PMC4407573.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2628,31,O3PUFA,"[{'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less executive decline and fewer white matter hyperintensities (WMH)'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Better executive function and reduced white matter hyperintensity volume'}, {'article': 'PMC3863786.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive function as measured by Trail Making Test Part B, WMS-R Logical Memory Story delayed, and MMSE'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less executive decline (Trails B)'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better executive function (Trail Making Test Part B)'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less white matter hyperintensity (WMH) burden'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Deceleration in executive decline trajectory'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better executive function'}, {'article': 'PMC3863786.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Executive function decline'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive dysfunction'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive decline'}]"
2629,31,OA,"[{'article': 'PMC6921051.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4336,31,oVEMP,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
320,31,AgRP,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ levels in AD mouse models'}]"
2631,31,OEF,"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4482,31,sMRI,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
1679,32,GFAP,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytic reactivity in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}, {'article': 'PMC4847010.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression'}, {'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Astrocytic cells in the dentate gyrus (DG)'}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Astrocyte reactivity surrounding Aβ deposits'}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in preclinical AD'}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Aβ deposition as quantified by Aβ PET'}, {'article': 'PMC8524356.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Selection: Distinguishing Aβ status with high AUC'}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ+ from Aβ– individuals with high accuracy'}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early reactive astrocytes in preclinical Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Astrocyte reduction'}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': 'Presence of: Neuroinflammation and Aβ pathology'}, {'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No astrocyte activation after TI stimulation'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrogliosis in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1678,32,GDS,"[{'article': 'PMC4200223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved GDS scores correlate with better quality of life in Alzheimer's Disease patients""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Depression in Alzheimer's Disease patients""}, {'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Geriatric Depression in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Geriatric Depression in Alzheimer's Disease""}]"
1695,32,GRN,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of amyloid plaque pathology and preservation of hippocampal neurons in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Onset of late-stage AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Lowered plaque load and prevented spatial memory deficits.'}]"
1677,32,GDNF,"[{'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Neuroprotection'}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Exercise blocks the surgery-induced decrease in GDNF levels in the hippocampus, suggesting its role in regulating immune and inflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: GDNF attenuates surgery-induced immune and inflammatory responses, which are important for POCD development'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Surgery-induced cognitive impairment in mice'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Neuroinflammation and reduction in brain cell genesis'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Neuroprotection and Reduced Cognitive Dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Brain response to surgery and treatment'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}]"
1676,32,GDN,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and neurite outgrowth'}]"
1674,32,GCLC,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]"
1668,32,GAD67,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1667,32,GAD,"[{'article': 'PMC3534053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Estrogen levels in ovariectomized rats'}]"
1696,32,GRP78,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1711,32,Gad67,"[{'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Loss of hippocampal GABAergic interneurons in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Kgp inhibitor COR271'}, {'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Hippocampal interneuron health in Alzheimer's Disease""}]"
333,33,Allobaculum,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1870,33,Helicobacteraceae,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]"
1869,33,Helicobacter,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]"
4238,33,locus coeruleus (LC),"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of depression in Alzheimer's Disease""}]"
2243,33,Lycium barbarum extract,"[{'article': 'PMC3097009.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3097009.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2083,33,Infliximab,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]"
2920,33,Polygonum multiflorum Thunb.,"[{'article': 'PMC4471648.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
734,33,Benson Figure Copy,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]"
1733,33,Gantenerumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III clinical trials in mild AD'}]"
3669,34,Uric acid,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Semagacestat treatment'}]"
3668,34,Urea,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2476,34,Myristic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1727,34,Gallic acid,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1726,34,Gallic Acid,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]"
1579,34,Ferulic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}]"
813,34,Butyric acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}]"
2560,34,Nervonic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive performance (attention and language domains) in Alzheimer's Disease""}]"
2954,34,Propionic acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1933,34,Homovanillic Acid,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Nilotinib treatment'}]"
3170,35,SOD2,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of SOD2 during osteogenesis in human MSCs'}]"
3167,35,SOD,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher SOD levels in intervention groups'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response in mTBI'}, {'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating mild cognitive impairment from healthy controls'}]"
3168,35,SOD activity,"[{'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased antioxidant defense mechanisms'}]"
3279,35,Sorcs1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
3171,35,SOD3,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in SOD3 levels during chondrogenesis'}]"
3172,35,SOM,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher levels of Aβ1–42 in Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'All-cause and cardiovascular mortality'}, {'article': 'PMC6174237.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]"
3174,35,SORL1,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3280,35,Souvenaid,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
3173,35,SORCS1,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}]"
3169,35,SOD1,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}]"
1465,36,Entorhinal (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1466,36,Entorhinal Cortical Thickness,"[{'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1467,36,Entorhinal cortex thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Mortality: Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1468,36,Entorhinal cortex volume,"[{'article': 'PMC4811920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1469,36,Entorhinal cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]"
1470,36,Entorhinal thickness,"[{'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4082,36,cortical thickness of the entorhinal cortex,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1218,36,Cortical thickness in entorhinal cortex,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1471,36,Entorrhinal cortex volume,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Cognitive decline'}]"
4120,36,entorhinal cortex thickness,"[{'article': 'PMC4846650.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Advanced clinical symptoms of Pre-AD'}]"
4121,36,entorhinal volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4119,36,entorhinal cortex,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]"
1446,37,Eglob,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Eglob values reflect global efficiency in brain networks of Alzheimer's Disease patients""}]"
1448,37,Egr3,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}]"
1423,37,EGlob,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improvements in EGlob values reflect better brain network global efficiency in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1422,37,EGCG,"[{'article': 'PMC4675859.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Combined with EE for spatial learning and memory deficits in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection for improving hippocampal-dependent spatial learning'}, {'article': 'PMC4675859.txt', 'relationship': 'RESPONDED_TO', 'object': 'Improved learning performance in Ts65Dn mice'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1421,37,EFEs+,"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Impairment in Alzheimer's Disease""}]"
1419,37,EFE+,"[{'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in neurodegenerative disorders'}]"
1442,37,EWS,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1401,37,ECog,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess gait in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}]"
1447,37,Egr-3,"[{'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""BDNF Signaling in Alzheimer's Disease""}]"
1418,37,EFE,"[{'article': 'PMC10092214.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduced positive emotional response to music with disease progression in Alzheimer's Disease""}]"
3158,38,SLUMS,"[{'article': 'PMC7745768.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia range in Alzheimer's Disease""}]"
4241,38,lowSWE,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3157,38,SLIs,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}]"
3156,38,SLI,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4182,38,high-sensitivity C-reactive protein,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
3114,38,SAA,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
819,38,C-reactive protein (CRP),"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
820,38,C-reactive protein (CRP) levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
821,38,C-reactive protein [CRP],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3115,38,SAFr,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""lower cognitive performance in Alzheimer's Disease""}]"
1883,38,High-sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3202,38,SWA,"[{'article': 'PMC9053232.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Auditory stimulation effects on Alzheimer's Disease""}]"
814,38,C reactive protein,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
1882,38,High-sensitivity C-Reactive Protein (hsCRP),"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}]"
3234,38,Serum high sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation levels in Alzheimer's Disease""}]"
3203,38,SWF,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
4239,38,lowSWA,"[{'article': 'PMC9053232.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Strong responders to auditory stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to auditory stimulation during sleep'}, {'article': 'PMC9053232.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhancement of slow-wave activity due to stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Auditory deep sleep stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Slow-wave enhancement for patients with Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Consideration of stimulation approaches in clinical trials for Alzheimer's Disease""}]"
3235,38,Serum high-sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2640,39,Olig2,"[{'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oligodendrocyte progenitor cells in Alzheimer's Disease""}]"
2498,39,NCAM2,"[{'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased proteolysis in AD hippocampus'}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Synaptic accumulation and proteolysis in Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cleavage of NCAM2 in AD brains, particularly in synaptosomes'}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4674770.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neuronal response to Aβ1-42 treatment'}, {'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3143,39,SHIP2,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2724,39,PEN2,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
934,39,CMRO2,"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1955,39,I2PP2A,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through inhibition of PP2A activity""}]"
1954,39,I2BS,"[{'article': 'PMC8481830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocytosis in Alzheimer's Disease""}]"
2551,39,Navβ2,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
866,39,CD2AP,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
867,39,CD2AP SNP rs9349407,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased neuritic plaque pathology'}]"
3492,39,TXB2,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular dynamics and inflammation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}]"
3520,40,Tau phosphorylation,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]"
3505,40,Tau PET pathology,"[{'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3519,40,Tau phosphorylated at threonine 181 (p-tau181),"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4351,40,p-Tau181,"[{'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster progression of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4352,40,p-tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between CA1 volume and retroactive interference (RI)'}, {'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau-related pathology progression in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in p-tau related to cognitive decline'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment effect in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant treatment effect observed'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No treatment effect'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to aducanumab treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to gantenerumab treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Lecanemab treatment response'}]"
4353,40,p-tau (phosphorylated tau proteins),"[{'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
3518,40,Tau phosphorylated at threonine 181,"[{'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4424,40,phosphorylated tau (ptau),"[{'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3517,40,Tau phosphorylated at Ser235 (MC6),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2847,40,Phosphorylated-Tau (p-Tau) in blood,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of tau burden in the brain and CSF'}]"
4354,40,p-tau depositions,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
3516,40,Tau phosphorylated at Ser202/Thr205 (AT8),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3515,40,Tau pathology,"[{'article': 'PMC4995360.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2660,40,P-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4571,40,total tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2662,40,P-tau181,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid P-tau181 and tau PET imaging parameters'}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnostic of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential dementia diagnosis'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4552,40,tau-p181,"[{'article': 'PMC9202553.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3503,40,Tau Neurofibrillary tangles,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic loss and cognitive decline'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4350,40,p-Tau ser396,"[{'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2627,40,N‐p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4184,40,higher t-tau and p-tau levels,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3599,40,Total tau (t-Tau),"[{'article': 'PMC4487699.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4548,40,tau proteins,"[{'article': 'PMC7662091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4362,40,p-tau181 (CSF),"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4361,40,p-tau181,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Abnormal brain amyloid-β status'}, {'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent decreases in p-tau181 concentration in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic interventions in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression and cognitive decline'}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in adults with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease pathology""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease progression""}, {'article': 'PMC8280160.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts Alzheimer's Disease pathology""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in adults with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher levels associated with worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC8280160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Cortical atrophy and brain hypometabolism'}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Predict: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guide treatment selection: Anti-tau compounds in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor drug effects on tau pathology in clinical trials'}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Confirm AD diagnosis'}, {'article': 'PMC8416781.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'AD diagnosis and patient recruitment into clinical trials'}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'AD neurodegeneration as measured by FDG-PET and grey matter volume'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid and tau pathology in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Therapy response in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Intermediate to high Consortium to Establish a Registry for Alzheimer's Disease neuritic plaques and Braak tau stages""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from non-AD dementia'}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease neuropathologic changes""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ status in Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in African Americans'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No change during treatment'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early detection of AD'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'PET amyloid and tau pathology, predicts AD dementia progression'}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher levels in married participants compared to non-married participants'}, {'article': 'PMC9716660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Changes in levels over time during intervention'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Plasma biomarker measured using a commercially validated single molecule array (Simoa) assay developed by Quanterix'}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slower cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Lecanemab treatment response'}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment effects and disease state'}]"
4425,40,phosphorylated-tau,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3598,40,Total tau (T-tau),"[{'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroaxonal degeneration in Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}]"
2846,40,Phosphorylated-Tau (P-Tau),"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2663,40,P-tau181P,"[{'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4360,40,p-tau(231),"[{'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3597,40,Total tau,"[{'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic effects of hUCB-MSC injection'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4573,40,total tau protein,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1193,40,Conformationally changed Tau (MC1),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3521,40,Tau protein,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome: Rapid cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegenerative changes in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'SUPPORTS_INTERVENTION', 'object': ""Intervention: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary tangles'}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Reduction of tau protein accumulation through 40-Hz auditory stimulation'}, {'article': 'PMC9539040.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function in patients with AD'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3501,40,Tau (t-tau and p-tau181),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3502,40,Tau (total tau and phosphorylated tau),"[{'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4572,40,total tau (t-tau),"[{'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]"
2626,40,N‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4359,40,p-tau(217),"[{'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3600,40,Total tau (t-tau),"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2664,40,P-tau217,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early AD brain pathology'}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early preclinical stages of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early stages of AD when insoluble tau aggregates are not yet detectable by tau-PET'}, {'article': 'PMC7653537.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Monitoring of treatment response in AD'}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology in the brain'}]"
1946,40,Hyperphosphorylated tau protein,"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4458,40,p‐tau181,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Predicts progression to cognitive impairment'}]"
2691,40,P301S Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4457,40,p‐tau (PHF),"[{'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
4456,40,p‐tau (AT8),"[{'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
2848,40,Phosphorylated-tau,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3510,40,Tau filaments,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary tangles'}]"
4523,40,t-Tau and p-tau181,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3509,40,Tau deposition,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2831,40,Phospho-Tau (181P),"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1940,40,Hyperphosphated tau protein,"[{'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
973,40,CSF P-Tau,"[{'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1944,40,Hyperphosphorylated tau (p-tau),"[{'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1941,40,Hyperphosphorylated Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1942,40,Hyperphosphorylated tau,"[{'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurovascular dysfunction and reduced energy supply'}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Near-infrared light treatment in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's disease-type dementia in Down syndrome individuals""}, {'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased hyperphosphorylated tau in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1943,40,Hyperphosphorylated tau (PHF1),"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
979,40,CSF t-tau,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
978,40,CSF p-tau(181),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4459,40,p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4460,40,p‐tau231,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early preclinical stage of Alzheimer's Disease""}]"
4526,40,t-tau in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3511,40,Tau formation,"[{'article': 'PMC6448216.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
3506,40,Tau Protein,"[{'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Vaccines or antibodies targeting tau protein'}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1945,40,Hyperphosphorylated tau (phospho-tau),"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2911,40,Plasma phosphorylated tau (p-tau),"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}]"
4355,40,p-tau in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4356,40,p-tau levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4357,40,p-tau pathology,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Memory performance and RI'}]"
2737,40,PG5 (Ser(P)409)-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2672,40,P181 tau,"[{'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2666,40,P-tau231,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3507,40,Tau accumulation,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
3513,40,Tau hyperphosphorylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2673,40,P181 tau (ptau),"[{'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2675,40,P231-Tau,"[{'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4358,40,p-tau(181),"[{'article': 'PMC8866346.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pathological cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3512,40,Tau fragments,"[{'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4549,40,tau tangles,"[{'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3508,40,Tau aggregates,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative disorders'}]"
2832,40,Phospho-Tau181,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3514,40,Tau isoforms,"[{'article': 'PMC4294473.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Disease-specific inclusion composition'}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1215,40,Cortical tau load,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'WMH burden'}]"
976,40,CSF p-tau,"[{'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Changes in phosphorylated tau (p-tau) levels in cerebral spinal fluid'}]"
4366,40,p-tau181Fuji,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2482,40,N-p-tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early amyloid-β pathology in cognitively unimpaired individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4540,40,tau hyperphosphorylation,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration and cell death in Alzheimer's Disease""}]"
4539,40,tau biomarkers,"[{'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression and prognosis in Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4345,40,p-Tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neurodegeneration and cognitive decline'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4346,40,p-Tau (Ser396),"[{'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
977,40,"CSF p-tau (T181, T217, T231)","[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
2836,40,Phosphor-tau181,"[{'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3921,40,anti-tau antibodies,"[{'article': 'PMC8088704.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapeutic development for Alzheimer's Disease""}]"
4347,40,p-Tau (Thr181),"[{'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2834,40,Phospho-tau181,"[{'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4348,40,p-Tau Ser 396,"[{'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}]"
2833,40,Phospho-tau (tau-p181),"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2842,40,Phosphorylated tau (p-tau(181)),"[{'article': 'PMC8866346.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Nonpathological (A−/T−/N−) cerebral spinal fluid profile'}]"
4553,40,tau-phosphorylated,"[{'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2423,40,Mid‐p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Early changes in preclinical Alzheimer's Disease""}]"
2422,40,Mid‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1557,40,FTD-4R tau,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mixed pathology in Alzheimer's Disease""}]"
4365,40,p-tau181ADx,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal Aβ status in Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2419,40,Mid-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (standard assay)""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2481,40,N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early amyloid-β pathology in cognitively unimpaired individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Levels reflect the presence of amyloid-β pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3601,40,Total tau protein,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4547,40,tau protein phosphorylation,"[{'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved Cognitive Functions'}]"
3602,40,Total-Tau,"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2839,40,Phosphorylated tau,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome: Rapid cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'RELATED_TO', 'object': 'Rapid progression toward AD'}]"
2840,40,Phosphorylated tau (P-tau),"[{'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain tangle pathology in Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4423,40,phosphorylated tau (p-tau181),"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]"
4422,40,phosphorylated tau (p-tau),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2838,40,Phosphorylated Tau (p-tau181),"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2837,40,Phosphorylated Tau,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Significant decrease following tACS'}]"
4542,40,tau pathology,"[{'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]"
4541,40,tau oligomers,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}]"
4554,40,tau-positive neuropil threads,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}]"
2259,40,MC1 (conformationally changed Tau),"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
4421,40,phosphorylated tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2841,40,Phosphorylated tau (P-tau181),"[{'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}]"
4419,40,phospho-tau,"[{'article': 'PMC4255368.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Selection of immunotherapy approaches'}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}]"
4417,40,phospho-Tau181,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (increased levels considered pathological)""}]"
3546,40,TgP301S Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4543,40,tau peptide fragments,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4544,40,tau phosphorylated at threonine 181 (p-tau),"[{'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
4545,40,tau phosphorylation,"[{'article': 'PMC4255368.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive and functional decline in Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced tau phosphorylation in Alzheimer's Disease mice treated with GV-971""}]"
3603,40,Total-Tau (T-Tau),"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4546,40,tau protein,"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Target for tau immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurofibrillary tangles and tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression and severity'}, {'article': 'PMC4255369.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased tau oligomers and tangles'}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: DC8E8 immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Targeting tau protein forms'}, {'article': 'PMC4255369.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Tau protein forms for immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in insoluble tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics: Decreased levels of insoluble tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Autophagic dysfunction in Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""reduced hyperphosphorylation in Alzheimer's Disease treatment""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5372260.txt', 'relationship': 'REDUCES', 'object': 'tau protein or its abnormal phosphorylation'}, {'article': 'PMC5372260.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'AADvac1 immunotherapy'}, {'article': 'PMC6201586.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: AADvac1 active vaccine'}, {'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurofibrillary tangles correlate with cognitive impairment and disease severity in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Hyperphosphorylated and abnormally folded tau protein contributes to neuronal death and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Development of Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Anti-tau drugs'}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4420,40,phospho-tau concentrations,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
4575,40,total-tau (t-tau),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2420,40,Mid-p-tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Higher accuracy in discriminating Aβ-positive from Aβ-negative individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3583,40,Total Tau,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4574,40,total-tau,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4550,40,tau-441,"[{'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2570,40,Neurofibrillary tangles (tau protein),"[{'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
4373,40,p-tau217WashU,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal Aβ status in Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression to Alzheimer's Disease Dementia""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4372,40,p-tau217Lilly,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1257,40,DA9-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
251,40,AT8 (Ser(P)202/Thr(P)205)-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
252,40,AT8-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4371,40,p-tau217Janss,"[{'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression to Alzheimer's Disease Dementia""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4370,40,p-tau217,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Abnormal brain amyloid-β status'}, {'article': 'PMC10115176.txt', 'relationship': 'PREDICTS', 'object': 'Future conversion to Alzheimer’s disease dementia (ADD)'}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'DIAGNOSTIC', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'PREDICTS_COGNITIVE_DECLINE', 'object': 'Preclinical cases of AD'}, {'article': 'PMC8416781.txt', 'relationship': 'DIFFERENTIATE', 'object': 'AD from controls and other tauopathies and neurodegenerative disorders'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Progression to Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Greater risk of progression to AD dementia in mild cognitive impairment patients'}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO_AD', 'object': 'Conversion to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Predictive marker for clinical progression to Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: AD progression'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Risk of conversion to AD dementia within 3 years'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict future decline in AD'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4349,40,p-Tau levels,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4369,40,p-tau181p,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2843,40,Phosphorylated tau (p-tau),"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4532,40,tTau levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2844,40,Phosphorylated tau (p-tau181),"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2972,40,P‐tau,"[{'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of motor symptoms as measured by UPDRS III'}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of cognitive executive function as measured by letter fluency'}]"
2845,40,Phosphorylated tau (p-tau181p),"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4368,40,p-tau181WashU,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4367,40,p-tau181P,"[{'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2830,40,Phospho-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3522,40,Tau protein tangles,"[{'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4374,40,p-tau231,"[{'article': 'PMC10115176.txt', 'relationship': 'PREDICTS', 'object': 'Future progression from mild cognitive impairment to ADD'}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Longitudinal cognitive decline and hippocampal volume changes'}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease diagnosis""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8043944.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline and neurodegeneration'}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': '1-year decrease in hippocampal volume and worsening MMSE scores'}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early tau deposition and disease progression'}, {'article': 'PMC8043944.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early tau deposition in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic trials targeting early Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Individuals at higher risk of Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Early Aβ deposition'}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurofibrillary tangles deposition in the entorhinal cortex'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early Aβ pathology before amyloid PET positivity'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4394,40,pTau Ser396,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4203,40,hyperphosphorylated tau protein,"[{'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3523,40,Tau proteins,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4392,40,pT181 tau protein,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4202,40,hyperphosphorylated tau,"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4375,40,p-tau231UGOT,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3524,40,Tau-P301L,"[{'article': 'PMC5516350.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
2462,41,Montreal Cognitive Assessment (MoCA),"[{'article': 'PMC10475546.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC8518196.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]"
2139,41,Jmild cognitive impairment S score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
1156,41,Cognitive Level (MMSE),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1159,41,Cognitive composite score,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
4071,41,cognitive measures,"[{'article': 'PMC4876902.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4067,41,cognitive assessments,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive decline in Alzheimer's Disease""}]"
1161,41,Cognitive disorders examination test,"[{'article': 'PMC3681660.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guide subjects with memory impairment to full memory consultations at hospitals'}]"
1162,41,Cognitive disorders examination test (CODEX),"[{'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4168,41,global cognitive status,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1164,41,Cognitive function (ADAS-cog),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in individuals with mild to moderate dementia'}]"
4072,41,cognitive performance,"[{'article': 'PMC4876902.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1167,41,Cognitive performance,"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
1170,41,Cognitive score,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1190,41,Composite z-scores for cognitive function,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive response to treatment in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
1171,41,Cognitive scores (ADAS-Cog11),"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}]"
1172,41,Cognitive scores (MMSE),"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
4323,41,neurocognitive measures,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}]"
1765,41,Global cognitive score,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}]"
1174,41,Cognitive test scores,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease based on cognitive decline""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2461,41,Montreal Cognitive Assessment,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]"
1175,41,Cognitive tests,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Cognitive impairment'}]"
313,41,Addenbrooke's Cognitive Examination (ACE) VL/OM ratio,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1308,42,Decreased alpha-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
337,42,Alpha power,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
336,42,Alpha oscillatory power,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3165,42,SO power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]"
741,42,Beta power,"[{'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Sleep quality assessment'}]"
739,42,Beta band,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Severe cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'PREDICTS', 'object': ""Development of Alzheimer's Disease""}]"
335,42,Alpha oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Transcranial alternating current stimulation (tACS)'}]"
334,42,Alpha band,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1407,42,EEG alpha power,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1309,42,Decreased beta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
20,43,18F-FDG PET,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Decline in relative CMRgl in Alzheimer disease–associated region'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES', 'object': 'Functional impairment of neurons'}, {'article': 'PMC9011335.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}]"
37,43,18F-fluorodeoxyglucose,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain metabolism in Alzheimer’s disease'}]"
1606,43,Fluorodeoxyglucose (FDG),"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
18,43,18F-FDG,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hypometabolism in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early posterior hypometabolism in Alzheimer's Disease""}]"
22,43,18F-FDG-PET,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild mesial temporal hypometabolism in Alzheimer's Disease""}]"
40,43,18FDG,"[{'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Disease progression in Alzheimer's Disease""}]"
41,43,18FDG-PET,"[{'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring functional changes in the brain during PE treatment'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Metabolic deficits associated with neuronal damage in Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Rapid progression to more severe Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'response to PE treatment in AD patients'}]"
3847,43,[18F]-fluoro-deoxyglucose PET (FDG-PET),"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}]"
1222,44,Cortico-motor plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]"
1223,44,Cortico-motor reactivity,"[{'article': 'PMC7360860.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
1207,44,Cortical Plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
1205,44,Cortical AD signature,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Alzheimer's Disease development""}]"
1213,44,Cortical plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'PREDICTS_THERAPEUTIC_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease patients""}]"
4077,44,cortical tau,"[{'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive impairment in Alzheimer's Disease""}]"
3448,45,TRPA1,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
3640,45,TrkA Mono,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3639,45,TrkA,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotrophin receptor activity in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3605,45,TrKA,"[{'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3449,45,TRPML1,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lipid accumulation and lysosomal trafficking correction'}]"
3450,45,TRx0237,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
1931,46,Homocysteine,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1932,46,Homocysteine (Hcy),"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1611,46,Folate,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1612,46,Folic Acid,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1864,46,Hcy (Homocysteine),"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and cardiovascular risk'}]"
4207,47,idea density,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
4449,47,proportions of pronouns,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
4450,47,proportions of verbs,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
4075,47,content density,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1474,48,Eotaxin-3 [CCL26],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1473,48,Eotaxin [CCL11],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1472,48,Eotaxin,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]"
4103,48,eCarb,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cognitive decline in Alzheimer's Disease""}]"
281,48,Acarbose,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}]"
4122,48,eotaxin,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4104,48,eCarb (digestible carbohydrates),"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults at risk for dementia'}]"
1400,48,ECbche,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
955,48,CREB,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RESPONDED_TO', 'object': ""J147 Treatment in Alzheimer's Disease""}]"
1232,48,Crenezumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III study in prodromal-to-mild AD'}]"
4123,48,eotaxin-3,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'reduced loss of hippocampal gray matter volume'}]"
1429,49,EQ VAS,"[{'article': 'PMC7749592.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improvement in self-rated health in Alzheimer's Disease""}]"
4581,49,vAChT,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
989,49,CVFT,"[{'article': 'PMC4380493.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}]"
3980,49,cVEMP,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4582,49,vAβ,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]"
990,49,CVLT-II,"[{'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3730,49,Visual Analog Scale (VAS),"[{'article': 'PMC4175156.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sustained emotional states in Alzheimer's Disease patients""}]"
3684,49,VIP,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Attenuation of Alzheimer’s disease pathology'}, {'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased VIP immunofluorescence in gamma-treated mice'}, {'article': 'PMC10917684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to 40Hz stimulation in Alzheimer's Disease models""}]"
3694,49,VR-DOT,"[{'article': 'PMC4307822.txt', 'relationship': 'PREDICTS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Conversion to Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides: Early identification and diagnosis of Alzheimer's Disease""}]"
3685,49,VIP interneurons,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Amyloid clearance in Alzheimer's Disease""}]"
3224,50,Semicircular canal function,"[{'article': 'PMC9344717.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3206,50,Saccular function,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3729,50,Vestibular loss,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2855,50,Physical function,"[{'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
4591,50,vestibular function,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}]"
3670,50,Utricular function,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3232,51,Serum calcium,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
3961,51,bone health,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
776,51,Bone Mineral Density (BMD),"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7505369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3233,51,Serum calcium concentration,"[{'article': 'PMC3212921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor occurrence of hypercalcemia and treatment response'}]"
4469,52,right middle temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3102,52,Right middle temporal gyrus (RMTG) metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease and differentiation from other cognitive impairments""}]"
2231,52,Local Gyrification Index (LGI),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]"
3101,52,Right middle temporal gyrus (RMTG) hypometabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective cognitive decline (SCD) and early stages of Alzheimer's Disease""}]"
4233,52,left middle temporal gyrus (MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2204,52,Left angular gyrus (AG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]"
3096,52,Right Middle Temporal Gyrus (R MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]"
2203,52,Left angular gyrus,"[{'article': 'PMC10439779.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""rTMS treatment for cognitive improvement in Alzheimer's Disease""}]"
1061,52,Cerebral blood flow (CBF) in left middle temporal gyrus (MTG),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive improvements in Strategic Reasoning and Executive Function'}]"
2196,52,Left Fusiform Gyrus (L FFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]"
2202,52,Left Middle Temporal Gyrus (L MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]"
4228,52,left fusiform gyrus (L FFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4406,53,parvalbumin,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2798,53,Parietal Activation,"[{'article': 'PMC6538045.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better response to cognitive training'}]"
2805,53,Parvalbumin,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2706,53,PARP1,"[{'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2705,53,PARP,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]"
2806,53,Parvalbumin (PV),"[{'article': 'PMC3534053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
914,54,CFr (carbohydrate/fat ratio),"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better global cognition in older adults at risk for dementia'}, {'article': 'PMC10236460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive health in older adults at risk for dementia'}]"
1010,54,Carbohydrate intake,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the posterior cingulate gyrus in preclinical Alzheimer's Disease""}]"
4106,54,eFat (total fat),"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults at risk for dementia'}]"
4105,54,eFat,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""slower cognitive processing speed in Alzheimer's Disease""}]"
282,55,Acceleration variance,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Sex differences in Alzheimer's Disease""}]"
1166,55,Cognitive intra-individual variability (IIV),"[{'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Functional decline and incident dementia'}]"
3630,55,Trial-to-trial CRT variance,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]"
3186,55,SRT variance,"[{'article': 'PMC4374455.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2114,55,Intraindividual Variability (IIV),"[{'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION_EVENT', 'object': ""From mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_MONITOR', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2748,56,PICALM,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ transport across the blood–brain barrier'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
4446,56,proNGF,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1584,56,Firmicutes,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_ABSENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease pathology""}]"
2964,56,Protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Neurotoxicity and cognitive deficits in Alzheimer's Disease""}]"
2864,56,Pioglitazone,"[{'article': 'PMC4615808.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
2862,56,Piezo1,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of brain Aβ load and improvement of cognitive dysfunction in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Mechanical sensor for detecting Aβ fibers in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated brain Aβ burden and cognitive impairment.'}]"
3489,56,TUNEL,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptosis'}]"
2949,56,Progranulin,"[{'article': 'PMC3389343.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]"
3396,56,TEMPOL,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3441,56,TOMM40,"[{'article': 'PMC5596480.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Risk assessment for mild cognitive impairment due to AD'}]"
4167,57,girl is,"[{'article': 'PMC5237556.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Probable Alzheimer's Disease""}]"
3249,57,Skin color,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]"
1194,57,Congo red,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mature amyloid plaques'}]"
3029,57,ROSA,"[{'article': 'PMC3218804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC3218804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC3218804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Assessing change due to treatment in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflecting response to treatment in Alzheimer's Disease""}]"
1488,57,Euphoria,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1390,57,Dysphoria,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2599,58,NfL levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1321,58,Delta Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]"
1322,58,Delta band,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4091,58,delta band functional connectivity,"[{'article': 'PMC6370863.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease therapy with Souvenaid""}]"
1324,58,Delta frequency band,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1325,58,Delta power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}, {'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'NREM sleep classification'}]"
2595,58,NfL,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in NfL levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Axonal Injury'}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Alzheimer's Disease treatment""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher levels associated with worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Disease progression and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor drug effects on Alzheimer's Disease pathology in clinical trials""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuronal death and axonal loss in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Therapy response in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from healthy controls'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia from Aβ-PET–negative healthy controls""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neural injury'}, {'article': 'PMC8524356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Worse prognosis in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ status in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Neurodegeneration'}, {'article': 'PMC5333515.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5333515.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment monitoring: Axonal degeneration in neurodegenerative disorders'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurodegeneration'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to BAN2401 treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring of: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Central nervous system damage'}, {'article': 'PMC9297091.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Treatment response and disease progression'}, {'article': 'PMC9297091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neurological disease progression'}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2069,58,Increased delta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2895,58,Plasma NfL,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1323,58,Delta band activity,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2506,58,NFL,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Acute tissue damage in Alzheimer's Disease patients""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1536,59,FDG-SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in multiple brain regions'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Temporo-parietal hypometabolism'}]"
1517,59,FDG,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment subtypes'}, {'article': 'PMC8905724.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Decreased FDG uptake indicating poorer prognosis in Alzheimer's Disease.""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assessment of metabolic activity in Alzheimer's Disease.""}]"
1518,59,FDG PET,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Detect and characterize antecedent changes in AD'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Hypometabolism correlating with onset of dementia'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced glucose metabolism in Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1519,59,FDG PET SUVR,"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Glucose metabolism changes in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]"
1521,59,FDG SUVR,"[{'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]"
1523,59,FDG-PET,"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of hypometabolism in the left parietal and left temporal regions'}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Abnormalities in brain glucose metabolism'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline'}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Hypometabolism associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease pathology in CBS patients""}, {'article': 'PMC4346122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Diagnostically useful in uncertain cases'}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain glucose metabolism in Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}, {'article': 'PMC4506984.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Hypometabolism in medial temporal lobes'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Hypometabolism'}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Typical AD (amnestic multidomain dementia)'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to liraglutide treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Brain glucose metabolism during treatment'}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral glucose metabolism changes in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1526,59,FDG-PET SUVRs,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1531,59,FDG-PET markers,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1535,59,FDG-ROI,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral glucose metabolic rate changes in Alzheimer's Disease""}]"
1532,59,FDG-PET measures,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1533,59,FDG-PET uptake,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1525,59,FDG-PET SUVR,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Alzheimer’s disease'}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Hypometabolism in Alzheimer's Disease""}]"
3468,60,TUG time,"[{'article': 'PMC7084863.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
3472,60,TUGdt (Dual-task Test),"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3462,60,TUG,"[{'article': 'PMC10475546.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Balance in older adults with cognitive decline'}, {'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in physical performance under Wii-Fit treatment'}, {'article': 'PMC8564955.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Higher risk of institutionalization or long-term care admission'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in functional mobility'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early cognitive impairment'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Future cognitive decline'}, {'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mobility problems and high risk of falls'}]"
2816,60,Performed Timed 'Up & Go' (TUG) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Gait and postural performance issues'}]"
3486,60,TUGdt test outcomes,"[{'article': 'PMC7662628.txt', 'relationship': 'USED_TO', 'object': 'Improve predictive capacity compared to demographic characteristics and standard cognitive test results alone'}, {'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Dementia incidence among patients with SCI or mild cognitive impairment'}]"
3467,60,TUG single-task,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]"
3463,60,TUG (Timed Up and Go test),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Low scores associated with worsening ADL'}]"
3465,60,TUG (Timed Up-and-Go) Test,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3464,60,TUG (Timed Up and Go),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mobility in Alzheimer's Disease""}]"
3466,60,TUG dual-task test (TUGdt),"[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Dementia incidence among patients with SCI or mild cognitive impairment'}]"
2770,61,PRP,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotection against Aβ42-induced toxicity in Alzheimer's Disease""}]"
4521,61,t-PrP,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from CJD'}]"
2164,61,LBP,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
3389,61,TC-PTP,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3391,61,TDP,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1680,61,GIP,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'EXERTS_NEUROPROTECTIVE_EFFECT', 'object': 'In AD mice'}]"
1681,61,GIP analogs,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
2152,61,Kp,"[{'article': 'PMC5209404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Blood-to-brain penetration'}]"
2149,61,Kgp,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2184,61,LTP,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Memory enhancement in Alzheimer's Disease""}]"
660,62,BA9,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
672,62,BAM-10 antibody,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ aggregates'}, {'article': 'PMC2868024.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Cognitive function rescue in Alzheimer's Disease mouse models""}]"
674,62,BAVLT,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
675,62,BAX,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
658,62,BA35 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]"
671,62,BAM-10,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'TARGETS', 'object': 'Aβ plaques'}]"
659,62,BA46,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
4110,63,eea1,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1428,63,EPS8,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1266,63,DC8E8,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Inhibits pathological tau–tau interactions'}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mis-disordered tau protein in Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2007,63,IL-8/CXCL8,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ aggregation and BDNF formation'}]"
2634,63,OPA1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of OPA1 enhances mitochondrial fusion in Alzheimer's Disease""}]"
1289,63,DO 80,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4322,64,neurocan,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4319,64,neocortex,"[{'article': 'PMC5619554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4164,64,genistein,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
1008,64,Calretinin,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
781,64,Bradykinin,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2555,64,Neopterin,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}]"
1111,64,Chemokines,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2904,64,Plasma genistein,"[{'article': 'PMC9635167.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to genistein treatment'}]"
3687,65,VLD (pixel-wide vessel density),"[{'article': 'PMC6445433.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}]"
3726,65,Vessel Density (VD),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2818,65,Peripapillary RPC VD,"[{'article': 'PMC6445433.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
2409,65,Microcapillary VD,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3727,65,Vessel Length Density (VLD),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3728,65,Vessel density (VD),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}]"
4489,66,scFv D10,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]"
3128,66,SCFAs,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaque deposition'}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Spatial memory deficits in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'EXERT_NEUROMODULATOR_EFFECTS_AND_ACT_ON_GASTROINTESTINAL_CELLS_STIMULATING_SYNTHESIS_OF', 'object': 'Leptin and GLP-1'}, {'article': 'PMC5445077.txt', 'relationship': 'HAVE_THERAPEUTIC_POTENTIAL_IN', 'object': 'Neurodegenerations'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3122,66,SCAG,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Senile dementia'}]"
3123,66,SCD,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
3130,66,SCOT,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4490,66,scFv D5,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]"
3125,66,SCD-Q,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3126,66,SCFA,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ levels'}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Microglial activation and Aβ plaque load'}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased Aβ plaque load and microglial recruitment'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased Aβ plaque burden in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'SCFA promotes AD progression via microglial activation and ApoE upregulation'}]"
1965,67,IDE,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Aβ protein accumulation in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Influence insulin levels affecting ketogenesis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ Degradation'}]"
2020,67,INI,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Restoration of white matter function impaired during cerebral ischemia in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Postoperative Delirium (POD)'}]"
2022,67,INSR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2035,67,ISI,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Insomnia Disorder in Alzheimer's Disease""}]"
2055,67,IgM,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2546,67,NSE,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuronal and glial death in Alzheimer's Disease""}]"
2089,67,Insula,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]"
2983,67,QUICKI,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Insulin sensitivity in Alzheimer's Disease""}]"
2038,67,IWIs,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement over test sessions'}]"
2037,67,IVIG,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1767,68,GluR1,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased membrane levels in XPro1595-treated rats'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved synaptic function in Alzheimer's Disease""}]"
1751,68,Ghrelin,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}]"
1143,68,Clock Drawing Test,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1144,68,Clock Drawing test,"[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]"
1146,68,Clock Test,"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1684,68,GLUT1,"[{'article': 'PMC6211704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Microvascular pathology in Alzheimer's Disease""}]"
1148,68,Clock-Drawing Test,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive impairment in Alzheimer's Disease""}]"
1147,68,Clock drawing,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4165,68,ghrelin,"[{'article': 'PMC5445077.txt', 'relationship': 'COUNTERACTS_MEMORY_DEFICITS_AND_SYNAPTIC_DEGENERATION_IN', 'object': ""Alzheimer's Disease animal models""}]"
1685,68,GLUT4,"[{'article': 'PMC6211704.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to anti-diabetic medications in Alzheimer's Disease""}]"
1149,68,Clock-drawing test,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1011,69,Cardiorespiratory fitness,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive benefits in older adults'}]"
3982,69,cardiorespiratory fitness,"[{'article': 'PMC5302785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'improved memory performance and reduced hippocampal atrophy'}]"
504,69,Asthma,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3267,69,Smoking,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Smoking associated with higher risk of Alzheimer's Disease""}]"
807,69,Breathing patterns,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]"
2501,70,NEUROTICISM,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with increased Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
4063,70,circuitousness,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3138,70,SENSORIMOTOR SYNCHRONIZATION (SMS),"[{'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in neurodegenerative disorders'}]"
2583,70,Neuroplasticity,"[{'article': 'PMC4804486.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3226,70,Sensorimotor network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
4330,70,neuronal viability,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved neuronal viability'}]"
1476,70,Epilepsy,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Reduced survival in Alzheimer's Disease""}]"
3495,70,Tactile Domain,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved sensory function in Alzheimer's Disease""}]"
2086,72,Innate immunity signaling,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4092,72,dendritic cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]"
806,72,BrdU-positive cells,"[{'article': 'PMC4159858.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased proliferation in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Sulforaphane treatment'}]"
3490,72,TUNEL-positive cells,"[{'article': 'PMC4747225.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Apoptosis in Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptotic cell death'}]"
3299,72,Stem cells,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}]"
2357,72,Mast cells,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1546,72,FJB-positive cells,"[{'article': 'PMC4747225.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal Death in Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Degenerating neurons'}]"
1110,72,ChAT immuno-positive neurons,"[{'article': 'PMC4159858.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cholinergic neuron loss in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}]"
3978,72,c-kit-positive cells,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection and repair mechanisms in Alzheimer's Disease""}]"
2550,72,Natural killer cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhanced activity under MBSR/MBCT/MBCR intervention'}]"
2095,73,Insulin Resistance (IR),"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in patients with non-dementia vascular cognitive impairment'}]"
2099,73,Insulin metabolism markers,"[{'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]"
4216,73,insulin sensitivity,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive deficits'}]"
1926,73,Homeostasis model of assessment-estimated insulin resistance (HOMA-IR),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]"
2094,73,Insulin Resistance,"[{'article': 'PMC10306194.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2092,73,Insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Protection of neurons from Aβ oligomers'}, {'article': 'PMC10233712.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta (Aβ) and pathological tau'}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Metformin'}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology and cognitive decline""}, {'article': 'PMC6211704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduced risk of major adverse metabolic events affecting cognitive functions'}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guiding treatment selection in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic intervention in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RESPONDED_TO', 'object': ""Responds to treatment by improving cognitive functions and reducing brain damage in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neuroprotective effects in cerebral ischemia'}]"
4215,73,insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease: cognitive decline""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease: cognitive protection""}, {'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Preservation of metabolic integrity of the brain in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Intranasal administration for cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility: Cognitive improvement in amnestic mild cognitive impairment or mild to moderate Alzheimer's Disease""}, {'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2356,73,Markers of insulin metabolism,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin metabolism in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
2990,73,Quantitative insulin sensitivity check index (QUICKI),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved insulin sensitivity in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin sensitivity in Alzheimer's Disease""}]"
3236,73,Serum insulin,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]"
2101,73,Insulin sensitivity,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2098,73,Insulin levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved insulin sensitivity and reduced cognitive impairment'}]"
1928,73,Homeostatic model of assessment for insulin resistance (HOMA-IR),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]"
3745,74,Voice,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3290,74,Speech timing,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
3288,74,Speech rate,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4498,74,speech production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3286,74,Speech Tempo,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
3285,74,Speech,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4499,74,speech rate,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
1195,74,Connected speech,"[{'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}]"
3264,74,Slower speech rate,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4500,74,speech timing,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]"
2039,75,Iba-1,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Reduced levels in J147-treated mice'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of microglial activation in AD mice'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced microglial activation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Microgliosis in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Microglial reaction in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2040,75,Iba1,"[{'article': 'PMC3520904.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CD163 immunoreactive microglia'}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}, {'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No reactive microglia after TI stimulation'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Loss of motility in microglia in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased Aβ phagocytosis in GF 5xFAD mice'}]"
1961,75,IBA-1,"[{'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of microglial activation in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
4479,75,sICAM-1,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ levels in AD mouse models'}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'n-3 PUFA supplementation effects'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3148,75,SICI,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease cognitive decline""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced short-interval intracortical inhibition in Alzheimer's Disease""}]"
3382,76,TAS Test single-key tapping,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
1583,76,Finger-Tapping Test,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Motor dysfunction in Alzheimer's Disease""}]"
4536,76,tapping frequency,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3246,76,Single-key tapping test,"[{'article': 'PMC10916999.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
3497,76,Tapping speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
713,76,BRAIN tap test,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early Alzheimer's Disease""}]"
4537,76,tapping variability,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
341,76,Alternate-key tapping test,"[{'article': 'PMC10916999.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
1626,77,Free and Cued Selective Reminding Test (FCSRT),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Memory impairments in Alzheimer's Disease""}]"
2383,77,Memory Alteration Test (M@T),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
3105,77,Rivermead Behavioural Memory Test (RBMT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment (MCI) associated with progression to Alzheimer's Disease""}]"
1201,77,Cookie Theft descriptions,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3809,77,Wisconsin Card Sorting Test,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3928,78,apoE3-V236E,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
209,78,APOE3-R145C,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for lipid disorders and cardiovascular diseases'}]"
3931,78,apoe4 carrier status,"[{'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Evaluated as a covariate in efficacy endpoints and disease progression models'}]"
198,78,APOE ε4 allele carriers,"[{'article': 'PMC6152871.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilvadipine treatment'}, {'article': 'PMC6152871.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Differential effects in Alzheimer's Disease treatment""}]"
217,78,APOε4 carriers,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced glucose metabolism in posterior cortical areas'}]"
208,78,APOE3-Jacksonville (APOE3-Jac),"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Healthy brain aging and decreased amyloid deposition'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reduction of apoE self-association and increased lipidation'}]"
207,78,APOE3-Christchurch (APOE3-Ch),"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Resistance against aggressive familial AD'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduced tau pathology and neurodegeneration'}]"
213,78,APOE4-R251G,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Protection against AD risk'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Potential changes in apoE structure and lipidation capability'}]"
3927,78,apoE3-R136S,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2645,79,Optineurin,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1381,79,Drebrin,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prevention of synaptic spine loss in AD mice'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2609,79,Nitrite,"[{'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]"
2606,79,Nilotinib,"[{'article': 'PMC4247762.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'p-Tau and Aβ1-42 reduction'}]"
2602,79,Nicastrin,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
4511,79,substantia nigra (SN),"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegenerative changes in Alzheimer's Disease""}]"
374,79,Amylin (IAPP),"[{'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]"
2118,79,Irisin,"[{'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2193,80,Latency to reach the platform,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2689,80,P300 amplitude and latency,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2690,80,P300 latency,"[{'article': 'PMC3923761.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2490,80,N200 latency,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2696,80,P3b latency,"[{'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2194,80,Latency to target,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}]"
2192,80,Latency to reach new platform,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Learning impairments in Alzheimer's Disease""}]"
1032,80,CentPT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive processing time in participants'}]"
1982,81,IL-12:IL-23p40,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1996,81,IL-1b,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1981,81,IL-12,"[{'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}]"
2058,81,Il6,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1988,81,IL-16,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1980,81,IL-10,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive deficits'}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Augmentation in Treg transferred 3xTg-AD mice'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective effects in AD models'}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Physical function decline in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor cognitive performance in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]"
1999,81,IL-2,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'slower cognitive decline in patients with mild cognitive impairment'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in Alzheimer's Disease risk through expansion of neuroprotective Treg cells""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
2016,81,IL2,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2017,81,IL6,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2006,81,IL-8,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'reduced Aβ42, Aβ40, and P-tau levels'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
1979,81,IL-1,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ formation and neuronal degeneration'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased neuroinflammation and cognitive impairment'}]"
2008,81,IL12,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2000,81,IL-22,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]"
1995,81,IL-1RA,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Resveratrol treatment in Alzheimer's Disease""}]"
2001,81,IL-3,"[{'article': 'PMC9527145.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
1986,81,IL-13,"[{'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1994,81,IL-1R4,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]"
1993,81,IL-18,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
2004,81,IL-6,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Microglial phagocytic capacity'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of inflammation in Alzheimer's Disease""}, {'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ elimination'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory processes in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation and cognitive decline'}, {'article': 'PMC5381339.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dietary patterns and accelerated cognitive decline'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of α-tocopherol'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1992,81,IL-17α,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1991,81,IL-17F,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1987,81,IL-15,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
2003,81,IL-5,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}]"
1990,81,IL-17A,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}]"
1989,81,IL-17,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]"
2002,81,IL-4,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility: AAV-mediated overexpression'}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Adaptive immune response in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]"
2010,81,IL17,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2005,81,IL-7,"[{'article': 'PMC8258160.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Immune system replenishment in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
804,82,BrainAGE score,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prediction of conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better prediction of Alzheimer's Disease compared to cognitive scores and other biomarkers""}]"
3970,82,brain network characteristics,"[{'article': 'PMC8795741.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
803,82,BrainAGE,"[{'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_CONVERSION_TO_AD', 'object': 'Within a time span of 36 months'}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse cognitive outcomes and disease severity'}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Conversion to Alzheimer's Disease in mild cognitive impairment subjects""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Higher risk of developing Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk of Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Survival: Higher BrainAGE scores predict increased risk of AD conversion'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher scores indicate increased risk of developing Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""BrainAGE reflects cognitive decline and disease progression in Alzheimer's Disease.""}]"
800,82,Brain-age gap,"[{'article': 'PMC10310693.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's disease and other neurodegenerative disorders""}]"
799,82,Brain water content,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain Edema'}]"
1794,82,Graph theory-based brain network changes,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pre-AD'}]"
789,82,Brain age,"[{'article': 'PMC9349172.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3969,82,brain morphology,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2452,82,Modular organization of the brain,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased modular organization in response to dance intervention'}]"
2704,83,PALT,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
943,83,COMT,"[{'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
951,83,CPT,"[{'article': 'PMC4407573.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1234,83,Cst7,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
983,83,CST7,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
969,83,CSE,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Homocysteine metabolism issues'}]"
901,83,CDT,"[{'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Visuo-spatial disturbances in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of cognitive decline in AD'}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive dysfunction in Alzheimer's Disease""}]"
859,83,CCT,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
3421,84,TMT B,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive flexibility deficits in Alzheimer's Disease""}]"
816,84,C-TMT-A,"[{'article': 'PMC4465490.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Malingering in head injury evaluations'}, {'article': 'PMC4465490.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Functional outcome in TBI patients'}]"
3010,84,RBMT,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related cognitive impairment""}]"
3419,84,TMT,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
817,84,C-TMT-B,"[{'article': 'PMC4465490.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Malingering in head injury evaluations'}, {'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in TBI patients'}]"
3425,84,TMTB,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3424,84,TMT-B,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3423,84,TMT-A (s),"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive function in Alzheimer's Disease""}]"
3420,84,TMT A,"[{'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}]"
3422,84,TMT-A,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3133,84,SDMT,"[{'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Total ADL and IADL in Alzheimer's Disease patients""}]"
714,84,BVMT-R,"[{'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Visuospatial memory in Alzheimer's Disease""}]"
4409,85,pharmacogenomic characteristics,"[{'article': 'PMC3764973.txt', 'relationship': 'PREDICTS_TOLERABILITY', 'object': 'Tolerability to acetylcholinesterase inhibitors (ChEIs)'}]"
2096,85,Insulin degrading enzyme,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Monomeric Aβ'}]"
2230,85,Liver enzyme elevations,"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Liver toxicity'}]"
576,85,Aβ-degrading enzymes,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4163,85,genetic variations in drug metabolism enzymes,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TOLERABILITY_AND_RESPONSE', 'object': 'Inter-individual variability in efficacy and tolerability of Alzheimer’s drugs'}]"
2494,85,NAD+ levels,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurodegenerative disorders'}]"
3887,85,aminotransferase elevations,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Liver toxicity'}]"
845,86,CASI,"[{'article': 'PMC8305709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9361147.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3984,86,caspase pathways,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Apoptosis'}]"
301,86,Activated Caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4065,86,cleaved caspase-3,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lack of apoptotic cells after TI stimulation'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4066,86,cleaved-caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
846,86,CASP4,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1131,86,Cleaved caspase-3,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1130,86,Cleaved caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1013,86,Caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neuronal death'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptosis'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2060,88,Imidazoline-2 binding sites,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
1462,88,Endothelin-1 (EDN1),"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cerebral hypoperfusion in Alzheimer's Disease""}]"
4107,88,eIF2α,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Protein homeostasis and Alzheimer's Disease""}]"
1826,88,HIF-1α,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cell adaptation to hypoxia in ischemia'}]"
338,88,Alpha-2 macroglobulin,"[{'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2474,88,Myelin proteins,"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3792,89,White matter hyperintensities,"[{'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3797,89,White matter hyperintensity (WMH) volume,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Slower progression of white matter hyperintensity in response to aerobic exercise'}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cerebrovascular disease'}]"
3796,89,White matter hyperintensities (WMHs),"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Patients with AD with minimal WMHs had better responses to rivastigmine patch compared to those with moderate WMHs'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4596,89,white matter hyperintensities,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""reduced Aβ42 levels in cerebral spinal fluid, associated with Alzheimer's Disease""}]"
3803,89,White matter lesion volume,"[{'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3805,89,White matter volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related to prognosis of Alzheimer's Disease""}]"
3786,89,White Matter Hyperintensities (WMH),"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrovascular Disease'}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with small vessel disease and subclinical pathology'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Decline'}, {'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral Small Vessel Disease'}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3787,89,White Matter Hyperintensities (WMHs),"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4597,89,white matter hyperintensity (WMH) volume,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3788,89,White Matter Hyperintensity Volume (WMH Volume),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3800,89,White matter hyperintensity volumetry,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3789,89,White Matter Hyperintensity Volume (WMHV),"[{'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42 levels in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42/Aβ40 ratio in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42/T-tau ratio in Alzheimer's Disease""}]"
3793,89,White matter hyperintensities (WMH),"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subclinical cerebrovascular disease'}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta (Aβ) deposition'}]"
3799,89,White matter hyperintensity volume (WMHV),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease progression""}]"
1657,90,Fusiform gyrus thickness,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1331,90,Dentate gyrus volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1330,90,Dentate gyrus (DG) volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Retroactive interference (RI)'}]"
1220,90,Cortical thickness in temporal gyri,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1219,90,Cortical thickness in inferior temporal gyri,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
2075,90,Inferior parietal gyrus cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
3941,91,balance,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2647,91,Orientation,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter interpausal units and longer pauses'}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Preclinical dementia'}]"
3942,91,balance function,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}, {'article': 'PMC9344717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
2925,91,Posture and Balance,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced fall risk in Alzheimer's Disease patients""}]"
718,91,Balance,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Positive changes in balance'}]"
2828,92,Phonemic paraphasia,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3573,92,TorCA Subscores,"[{'article': 'PMC6052695.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mild Cognitive Impairment'}]"
1922,92,Hirano bodies,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3221,92,Semantic Paraphasia,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3990,93,cerebellum,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2195,93,Left Cerebellum,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]"
3265,93,Small intraventricular mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
4074,93,composite-cerebellum SUVR,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2869,93,Pituitary mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
1042,93,Cerebellar hemispheric mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3457,94,TT,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in gait under Wii-Fit treatment'}]"
3496,94,Talk testing (TT),"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intensity and breathing difficulty in Alzheimer's Disease patients""}]"
4577,94,ttau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
3461,94,TTs,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in plasma'}]"
3460,94,TTR,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3458,94,TT (Tinetti Test),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Gait improvements in Alzheimer's Disease""}]"
3459,94,TT aglycones,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}]"
4531,94,tTau,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1503,95,FA-rate,"[{'article': 'PMC4374455.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4234,95,left precuneus fALFF,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1501,95,FA,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""White matter alterations in mild cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Cognitive Deficits in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: White matter microstructure changes in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduction in step length over time'}]"
1576,95,Fasudil,"[{'article': 'PMC6145937.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reduction of Aβ burden and protection against synapse loss'}]"
4127,95,fALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia of Alzheimer’s disease'}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia of Alzheimer’s disease'}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1507,95,FAQ,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diagnose: Impaired function consistent with dementia'}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC9871821.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1508,95,FAQ scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4131,95,fasudil hydrochloride,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]"
4265,96,memantine,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Advanced AD'}]"
2381,96,Memantine,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Glutamatergic Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease and Related Dementia (ADRD)""}, {'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4743597.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
2399,96,Metformin,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}, {'article': 'PMC9755275.txt', 'relationship': 'RESPONDED_TO', 'object': 'cognition'}]"
2400,96,Methionine,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Longevity and Alzheimer's Disease""}]"
3348,97,Swimming speed,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4454,97,pulse wave velocity,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cerebral Aβ accumulation in Alzheimer's Disease""}]"
4587,97,velocity,"[{'article': 'PMC4465490.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4594,97,walking speed,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive impairment and senile dementia'}]"
3779,97,Walking speed,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher number of total, periventricular and deep white matter hyperintensities'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Smaller hippocampal volume and presence of microbleeds and lacunar infarcts'}]"
1083,98,Cerebral spinal fluid Mid-p-tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
4045,98,cerebral spinal fluid t-tau,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}]"
4051,98,cerebral spinal fluid total tau (T-tau),"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4052,98,cerebral spinal fluid total-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal damage early in Alzheimer's Disease""}]"
4032,98,cerebral spinal fluid phospho-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal damage early in Alzheimer's Disease""}]"
4033,98,cerebral spinal fluid phosphorylated tau,"[{'article': 'PMC4132648.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}]"
4034,98,cerebral spinal fluid phosphorylated tau (P-tau),"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4050,98,cerebral spinal fluid total tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased levels indicate better prognosis in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'PD and DLB progression'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}]"
4035,98,cerebral spinal fluid phosphorylated tau (p-tau),"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in cerebral spinal fluid phosphorylated tau (p-tau) in response to semagacestat treatment'}]"
4037,98,cerebral spinal fluid p‐tau,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Progression from cognitively unimpaired to mild cognitive impairment and eventually to AD dementia'}, {'article': 'PMC7721364.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive impairment'}, {'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
4038,98,cerebral spinal fluid p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4031,98,cerebral spinal fluid p-tau181 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower levels in African Americans may indicate less neurodegeneration'}]"
1084,98,Cerebral spinal fluid N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
1085,98,Cerebral spinal fluid N-p-tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
1086,98,Cerebral spinal fluid Phospho-tau,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1087,98,Cerebral spinal fluid Total tau,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4047,98,cerebral spinal fluid tau,"[{'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal injury and neurodegeneration'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Severity of cognitive impairment'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4030,98,cerebral spinal fluid p-tau181,"[{'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased levels indicate better prognosis in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic dysfunction in Alzheimer's Disease""}]"
4029,98,cerebral spinal fluid p-tau,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment'}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'PD and DLB progression'}]"
4023,98,cerebral spinal fluid T-tau,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'High diagnostic accuracy for AD'}, {'article': 'PMC6945608.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease prognosis""}]"
4020,98,cerebral spinal fluid P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with worse prognosis in Alzheimer's Disease""}]"
4019,98,cerebral spinal fluid P-tau,"[{'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'High diagnostic accuracy for AD'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}, {'article': 'PMC6945608.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
4018,98,cerebral spinal fluid N‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1092,98,Cerebral spinal fluid t-tau,"[{'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4014,98,cerebral spinal fluid Mid‐p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]"
1091,98,Cerebral spinal fluid p-tau,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}, {'article': 'PMC4970664.txt', 'relationship': 'DIAGNOSITIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
4039,98,cerebral spinal fluid p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early stages of autosomal‐dominant AD'}]"
4040,98,cerebral spinal fluid p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early changes in tau metabolism in preclinical Alzheimer's""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]"
4343,99,p-H2A.X Ser139,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2250,99,MAN2A1,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3754,99,WHOdas 2.0,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}]"
4382,99,p62/SQSTM1,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}, {'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'VCP-associated disease'}, {'article': 'PMC4489713.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Muscle pathology and autophagy dysfunction'}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}]"
3119,99,SASP factors,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}]"
3874,99,[¹⁸F]FEBU,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3872,99,[62Cu]ATSM,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
226,100,APP mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Myelin integrity loss in frontostriatal circuits'}]"
225,100,APP mRNA,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
222,100,APP gene,"[{'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
223,100,APP gene mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s disease'}]"
93,100,A673T mutation in APP,"[{'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2740,100,PGRN mutation carriers,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Presenting with mixed PPA profiles (lvPPA and nfvPPA)'}]"
1200,101,Controlled Oral Word Association Test (COWAT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3720,101,Verbal fluency difficulties,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3719,101,Verbal fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}]"
3717,101,Verbal Performance (number of animals recited),"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3715,101,Verbal Fluency—Animals,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3714,101,Verbal Fluency test,"[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]"
3713,101,Verbal Fluency (animal names),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]"
3712,101,Verbal Fluency (VF) tests,"[{'article': 'PMC5147824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3711,101,Verbal Fluency,"[{'article': 'PMC5147824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2215,101,Letter fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3721,101,Verbal fluency test,"[{'article': 'PMC3681660.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guide subjects with memory impairment to full memory consultations at hospitals'}, {'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2214,101,Letter (FAS) and Category Verbal Fluency,"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Verbal Fluency Impairment in Alzheimer's Disease""}]"
1631,102,Frontal Assessment Battery (FAB) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Executive function abnormalities'}]"
1629,102,Frontal Assessment Battery,"[{'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function impairment in Alzheimer's Disease""}]"
1630,102,Frontal Assessment Battery (FAB),"[{'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improvement in frontal function in Alzheimer's Disease patients with minimal WMHs""}, {'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Frontal cognitive improvement'}]"
1635,102,Frontal lobe function (FAB score),"[{'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved frontal lobe function in patients with AD with minimal WMHs'}]"
906,102,CERAD battery of mental status tests,"[{'article': 'PMC4983010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3241,102,Severe Impairment Battery (SIB),"[{'article': 'PMC3126705.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive benefit in response to Donepezil 23 mg/d treatment'}]"
3063,102,Repeatable Battery for the Assessment of Neuropsychological Status (RBANS),"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction associated with Alzheimer's Disease""}]"
2588,102,Neuropsychological Test Battery (NTB),"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3477,103,"TUGdt MB, months/10 s","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4307,103,months/10s,"[{'article': 'PMC7392684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3474,103,TUGdt MB months/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]"
3475,103,TUGdt MB number of months,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]"
3478,103,"TUGdt MB, number of months","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4308,103,months/10 s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage dementia'}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]"
1728,104,Gamified cognitive tasks,"[{'article': 'PMC8281974.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]"
1764,104,Global cognition,"[{'article': 'PMC5016950.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
1333,104,Design Fluency,"[{'article': 'PMC4854436.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Decline in Alzheimer's Disease""}]"
4154,104,functional skills,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
4069,104,cognitive function,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of hospitalization due to Alzheimer's Disease and vascular dementia""}, {'article': 'PMC4981900.txt', 'relationship': 'RESPONDED_TO', 'object': 'EMF treatment in AD patients resulted in significant improvement in cognitive measures'}]"
1163,104,Cognitive function,"[{'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis in AD mice'}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Improvement in Alzheimer's Disease""}]"
1155,104,Cognition,"[{'article': 'PMC3581819.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive function in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
3281,104,Spatial abilities,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
366,105,Ammonia,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2965,105,Pseudoflavonifractor,"[{'article': 'PMC8266337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive dysfunction and memory impairment'}]"
4496,105,sodium benzoate,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
4341,105,ozagrel sodium,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]"
2905,105,Plasma kallikrein,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2826,105,Phenylalanine,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiation between mild cognitive impairment due to AD and healthy controls'}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GV-971 treatment'}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through neurotoxicity and cognitive disruption""}]"
4565,105,theobromine,"[{'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function related to Alzheimer's Disease""}]"
2825,105,Phenserine,"[{'article': 'PMC4890804.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
3269,105,Sodium,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4095,105,dipeptides,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]"
745,105,Bexarotene,"[{'article': 'PMC4731943.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Reduction of brain amyloid levels in apoe4 noncarriers'}]"
122,106,ADAS,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-specific symptoms""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
123,106,ADAS-Cog,"[{'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Changes in cognitive function'}, {'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive and non-cognitive AD-specific symptoms'}, {'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to masitinib treatment in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Primary endpoint for assessing cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive decline in response to cycling intervention'}, {'article': 'PMC4380493.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Assessment in Alzheimer's Disease""}, {'article': 'PMC8386362.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment response in Alzheimer's Disease patients""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognition in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4764002.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Functioning in Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to rivastigmine patch therapy in Alzheimer's Disease patients""}, {'article': 'PMC5546604.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Clinical improvement in Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Clinical improvement in Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Effectiveness of intervention in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function changes in Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in cognition in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
125,106,ADAS-Cog 11,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
140,106,ADAScog11,"[{'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
130,106,ADAS-Cog-11,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
134,106,ADAS-cog,"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive Progression in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of cognitive performance in AD'}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4353453.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Clinically relevant improvement in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Continuous non-significant decline in cognitive function.'}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and assessment of Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive benefits in Alzheimer's Disease treatment""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Worsening dementia'}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease cognitive decline""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive deterioration in Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
139,106,ADAS-mem,"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Non-significant progressive improvement of the ADAS-mem values.'}]"
311,106,Adalimumab,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]"
133,106,ADAS-Cog14,"[{'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}]"
138,106,ADAS-cog12,"[{'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
126,106,ADAS-Cog 13,"[{'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}]"
131,106,ADAS-Cog11,"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}]"
137,106,ADAS-cog11,"[{'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
136,106,ADAS-cog-13,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3624,107,Traumatic Brain Injury (TBI),"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
927,107,CLQT Composite Severity,"[{'article': 'PMC4283612.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Higher scores are associated with more improvement in therapy tasks.'}, {'article': 'PMC4283612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
3320,107,Stroke lesion volume,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3319,107,Stroke,"[{'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]"
1100,107,Cerebrovascular disease,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3998,107,cerebral small vessel disease (CSVD),"[{'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'cognitive impairment'}]"
1978,108,IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Frontal gray and white matter integrity changes on MRI scans'}, {'article': 'PMC4406069.txt', 'relationship': 'PREDICTS', 'object': 'Greater cognitive decline'}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Predict impending cognitive decline and increased mortality risk'}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3656,108,UFOV,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
247,108,ASV_9,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}]"
1688,108,GMV,"[{'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in all regions of interest'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Medial-temporal atrophy'}]"
1710,108,GV1001,"[{'article': 'PMC7995588.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1687,108,GM-CSF,"[{'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved MMSE scores in AD patients following treatment'}]"
2274,108,MEV,"[{'article': 'PMC5068716.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects Alzheimer's Disease progression""}]"
246,108,ASV_19,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}]"
1437,109,ERN (Error-related negativity) amplitude,"[{'article': 'PMC8281974.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2688,109,P300 amplitude,"[{'article': 'PMC3923761.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2685,109,P3 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related cognitive decline""}]"
2271,109,MEP amplitude,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}, {'article': 'PMC7360860.txt', 'relationship': 'PREDICTS', 'object': ""Clinical response in Alzheimer's Disease patients""}]"
2695,109,P3b amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2487,109,N100 amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attention and memory deficits in Alzheimer's Disease""}]"
2272,109,MEP amplitudes,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2693,109,P3a amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attention and executive function deficits in Alzheimer's Disease""}]"
2484,109,N1 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
2489,109,N200 amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2670,109,P1 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive processing in Alzheimer's Disease""}]"
1486,110,Etanercept,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]"
844,110,CANTAB-RVP,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
495,110,Arc,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3981,110,cadence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'microbleed presence'}]"
3033,110,RPTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
812,110,Butyrate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2769,111,PQ912,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Inhibition of QC activity to reduce pGlu-Aβ production'}, {'article': 'PMC6182869.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Reduction of cognitive decline in Alzheimer's Disease""}]"
823,111,C1qb,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2542,111,NQ01,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]"
77,111,73Q,"[{'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of neuronal hyperexcitability in Alzheimer's Disease models.""}]"
822,111,C1q,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ phagocytosis and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ clearance'}]"
67,111,48Q,"[{'article': 'PMC4899632.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with impaired motor coordination and reduced survival in Alzheimer's Disease models.""}]"
2507,111,NFQ,"[{'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1548,111,FMQ,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
42,111,18Q,"[{'article': 'PMC4899632.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with better motor coordination and extended survival in Alzheimer's Disease models.""}]"
46,111,23Q,"[{'article': 'PMC4899632.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Used to diagnose and study disease progression in Alzheimer's Disease models.""}]"
1152,111,CoQ10,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
953,112,CR1,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD risk'}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment and amyloid plaque formation'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4200,112,hs-CRP,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation and Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Inflammation in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]"
959,112,CRT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]"
958,112,CRT,"[{'article': 'PMC4407573.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4656817.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4656817.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}]"
1113,112,Cho/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
957,112,CRP levels,"[{'article': 'PMC4013077.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower levels in ApoE ε4 allele carriers'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced systemic inflammation'}]"
956,112,CRP,"[{'article': 'PMC4013077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher CRP levels in the n-IF group were associated with poorer outcomes and increased inflammation.'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in older adults with mild cognitive impairment'}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4249,112,mI/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'APOE ε4 carriership'}]"
954,112,CR3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4564,113,the window,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Probable Alzheimer's Disease""}]"
3491,113,TVPAC,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI), a precursor to Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amild cognitive impairment detection'}]"
1258,113,DAD,"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disability Assessment in Dementia due to Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess: Functional impairment in Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Functional response to galantamine treatment in memantine nonusers'}, {'article': 'PMC5111338.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Functional outcome monitoring during treatment'}, {'article': 'PMC5403784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2256,113,MBA,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β associated with Alzheimer's Disease""}]"
86,113,A,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1553,113,FR,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proactive balance and physical frailty'}]"
1444,113,Education,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Object and action naming performance in PPA'}]"
4563,113,the mother,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Probable Alzheimer's Disease""}]"
1263,113,DAS,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1150,114,Clusterin,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}]"
3979,114,cAMP,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Impaired cognition and neurodegeneration in Alzheimer's Disease""}]"
1151,114,Clusterin genotype,"[{'article': 'PMC4846650.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pre-AD'}]"
2561,114,Nestin,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1936,114,Huntingtin,"[{'article': 'PMC4899632.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Huntington's Disease model in Alzheimer's research""}]"
2015,115,IL1β,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
1998,115,IL-1β,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Canakinumab'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in rats and mice exposed to isoflurane'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in rodents after isoflurane exposure'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation and stress, which are associated with Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Clinical treatments for inflammation and related diseases'}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation in AD models'}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of oleanolic acid, β-sitosterol, and α-tocopherol'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased astrocyte activation and Aβ accumulation'}]"
2109,115,Interleukin-1 (IL-1),"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2112,115,Interleukin-6 (IL-6),"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Alzheimer’s Disease'}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3434,115,"TNF-α, IL-1β and IL-6","[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Inflammation'}]"
4220,115,interleukin-6,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
2110,115,Interleukin-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]"
2111,115,Interleukin-6,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]"
4259,116,mature NGF,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2617,116,Nrf2,"[{'article': 'PMC4159858.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment mechanism""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2543,116,NRF2,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Antioxidant response in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Activation of antioxidant response element (ARE) genes'}]"
2509,116,NGF,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Weight loss and back pain in Alzheimer's Disease patients""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guiding treatment selection for Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cholinergic neuronal morphology and memory improvement'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Performance in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INCREASES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and neuronal/glial maturation'}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Nerve growth factor (NGF) release for Alzheimer's Disease therapy""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in AD models'}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""NGF release is induced by NBM activity, which may be associated with improved prognosis in Alzheimer's Disease.""}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neuronal survival'}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Elevated neurotrophin levels indicating improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function and performance'}, {'article': 'PMC6893800.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal plasticity and cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment Response in Alzheimer's Disease""}]"
3027,116,RNFL thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4529274.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""treatment selection in Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}]"
3026,116,RNFL,"[{'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Correlated with MMSE scores in AD patients'}, {'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Retinal nerve fiber layer thickness is a useful tool for AD diagnosis'}, {'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
2808,117,Patient Health Questionnaire (PHQ-9),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]"
307,117,Activities of Daily Living Questionnaire,"[{'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Functional impairment in Alzheimer's Disease""}]"
1641,117,Functional Assessment Staging Scale (FAST),"[{'article': 'PMC7313126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
3214,117,Schedule for the Evaluation of Individual Quality of Life - Direct Weighing (SEIQoL-DW),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Individual quality of life domains in Alzheimer's Disease""}]"
2221,117,Life Experience Questionnaire (LEQ),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1399,118,ECG/HRV,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]"
3071,118,Resting heart rate,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Lowering of resting heart rate'}]"
1866,118,Heart Rate Variability (HRV),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}]"
1398,118,ECG,"[{'article': 'PMC7729136.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cardiovascular health in Alzheimer's Disease""}]"
1868,118,Heart rate,"[{'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}, {'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intensity and physical activity in Alzheimer's Disease patients""}, {'article': 'PMC9412195.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Physical activity and treatment response in Alzheimer's Disease""}]"
1859,119,Handwriting,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3160,119,SMS,"[{'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Sensorimotor Synchronization in Neurocognitive Disorders'}, {'article': 'PMC10092214.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Motor and Socioemotional Responses to Music Rhythm'}]"
3161,119,SMS consistency,"[{'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Motor and cognitive dysfunction in Alzheimer's Disease""}]"
3545,119,Text,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2456,120,Monoamine oxidase B,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
75,120,67-kDa laminin receptor,"[{'article': 'PMC4675859.txt', 'relationship': 'TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
453,120,Annexin A2,"[{'article': 'PMC3835777.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4225,120,lamin B1,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neural stem cell division and neurogenesis'}]"
2251,120,MAO-B,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease: Neuroinflammatory processes in glial cells""}, {'article': 'PMC5478550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease: Reduction of neurodegenerative processes""}, {'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
153,121,ADNC scores,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
155,121,ADS score,"[{'article': 'PMC5442667.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
144,121,ADCS-ADL scores,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
809,121,Bristol ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
142,121,ADCS ADL total score,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Activities of daily living performance in Alzheimer's Disease patients""}]"
810,121,Bristol scores ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
88,122,A/T/N system,"[{'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
87,122,A+T+ profile,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1142,122,Clock C,"[{'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in hypertensive patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher proportion of progression to AD in hypertensive group'}]"
2472,122,Munc18c,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dopamine release and cognitive function in AD'}]"
1145,122,Clock T3111C,"[{'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher risk of conversion to Alzheimer's Disease in carriers with hypertension""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Conversion to Alzheimer's Disease in hypertensive patients""}]"
60,122,30CST,"[{'article': 'PMC10475546.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower-body strength in older adults with cognitive decline'}]"
2368,123,Mean plasticity (T5–30),"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]"
2257,123,MC max. plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2916,123,Plasticity T10,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]"
3372,123,T10 plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]"
2362,123,Maximum plasticity (T5–30),"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]"
2258,123,MC mean plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3376,123,T5 plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]"
2369,123,Mean plasticity T5-T30,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]"
2361,123,Maximum plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]"
2917,123,Plasticity T5,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]"
2918,123,Plasticity measures,"[{'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive function in Alzheimer's Disease""}]"
3418,123,TMS-induced plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Changes in cognition after rTMS and cognitive training'}]"
1861,124,HbA1c,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Thinner cortical thickness in the lateral orbitofrontal cortex, frontal gyrus, motor region, lateral temporal lobe, and superior and inferior parietal cortex.'}, {'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1862,124,HbA1c levels,"[{'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
2658,124,Oxygenated hemoglobin (Oxy-Hb),"[{'article': 'PMC6893800.txt', 'relationship': 'RESPONDED_TO', 'object': 'Dark chocolate intake'}]"
1872,124,Hemoglobin,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Anemia in Alzheimer's Disease patients""}, {'article': 'PMC4153084.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Hemodilution in Alzheimer's Disease patients""}]"
4173,124,glycated hemoglobin,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'cognition'}]"
1873,124,Hemoglobin A1c (HbA1c),"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1871,124,Heme oxygenase 1 (HO-1),"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of oxidative stress in AD mice'}]"
1789,125,Granule cell layer cellularity,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Restored by T3D-959 treatment'}]"
4176,125,granulovacuolar degeneration (GVD),"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}]"
1793,125,Granulovacuolar degeneration,"[{'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
1792,125,Granulocytes-to-lymphocytes ratio,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]"
1790,125,Granule cell layer thickness,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Partially restored by T3D-959 treatment'}]"
1791,125,Granulocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]"
3724,126,Verrucomicrobia,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1812,126,Gut hormones,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Influence on Alzheimer's Disease processes""}]"
1128,126,Cirrhosis,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
493,126,Appetite/eating abnormalities,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
518,126,Autophagy,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Improvement in Alzheimer's Disease treatment""}]"
1867,126,Heart disease,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition associated with Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]"
496,126,Argyrophilic grain disease (AGD),"[{'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Amnestic cognitive impairment in Alzheimer's Disease""}]"
2042,126,Idalopirdine,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
3682,127,VILIP-1,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Incipient cognitive decline, cognitive decline rates, and brain atrophy rates in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease diagnosis""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}]"
843,127,CAMCOG,"[{'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
842,127,CAM,"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}]"
2722,127,PECAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3683,127,VILIP1,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4486,127,sVCAM-1,"[{'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
780,128,Braak stages,"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3084,128,Retroactive interference (RI) performance,"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology""}]"
1179,128,Communication Problems Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Semantic and pragmatic communication issues in Alzheimer's Disease""}]"
811,128,Burst firing patterns,"[{'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Critical component of NBM function and effective stimulation'}]"
4518,129,synaptophysin,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No change in synapse density after TI stimulation'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
3357,129,Synaptophysin expression,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3356,129,Synaptophysin,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Maintenance of synaptic density in AD mice'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Environmental Enrichment'}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
3351,129,Synapsin-1,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prevention of synaptic vessel release in AD mice'}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved synaptic function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased expression in the hippocampus associated with exercise-induced protection against reduction of synaptic proteins after surgery'}]"
4519,129,synaptotagmin,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Patient selection'}]"
3359,129,Synaptotagmin,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]"
3350,129,Synapsin 1,"[{'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Synaptic loss in Alzheimer's Disease""}]"
4517,129,synaptopathy,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3352,129,Synapthophysin,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved synaptic function in Alzheimer's Disease""}]"
2800,130,Parietal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Compensatory mechanisms in Alzheimer's Disease""}]"
4090,130,daytime activity level,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]"
308,130,Activity,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
309,130,Activity Levels,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3881,130,activity count,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4089,130,daytime activity,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]"
3783,131,Whishaw index,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Swimming efficiency in cognitive assessments'}]"
1725,131,Gallagher index,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor reference memory in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive flexibility impairments in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3340,131,Sum Index,"[{'article': 'PMC6052695.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Decline in Alzheimer's Disease""}]"
701,131,BI (Barthel Index),"[{'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Scores reflect functional capacity and response to treatment'}]"
3574,131,TorCA Sum Index,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
721,131,Barthel Index,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Activities of daily life (ADL) in Alzheimer's Disease""}, {'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4488,132,salivary cortisol,"[{'article': 'PMC8336239.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Diurnal neuroendocrine activity'}]"
1228,132,Cortisolism,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in Alzheimer's Disease patients""}]"
3207,132,Salivary cortisol,"[{'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in salivary cortisol levels after yoga and compassion meditation program'}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3309,132,Stress and cortisol,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hippocampal shrinkage associated with Alzheimer's Disease""}]"
1225,132,Cortisol,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress linked to Alzheimer's Disease""}, {'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to yoga and compassion meditation program intervention'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Exacerbation of behavioral disorders in Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep-wake disorders in persons with Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in sleep-wake disturbances (SWDs)'}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Accelerated disease progression in Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved executive function (Stroop performance)'}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive function improvement in mild cognitive impairment'}]"
4083,132,cortisol,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative DNA and RNA damage'}, {'article': 'PMC3652205.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Stress'}, {'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to yoga and compassion meditation program'}, {'article': 'PMC3652205.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition'}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1227,132,Cortisol levels,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in patients with Alzheimer's Disease""}]"
1226,132,Cortisol (COR),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3085,133,Rey Auditory Verbal Learning Test,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3088,133,Rey Auditory Verbal Learning Test (RAVLT) total score,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amnestic mild cognitive impairment (amild cognitive impairment)'}]"
3087,133,Rey Auditory Verbal Learning Test (RAVLT) delayed recall score,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amnestic mild cognitive impairment (amild cognitive impairment)'}]"
3086,133,Rey Auditory Verbal Learning Test (RAVLT),"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Long-term memory in Alzheimer's Disease""}]"
3718,133,Verbal expression and learning scores,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
1007,133,"California Verbal Learning Test-Second Edition, Adult Version (CVLT-II)","[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Verbal Learning and Memory Impairment in Alzheimer's Disease""}]"
1187,133,Complutense Verbal Learning Test (TAVEC),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Memory and learning processes in Alzheimer's Disease""}]"
2212,134,Leptin,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ' Restoration of leptin levels in diabetic rats'}]"
4236,134,leptin,"[{'article': 'PMC5445077.txt', 'relationship': 'ACTS_AS_NEUROTROPHIC_FACTOR_AND_EXERTS_NEUROPROTECTIVE_EFFECTS_AGAINST', 'object': 'Aβ oligomer-induced toxicity'}]"
4503,134,statin,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]"
3298,134,Statins,"[{'article': 'PMC4615808.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Aβ levels in Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]"
1875,135,Hey1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]"
2544,135,NRG1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
1586,135,Fis1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Down-regulation of Fis1 expression improves mitochondrial function in Alzheimer's Disease""}]"
705,135,BMAL1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Circadian rhythm regulation in Alzheimer's Disease""}]"
3493,135,TYK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
3658,135,ULK1,"[{'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Autophagy levels in Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagy'}, {'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3149,135,SIK1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3019,135,RIPK1,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of Aβ accumulation and improvement of behavioral deficits in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inhibition of microglial phagocytic activity in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced amyloid burden, levels of inflammatory cytokines, and memory deficits.'}]"
2669,135,P1,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's Disease""}]"
2632,135,OGG1,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]"
2483,135,N1,"[{'article': 'PMC4195286.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3659,135,ULK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
53,136,2DG,"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain metabolism impairment in Alzheimer's Disease mouse models""}, {'article': 'PMC6015016.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glucose metabolism in Alzheimer's Disease""}]"
3030,136,RPS6KA1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3031,136,RPS6KA2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3032,136,RPS6KB1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
55,136,2DG6P,"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
898,137,CDR-Sb,"[{'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}]"
897,137,CDR-SOB,"[{'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher CDR-SOB scores in participants with dementia'}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia severity in Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in clinical dementia rating in patients with Alzheimer's Disease""}]"
896,137,CDR-SB scores,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Change in disease severity over 12 months'}]"
895,137,CDR-SB score,"[{'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]"
894,137,CDR-SB,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia severity in Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia Severity'}]"
899,137,CDR-sb,"[{'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
900,137,CDRS,"[{'article': 'PMC9871821.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]"
892,137,CDR score,"[{'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9395831.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of Alzheimer's Disease""}]"
891,137,CDR Sum of Boxes,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment severity in Alzheimer's Disease""}]"
890,137,CDR (global),"[{'article': 'PMC8028783.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of dementia severity in Alzheimer's Disease""}]"
893,137,CDR total score,"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
889,137,CDR,"[{'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Staging of Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease at mild dementia stage or prodromal AD""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Clinical Dementia Rating scale score for defining mild-to-moderate AD'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8305709.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Dementia Severity Assessment'}, {'article': 'PMC5619332.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Dementia progression in Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of dementia in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess acquiring new skills in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Dementia severity in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease dementia severity""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in Alzheimer's Disease""}]"
3875,138,aMT,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severity of cognitive dysfunction in Alzheimer's Disease""}]"
2140,138,K-BNT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Language Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
1827,138,HKLLT,"[{'article': 'PMC9871821.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved verbal memory after tPBM treatment'}]"
2280,138,MGnD,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2545,138,NRGN,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in NRGN levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
3034,138,RT,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2548,138,NTB,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory and executive function in mild to moderate AD'}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2344,138,MVGT,"[{'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3012,138,RD,"[{'article': 'PMC8351379.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: White matter microstructure changes in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Gait characteristics in the same way as MD'}]"
1040,139,Central memory helper T lymphocytes (CD45RA−CCR7+),"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
2992,139,Qβ-induced T-cell responses,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Immune response to amyloid-beta in Alzheimer's Disease""}]"
740,139,Beta cell function,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved beta cell function in Alzheimer's Disease""}]"
2919,139,Platelets-to-lymphocytes ratio,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]"
1927,139,Homeostatic model assessment for B-cell function (HOMA-B),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]"
1445,139,Effector helper and cytotoxic T lymphocytes (CD28−),"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
4604,139,α-syn-specific T cell reactivity,"[{'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4025,140,cerebral spinal fluid amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1081,140,Cerebral spinal fluid Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}]"
4556,140,tau/cerebral spinal fluid Aβ42 ratios,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid PET Centiloids'}]"
4046,140,cerebral spinal fluid t-tau/Aβ42 ratio,"[{'article': 'PMC5668981.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Cognitive impairment in African Americans and Caucasians'}]"
4004,140,cerebral spinal fluid Aβ1–42,"[{'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid positivity in Alzheimer's Disease""}]"
1088,140,Cerebral spinal fluid amyloid-β 42 peptide (Aβ42),"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4048,140,cerebral spinal fluid tau/Aβ42 ratio,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early AD marker'}]"
1080,140,Cerebral spinal fluid Aβ42/40 ratio,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1079,140,Cerebral spinal fluid Aβ42 measurement,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Target engagement and amyloid accumulation'}]"
4007,140,cerebral spinal fluid Aβ42/40,"[{'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}]"
4008,140,cerebral spinal fluid Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4005,140,cerebral spinal fluid Aβ42,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Clinical diagnosis of AD'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}]"
1078,140,Cerebral spinal fluid Aβ42,"[{'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Parenchymal Aβ42'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}]"
1076,140,Cerebral spinal fluid Aβ(1–42) levels,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Crenezumab treatment'}]"
1075,140,Cerebral spinal fluid Aβ levels,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4010,140,cerebral spinal fluid Aβ42/t-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment due to Alzheimer's Disease""}]"
4009,140,cerebral spinal fluid Aβ42/p-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment due to Alzheimer's Disease""}]"
4003,140,cerebral spinal fluid Aβ1–40,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reduction in levels consistent with atabecestat's inhibitory effect""}]"
4242,140,lower cerebral spinal fluid Aβ42,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4044,140,cerebral spinal fluid t-Tau/Aβ42 ratio,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4002,140,cerebral spinal fluid Aβ,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4024,140,cerebral spinal fluid amyloid (Aβ42),"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1077,140,Cerebral spinal fluid Aβ40,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4006,140,cerebral spinal fluid Aβ42 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'β-amyloidopathy in cognitively impaired subjects'}]"
1340,141,Dialister,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less AD pathology'}]"
2623,141,Number of revolutions,"[{'article': 'PMC9203627.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Personalized treatment for Alzheimer's Disease""}]"
176,141,AN-1792,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II due to meningoencephalitis'}]"
3834,141,Zarit Burden Interview,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in caregiver burden in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
4305,141,modularity,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
201,142,APOE-4,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease diagnosis""}]"
204,142,APOE-ε4,"[{'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC546007.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher risk of Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy: Oligogenic risk score for Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher risk for Alzheimer's Disease with lower burden of common AD risk alleles""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia (Alzheimer's Disease)""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prevalence of low Aβ pathology burden in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4820235.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of cognitive decline'}, {'article': 'PMC4820235.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater response to physical activity'}, {'article': 'PMC4820235.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4820235.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4820235.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher cerebral spinal fluid cortisol and worse prognosis in Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression from mild cognitive impairment to Alzheimer's Disease""}]"
205,142,APOE2,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased levels of PSD95 in superior temporal cortex'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Most phospholipids'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased HDL, CRP, vitamin D, CysC, ApoA, creatinine, and alkaline phosphatase'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced LDL, IGF-1, bilirubin, and ApoB'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced total cholesterol, LDL, lipoprotein A, and ApoB'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased apoA1'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced Aβ burden'}]"
206,142,APOE3,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
202,142,APOE-ɛ4,"[{'article': 'PMC8351379.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
192,142,APOE ɛ4,"[{'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau in APOE ɛ4 carriers'}]"
189,142,APOE fragments,"[{'article': 'PMC7223540.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease treatment with COR388""}]"
214,142,APOEε4,"[{'article': 'PMC10013957.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased lifetime risk of developing AD dementia'}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Stratification based on APOEε4 genotype for treatment response'}, {'article': 'PMC6146627.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher proportion in amyloid-positive group'}, {'article': 'PMC6909550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Gantenerumab dose-titration'}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7505369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early increased hippocampal volume in cognitive normal carriers'}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Decreased FC of frontostriatal pathway, potentially indicating lower capacity for adaptation and higher chance of disease progression'}]"
216,142,APOε4,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for late-onset Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment effect in Alzheimer's Disease""}]"
196,142,APOE ε4,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced MTL activation in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer memory performance and increased risk for Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Reduced hippocampal volume and activation in elderly carriers'}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavior changes: mental activities and diet at 6 weeks among self-referred participants'}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with prognosis in Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased intra-individual variability (IIV) in cognitive performance'}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4481070.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased functional connectivity in default mode network (DMN) regions'}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Decreased functional connectivity in cerebellar tonsils and retrosplenial regions'}, {'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and functional connectivity changes in brain regions'}, {'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster decline in cognitive scores'}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease in APOE ε4 carriers with more severe Aβ amyloid angiopathy and capillary amyloid accumulation""}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""greater volume of white matter hyperintensities in Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased risk of Aβ amyloid angiopathy-associated lobar haemorrhage'}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in carriers""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower baseline cerebral spinal fluid Aβ42 levels'}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced delivery of DHA to the brain'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive improvements in non-carriers'}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8074126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Diagnosis and treatment selection for Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Behavioral changes in health and insurance'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility for: Alzheimer's Disease treatment""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4607601.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4862247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology and progression""}, {'article': 'PMC5067903.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher plasma tau levels in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of developing Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Anxiety and depression in FDRs of AD patients'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Test-related distress in ε4-positive participants'}, {'article': 'PMC5103503.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Behavioral changes in insurance uptake and health-related behavior'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory functioning differences in ε4-positive participants'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated test-related distress and depressive symptoms'}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Changes in health-related behavior and subjective memory functioning'}, {'article': 'PMC5315443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Early functional connectivity alterations in preclinical Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Treatment: Atabecestat'}, {'article': 'PMC6106931.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy: Alzheimer's Disease treatment""}, {'article': 'PMC6152871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease, particularly in European and Asian populations""}, {'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of death and dementia in adults with Down syndrome'}, {'article': 'PMC6439956.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts earlier dementia diagnosis and higher mortality risk'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased mortality risk'}, {'article': 'PMC6439956.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Earlier dementia diagnosis'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduction in right cortical surface area in Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cortical surface area reduction in the right hemisphere'}, {'article': 'PMC6547570.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cortical surface area reduction in the right hemisphere'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical surface area decline in Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk factor for early-stage Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts cognitive decline in SCD individuals'}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of dementia'}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease prognosis'}, {'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of late-life dementia'}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD'}]"
3929,142,apoE4,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of tau phosphorylation'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced cognitive function and faster disease progression'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced Aβ deposition and improved cognitive function'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Therapeutic strategies to modulate apoE levels'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-beta plaques and cerebral amyloid angiopathy'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: HAE-4 antibody injection'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: AAV-mediated expression of APOE2'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ and tau aggregation, inflammation, and lipid dysregulation'}, {'article': 'PMC9644639.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Cognitive decline and AD progression'}, {'article': 'PMC9644639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive function and synaptic loss'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Plasma replacement therapy and albumin replacement'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Isoform-specific therapeutic interventions'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Peripheral apoE modulation'}]"
3930,142,apoe4,"[{'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased amyloid burden and aggregation'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Response to bexarotene treatment'}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'ALZ-801 treatment'}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-Onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-Onset Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk for CVD and T2DM'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased prevalence and hazard for metabolic syndrome'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Disrupted pathways related to synaptic formation and increased synaptic transmission'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Altered cholesterol metabolism and impaired Aβ uptake'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less efficient Aβ clearance and activation of inflammatory genes in microglia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vulnerability to bioenergetic deficits'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced synaptic and mitochondrial function and increased neuroimmune signaling'}]"
480,142,ApoEε4,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurofibrillary tangles formation in Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
191,142,APOE status,"[{'article': 'PMC6004911.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
474,142,ApoE-4,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD conversion risk'}]"
477,142,ApoE4,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive dysfunction and spatial learning deficits in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Increased seizure susceptibility in female mice'}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence of PIB-negativity in Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Genotype-specific response to bexarotene treatment in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher prevalence of ApoE4 carriers in amyloid positive group'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk and amyloid positivity""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy Choice: Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with higher neurogranin values'}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Worse outcomes in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive Training Benefits'}]"
210,142,APOE4,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10002844.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduced risk of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APOE ε4 carriers""}, {'article': 'PMC10233712.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10306194.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to INI therapy in AD patients'}, {'article': 'PMC10306194.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'No cognitive benefits or decline in memory in APOE-ε4+ subjects'}, {'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Episodic memory deficits in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease patients""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Efficacy of AC-1202 treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for memantine treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline as measured by ADAS-Cog scores'}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO', 'object': 'Treatment: AC-1202'}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection based on APOE4 status for Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Predicts response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in ADAS-Cog scores in APOE4(-) subjects at Day 45'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in ADAS-Cog scores in APOE4(-) subjects at Day 90'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in MMSE scores in APOE4(+) subjects at Day 104'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved MMSE scores in APOE4(+) subjects at Day 104'}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Guiding selection based on APOE4 status'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to AC-1202 therapy in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Treatment eligibility in E4(-) AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment using AC-1202""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Determine eligibility for MCT treatment in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Early functional signs of emerging Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Learning and Memory Deficits'}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Age-dependent Impairments of Hilar GABAergic Interneurons'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of conversion to mild cognitive impairment'}, {'article': 'PMC3767625.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk for future cognitive decline'}, {'article': 'PMC4055052.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse memory score in older NHW individuals'}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related prognosis: Alzheimer's Disease progression""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease patients without APOE4""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Genetic susceptibility testing for Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormalities-edema (ARIA-E)'}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4410460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age at onset (AAO) of Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Determine treatment response based on APOE4 carrier status'}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved MMSE scores in APOE4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ on composite measure in APOE4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant difference in Aβ measures among APOE4 carriers'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'ARIA-E'}, {'article': 'PMC4886210.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased Alzheimer's Disease risk and decreased brain clearance of Aβ""}, {'article': 'PMC4888851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease based on carrier status""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Alzheimer’s disease'}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Eligibility and Allocation in Clinical Trial'}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Discontinuation of lecanemab treatment'}, {'article': 'PMC8053280.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher incidence of ARIA-E'}, {'article': 'PMC8053280.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Lecanemab dose adjustment for APOE4 carriers'}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility: APOE4 carriers for lecanemab treatment'}, {'article': 'PMC8201462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8211849.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Indicates treatment eligibility for study participation in Alzheimer's Disease research""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease eligibility""}, {'article': 'PMC8502814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer prognosis in Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (trend level contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of converting to Alzheimer's Disease dementia""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4923754.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}, {'article': 'PMC5103503.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Decrease in CES-D at 12 months'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory functioning in participants'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Behavioral changes and lifestyle modifications'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Psychological effects such as anxiety and depression'}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset sporadic Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6004911.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Age at onset of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease risk""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6126036.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6152871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Micro-haemorrhages and haemosiderin detection in AD patients'}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6292112.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Mortality in individuals with Down syndrome and dementia'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Dementia in Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cerebral amyloid angiopathy'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of typical or limbic predominant AD'}, {'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dose-titration scheme based on APOE genotype'}, {'article': 'PMC6909550.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility: Alzheimer's Disease clinical trials""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sporadic Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Response to Nilvadipine treatment in Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in middle-aged adults'}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis and response to physical activity intervention""}, {'article': 'PMC7364345.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better outcome in clinical response to ALZ-801'}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher risk of early AD progression'}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and amyloid accumulation in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of developing Late-onset Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC9269742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cerebral blood flow regulation'}, {'article': 'PMC9269742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Sporadic Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9269742.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Exercise intervention'}, {'article': 'PMC9269742.txt', 'relationship': 'RESPONDED_TO', 'object': 'Exercise'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral blood flow response to exercise'}, {'article': 'PMC9289357.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Early-stage preclinical Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for other dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lewy body pathology'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Parkinson’s disease dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater cognitive impairment in vascular dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and neurodegeneration'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased tau aggregation and neurotoxicity'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced retinal capillary density'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decreased cholesterol transport capacity and increased lipid droplet accumulation'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Long-term treatment with angiotensin receptor blockers'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'LysoPE and acylcarnitine species'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'PE(O), PE(P), ceramides, and triglycerides'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced levels of phosphatidylinositol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced levels of CAR, LPC, LPE, PA, PC, PE, PI, PS, SM, and ST'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced hyperlipidemia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased VLDL-cholesterol and reduced HDL-cholesterol levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced LysoPC(18:1), LysoPC(P-18:0), and Cardiolipin'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher levels of cholesterol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased LDL, IGF-1, SHBG, bilirubin, triphosphate, ApoB, and total cholesterol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased SNAP-25 in cognitively normal patients'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased Aβ burden and tau burden'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased VILIP-1 in preclinical AD'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased levels of CDH6 and HAGH in AD patients'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased NP1 levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease (AD)""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid accumulation in the vasculature'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression and pathogenesis'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: CRISPR/Cas9 genome-editing'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Higher baseline amyloid levels in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Higher baseline PET SUVr levels in APOE4 carriers'}, {'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
186,142,APOE,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease mortality and outcomes""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease groups""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4983010.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for PREADVISE study'}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8066440.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8201462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Genetic risk factor for Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC8302739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease clinical trials""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved prediction accuracy for Alzheimer's Disease diagnosis""}, {'article': 'PMC8302739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Identify individuals at higher risk of developing Alzheimer's Disease or dementia""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cortical morphometry changes in SCD related to Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Firmicutes and Clostridiales in APOE2/E3 genotype'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower abundance of Prevotellaceae in APOE2/E3 genotype compared to other APOE genotypes'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Ruminococcaceae in APOE2/E3 compared to APOE3/E3, APOE3/E4, or apoe4/E4'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Gemmiger in APOE2/E3 compared to APOE3/E3 and APOE3/E4'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Roseburia in APOE3/E3 compared to other APOE genotypes'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Disease-Associated Microglia (DAM) phenotype in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Late-onset Alzheimer's Disease (LOAD)""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Tauopathies and Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'PSD95 levels in superior temporal cortex in AD'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'LDL cholesterol levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'GlycA, isoleucine, LDL-TG, VLDL-TG, and M-VLDL'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CRP, ApoB, IL-13, and CXCL9 levels'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic interventions in Alzheimer's Disease""}]"
187,142,APOE e4,"[{'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Higher genetic risk for Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
467,142,ApoE,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Increased Aβ plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Microglial-mediated Aβ deposition in early stages of amyloidogenesis'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaques'}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'ApoE expression levels predict AD progression'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Brain amyloidosis'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Outcome""}, {'article': 'PMC8088704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection for Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6126036.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Associated with: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ detection and clearance'}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Prodromal Alzheimer's Disease""}]"
193,142,APOE ε2,"[{'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Shows protective influence on dementia risk'}]"
472,142,ApoE ε4,"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Carrier status for ApoE ε4 allele'}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis in carriers vs. noncarriers""}, {'article': 'PMC4918115.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lack of clinical efficacy in treatment response'}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Lower MMSE scores and longer duration of Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Bapineuzumab treatment response'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Presence of dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk factor for Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related dementia""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased risk of Alzheimer's Disease progression""}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher rate of conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in dyslipidemic patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher proportion of progression to AD'}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
471,142,ApoE status,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1285,143,DMS48,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Visual recognition memory deficits in Alzheimer's Disease""}]"
1290,143,DPs,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1282,143,DMN,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
1304,143,DYRK1A kinase activity,"[{'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neurocognitive symptoms and neurodegenerative phenotypes in Down syndrome'}]"
1303,143,DYRK1A,"[{'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic model""}, {'article': 'PMC4675859.txt', 'relationship': 'MODULATES', 'object': ""Alzheimer's Disease""}]"
1372,143,Dkk1,"[{'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ synaptotoxicity'}, {'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ production and synapse loss'}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1253,143,D54D2,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid presence in Alzheimer's Disease""}]"
177,144,AN1792,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Active immunotherapy targeting Aβ'}]"
92,144,A673T,"[{'article': 'PMC4304279.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1966,144,IDE rs2251101,"[{'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
839,144,CAB101,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
841,144,CAD106,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II/III clinical trials in cognitively unimpaired individuals with 2 apoe4 genes'}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Active immunotherapy targeting Aβ'}]"
673,144,BAN2401,"[{'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Disease progression and drug effects'}, {'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta species'}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma Aβ(1-40)'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II trial in early AD'}]"
840,144,CAB102,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3655,144,UE2343,"[{'article': 'PMC5301048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain 11β-HSD1 inhibition and cognitive enhancement in Alzheimer's Disease""}]"
1441,144,EVP-0962,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II clinical trials'}]"
2496,144,NAP226-90,"[{'article': 'PMC5075013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Steady-state plasma concentrations in patients with Alzheimer’s disease'}, {'article': 'PMC5075013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Rivastigmine metabolism'}, {'article': 'PMC5075013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dosing in patients with renal impairment'}, {'article': 'PMC5075013.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'No dose adjustment required in patients with renal impairment'}]"
4472,144,rs2143466,"[{'article': 'PMC6158742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age of onset in Alzheimer's Disease""}]"
3374,144,T3D-959,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic effects in experimental Alzheimer's Disease models""}, {'article': 'PMC4979550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Efficacy in preserving spatial learning and memory in Alzheimer's Disease models""}]"
1392,144,E2609,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase III clinical trials for Alzheimer's Disease""}]"
2523,144,NNI-362,"[{'article': 'PMC7805132.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7805132.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and improved memory function in aging mice'}]"
2378,145,Mediterranean diet,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1785,145,Glycemic control,"[{'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2377,145,Mediterranean Diet Adherence,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Adherence to Mediterranean diet lowers Alzheimer's Disease risk""}]"
1878,145,High glycemic diet,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the precuneus, lateral temporal lobe, and posterior cingulate gyrus in preclinical Alzheimer's Disease""}]"
2624,145,Nutrition,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4093,145,dietary changes,"[{'article': 'PMC9755275.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'cognition'}]"
1343,145,Diet (MIND diet),"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of Alzheimer's Disease""}]"
181,146,ANU-ADRI risk,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}]"
182,146,ANU-ADRI total,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}]"
3883,146,aducanumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Monoclonal antibody targeting Aβ'}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}]"
317,146,Aducanumab,"[{'article': 'PMC4888851.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III trials in early AD'}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2961,147,Protein carbonyl content,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]"
2962,147,Protein carbonyls,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
3595,147,Total protein,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1112,147,Chitinase-3-like protein 1 (CHI3L1 or YKL-40),"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2960,147,Protein carbonyl,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3094,147,Ribosomal proteins,"[{'article': 'PMC2432467.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cellular stress response'}]"
3876,147,abnormal protein deposition,"[{'article': 'PMC3389343.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
694,148,BEC 96 Total,"[{'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
833,148,C9orf72,"[{'article': 'PMC6158742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
832,148,C9ORF72,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Linked to primary progressive aphasia (PPA) variants'}]"
831,148,"C99, C89, and C83","[{'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
695,148,BEC96,"[{'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1367,149,Discrimination learning,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3051,149,Reduced primacy effects,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5226952.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease""}]"
4444,149,primacy/recency ratio,"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant difference from Experiment 1'}]"
4162,149,generalization,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2260,150,MCP-1,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation, which is linked to Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2261,150,MCP-1/CCL2,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2262,150,MCS-B,"[{'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia severity as assessed by Pfeffer-FAQ and CDR'}]"
2282,150,MIP-1α,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Immune cell migration and inflammation'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2345,150,"Macrophage inflammatory protein-1α [MIP-1α, CCL3]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2283,150,MIP-1β [CCL4],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3018,151,RICTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3035,151,RUD-Lite,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2179,151,LICI,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced long-interval intracortical inhibition in Alzheimer's Disease""}]"
3974,151,brevican,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3195,151,SUVRMNI-WM,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid accumulation in Alzheimer's Disease""}]"
3194,151,SUVRMNI-CB,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid accumulation in Alzheimer's Disease""}]"
4405,151,parietal lobule,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]"
3975,151,bumetanide,"[{'article': 'PMC10002844.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced risk of Alzheimer’s Disease'}]"
2975,152,QC activity,"[{'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2976,152,QC inhibition,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Biological effect on QC inhibition'}]"
2084,152,Inhibition cost,"[{'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]"
2085,152,Inhibitory/Excitatory Intracortical Circuits,"[{'article': 'PMC7360860.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""rTMS treatment in Alzheimer's Disease""}]"
327,153,Alanine Transaminase (ALT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
328,153,Alanine aminotransferase (ALT),"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver function during indomethacin treatment'}]"
365,153,"Amino acids (phenylalanine, isoleucine, histidine)","[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""GV-971 treatment in Alzheimer's Disease""}]"
364,153,Amino acid levels,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
503,153,Aspartate aminotransferase (AST),"[{'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Normalized within four weeks after treatment discontinuation'}]"
502,153,Aspartate Transaminase (AST),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4512,154,superficial parafoveal vessel density,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
2393,154,Meningeal Lymphatic Vessels,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
4402,154,parafoveal and peripapillary densities,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
4101,154,dura mater lymphatic vessels,"[{'article': 'PMC4493418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired macromolecule clearance from the brain'}, {'article': 'PMC4493418.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4022,155,cerebral spinal fluid SOM,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42 concentrations and blood total cholesterol levels'}]"
4011,155,cerebral spinal fluid BACE,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}]"
4028,155,cerebral spinal fluid homovanillic acid (HVA),"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Nilotinib treatment'}]"
4041,155,cerebral spinal fluid sAPPα,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dose-related increase in levels'}]"
4016,155,cerebral spinal fluid NSE,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cell death after brain trauma'}]"
4036,155,cerebral spinal fluid protein markers,"[{'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Decrease in synaptic dysfunction markers'}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
1074,155,Cerebral spinal fluid (CSF) tests,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1073,155,Cerebral spinal fluid (CSF) biomarkers,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
4013,155,cerebral spinal fluid F2-isoprostane levels,"[{'article': 'PMC4202787.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to E/C/ALA treatment'}]"
1072,155,Cerebral spinal fluid (CSF),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1071,155,Cerebral spinal fluid,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4012,155,cerebral spinal fluid DJ-1,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response'}]"
4042,155,cerebral spinal fluid sAPPβ,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in levels consistent with β-secretase inhibition'}]"
1089,155,Cerebral spinal fluid biomarkers,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection: Alzheimer's Disease""}]"
4043,155,cerebral spinal fluid sVCAM-1 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Correlated with vascular risk factors and white matter hyperintensity (WMH) volume in Caucasians'}]"
4053,155,cerebral spinal fluid tracer (FITC-Dextran-3kD),"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cerebral spinal fluid dynamics in Alzheimer's Disease""}]"
3999,155,cerebral spinal fluid (CSF) cholinergic markers,"[{'article': 'PMC4936020.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NGF-ECB treatment'}]"
4000,155,cerebral spinal fluid (CSF) clearance,"[{'article': 'PMC4493418.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4049,155,cerebral spinal fluid total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent decrease in levels'}]"
4026,155,cerebral spinal fluid biomarker,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pharmacological activity of neflamapimod in Alzheimer's Disease""}]"
1082,155,Cerebral spinal fluid F2-IsoPs,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4017,155,cerebral spinal fluid NfL levels,"[{'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower levels in African Americans without cognitive impairment'}]"
4021,155,cerebral spinal fluid S100B,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Glial death in the brain'}]"
4001,155,cerebral spinal fluid AD biomarkers,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease severity in Alzheimer's Disease patients""}]"
3291,155,Spinal fluid measures,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring disease progression in Alzheimer's Disease""}]"
1093,155,Cerebro-cerebral spinal fluid examination,"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1090,155,Cerebral spinal fluid markers,"[{'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}]"
1055,155,Cerebral Spinal Fluid (CSF) Influx,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
4027,155,cerebral spinal fluid biomarkers,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Determine preclinical AD pathology in APOEε4 carriers'}, {'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4015,155,cerebral spinal fluid NPY,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diabetes and low plasma cholesterol levels'}]"
865,156,CD25high Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3446,156,TREM2 R47H,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Early-onset dementia'}]"
872,156,CD39+ Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
863,156,CD127low-neg Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3627,156,Tregs,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia status changes'}, {'article': 'PMC6584558.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3444,156,TREM1,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3628,156,Trehalose,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]"
3445,156,TREM2,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Ameliorated amyloid pathology in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of AD pathology'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated amyloid pathology and behavioral deficits.'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial response around senile plaques in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial Activation in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease susceptibility""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6158742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory response and microglial phagocytosis'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Phagocytic response'}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease Progression""}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased levels in Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3443,156,TREM-2,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}]"
3629,156,Trem2,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Disease-Associated Microglia (DAM) phenotype in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ detection and clearance'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3878,157,acquisition z-scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2065,157,Immediate memory domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in memory functions in suspected mild cognitive impairment'}]"
4465,157,recall-ratio z-scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5226952.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Changes in cognitive function across trials'}]"
3582,157,Total Recall (TR) scores,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]"
1625,157,Free Recall (FR) scores,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]"
2237,157,Low memory scores,"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]"
2702,157,PAL first trial memory score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Clinical dementia'}]"
1319,157,Delayed memory domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in delayed memory functions in suspected mild cognitive impairment'}]"
2331,158,MRI-derived total WMH,"[{'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'n-3 PUFA supplementation effects'}]"
2328,158,MRI-derived WMH,"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease risk in older adults'}]"
1947,158,Hyperpolarized 129Xe MRI,"[{'article': 'PMC7554935.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral perfusion changes associated with Alzheimer’s disease'}]"
51,158,2D T2-weighted FLAIR MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
52,158,2D T2-weighted GRE MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
62,158,3D T1-weighted MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3569,159,Timed Gait Test,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
3283,159,Spatio-temporal analysis of walking (GAITRite),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Gait impairments'}]"
1670,159,GAITRite®,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Gait parameters in Alzheimer's Disease""}]"
1715,159,Gait characteristics,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4158,159,gait variability,"[{'article': 'PMC3898226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease and related disorders (ADRD)'}]"
1717,159,"Gait variables (velocity, variability, frequency)","[{'article': 'PMC4406069.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Dementia due to Alzheimer's Disease""}]"
4156,159,gait,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved balance and reduced fall risk in older adults'}, {'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}]"
1712,159,Gait,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}, {'article': 'PMC4197903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
3589,160,Total brain volume (TBV),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3807,160,Whole brain volume,"[{'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3588,160,Total brain volume,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}]"
3576,160,Total Brain Volume (TBV),"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Impairment'}, {'article': 'PMC8570373.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Post-Stroke Neurodegeneration'}, {'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in stroke patients'}]"
3333,160,Subiculum volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
796,160,Brain volume,"[{'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Primary progressive aphasia'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Attenuated brain volume decline in Alzheimer's Disease""}]"
2614,160,Normalized Brain Volume (NBV),"[{'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1221,160,Cortical volume,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease progression""}]"
3330,160,Subcortical Volumes,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]"
3971,160,brain volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in older adults with mild cognitive impairment'}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'slower dementia progression and reduced risk of dementia'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Structural changes in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Age-related improvements or attenuated decline in cognition'}]"
3013,160,REGIONAL CEREBRAL VOLUME,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
4061,161,circRNAs,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aging and Alzheimer's Disease""}]"
2891,161,Plasma Mir107 expression,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Cortical Thickness (CT)'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Surface Area (SA)'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Local Gyrification Index (LGI)'}]"
2892,161,Plasma Mir107 levels,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Pathogenesis of Alzheimer's Disease""}]"
4289,161,microRNAs,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression in LOAD'}]"
4288,161,microRNA-130a,"[{'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2406,161,MicroRNA-155 (miR155) and IFN-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Restricted neurodegenerative pathology and preserved cognitive function.'}]"
2582,162,Neurophysiological measures,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Interventions in Alzheimer's Disease""}]"
1455,162,Electrophysiological response,"[{'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Memory performance in Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Response to PLAS intervention in Alzheimer's Disease""}]"
2470,162,Motor-evoked potentials (MEPs),"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cortico-motor reactivity and cortical plasticity in Alzheimer's Disease""}]"
1582,162,Field excitatory postsynaptic potentials (EPSPs),"[{'article': 'PMC3362564.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'XPro1595 therapy'}]"
2611,162,Noradrenergic modulation,"[{'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4445,162,primary somatosensory cortex (PSC),"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4109,163,eProt,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}]"
1391,163,E-Selectin,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1394,163,EAAT1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1427,163,EPHA1,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1395,163,EAAT2,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1457,163,Emp1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'BBB assembly'}]"
4062,164,circadian rhythms,"[{'article': 'PMC8317398.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Bright Light Therapy (BLT)'}]"
1224,164,Corticosteroid Circadian Rhythm,"[{'article': 'PMC6520689.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1127,164,Circadian Clocks Desynchronization,"[{'article': 'PMC6520689.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3957,164,beta1 rhythm,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
787,164,"Brain Rhythms (δ, θ, α1, α2, β1, β2, γ)","[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
3884,165,advanced glycation end products,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4174,165,glycine recognition sites (GlyRS),"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""chronic anxiety in Alzheimer's Disease""}]"
3045,165,Receptor for advanced glycation end products,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
4183,165,higher strychnine-sensitive glycine receptor (GlyRS) functioning,"[{'article': 'PMC9213384.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
1786,165,Glymphatic Exchange,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
4175,165,glymphatic system,"[{'article': 'PMC4493418.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1784,165,GlyRS functioning,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety in Alzheimer's Disease""}]"
2165,166,LC-MS-Arc Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
618,166,Aβ42 levels,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease (cerebrospinal fluid Aβ42 levels ≤600 pg/mL)""}]"
625,166,Aβ42/Aβ40 ratio,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at 1-week follow-up'}, {'article': 'PMC11493878.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive outcomes in older adults with cognitive impairment'}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β burden in Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Brain amyloidosis'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC5297247.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (reduced levels considered pathological)""}]"
536,166,Aβ 42/40,"[{'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
598,166,Aβ11-42,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
599,166,Aβ18–35,"[{'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plasma levels increased following GSK933776 treatment'}]"
645,166,AβX–38,"[{'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Elevated levels in cerebral spinal fluid following administration of GSK933776'}]"
617,166,Aβ42,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plaque formation and oligodendrocyte death'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in the ratio of t-tau to Aβ42 in cerebral spinal fluid'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'MRIgFUS treatment'}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive decline in non-demented subjects'}, {'article': 'PMC3523068.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early amyloidosis in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Lower levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with Solanezumab in mild to moderate AD'}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'RP reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'SS reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in Aβ42 levels in blood at low concentrations of semagacestat'}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques and Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Subjects with increased PET amyloid load'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""White matter lesions (WML) mainly in Alzheimer's Disease (AD)""}, {'article': 'PMC4746584.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease via PET imaging""}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk for Alzheimer's Disease development""}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter lesions (WML) in AD dementia'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Association with white matter lesions (WML) in the temporal lobes in Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'INNOTEST ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Plaque density'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular disease (e.g., white matter lesions, cerebral microbleeds, hypertension, diabetes, ischemic heart disease)'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Amyloid deposition in the brain'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease based on cerebrospinal fluid Aβ42/Aβ40 ratio""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathologic cerebrospinal fluid signature in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target of Aβ antibodies (solanezumab, crenezumab, and aducanumab)'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early AD-related changes'}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid deposition in mid-life'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced delivery of DHA to cerebral spinal fluid'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'PREDICTS_RESPONSE', 'object': 'Change in DHA levels after supplementation'}, {'article': 'PMC4928349.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Correlation with DHA levels in cerebral spinal fluid'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloidosis in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid-beta pathology in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid plaques'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic effects of hUCB-MSC injection'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease identification""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β burden in Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain amyloidosis in preclinical Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ38'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain Aβ buildup in Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to dementia'}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Decreases in Aβ42 levels over 2 years'}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Stabilization in resveratrol-treated AD patients'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Reduction in cerebral spinal fluid levels indicates presence of Alzheimer's Disease.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage Alzheimer’s disease'}, {'article': 'PMC6158897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diagnose: Early-stage Alzheimer’s disease'}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher levels of Aβ42 linked to cognitive impairment in AD'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid depositions in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (reduced levels considered pathological)""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cerebrospinal fluid Aβ biomarkers'}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Aerobic exercise reduced plasma Aβ42 by ~6%'}, {'article': 'PMC9716660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Stretching increased plasma Aβ42 by 24%'}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
609,166,Aβ28–42,"[{'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plasma levels increased following GSK933776 treatment'}]"
610,166,Aβ38,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased white matter lesions (WML)'}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased White Matter Lesions (WML) volume'}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'EUROIMMUN ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD-related cognitive decline and dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of γ-secretase modulators for disease-altering therapy'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Risk of developing AD dementia and cognitive decline'}, {'article': 'PMC8901176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Longitudinal change in cognition as measured by the MMSE scale'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less decline in MMSE score over time'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less decline in MMSE score and lower risk of developing AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD-related changes'}, {'article': 'PMC8901176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease progression""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
611,166,Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Vessel wall damage and pericyte damage'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'MRIgFUS treatment'}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'RP reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'SS reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased white matter lesions (WML)'}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased White Matter Lesions (WML) volume'}, {'article': 'PMC4746584.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment, Alzheimer's Disease, and Cerebral Amyloid Angiopathy (CAA)""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Microvascular dysfunction'}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter lesions (WML) and cerebral amyloid angiopathy (CAA)'}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter hyperintensity (WMH) in plasma'}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'EUROIMMUN ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular disease (e.g., white matter lesions, cerebral microbleeds, hypertension, diabetes, ischemic heart disease)'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Cardiovascular mortality in coronary heart disease'}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Hypertension, diabetes, and ischemic heart disease'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease based on cerebrospinal fluid Aβ42/Aβ40 ratio""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathologic cerebrospinal fluid signature in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloidosis in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid fibrils'}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid plaques'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less decline in MMSE score'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related amyloid production""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction after Nilotinib treatment'}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Stabilization in resveratrol-treated AD patients'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Reduction in cerebral spinal fluid levels indicates presence of Alzheimer's Disease.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-beta pathology'}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC6152871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
648,166,"Aβx-38, Aβx-40, and Aβx-42","[{'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Semagacestat treatment'}]"
612,166,Aβ40 and Aβ42,"[{'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
649,166,Aβx-40,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'AAB-003 treatment'}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
613,166,Aβ40 levels,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
616,166,Aβ40/Aβ42,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid-β burden'}]"
650,166,Aβx-42,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
1452,166,Elecsys Aβ1–42,"[{'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]"
608,166,Aβ22-28,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Semagacestat treatment'}]"
615,166,Aβ40 ratio,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
646,166,AβX–42,"[{'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Elevated levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
636,166,Aβ42EI/Aβ40EI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
637,166,Aβ42IT,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
640,166,Aβ43,"[{'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
641,166,Aβ5-40,"[{'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
624,166,Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse SO/spindle coupling strength and higher dementia risk'}, {'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Beneficial amyloid response to PLAS'}, {'article': 'PMC10758173.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Identifying individuals who may benefit most from PLAS'}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with improved diagnostic accuracy""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain amyloidosis in preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improve performance in different stages of AD diagnosis'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
622,166,Aβ42/Aβ38,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with better diagnostic performance""}]"
642,166,Aβ5-42,"[{'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
621,166,Aβ42/40 ratio,"[{'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain amyloid status'}, {'article': 'PMC8088704.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Presence of brain amyloidosis'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for Treatment: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via decreased ratio""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease continuum""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'PET amyloid load and cerebral spinal fluid Aβ42/40 ratio'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Plasma biomarker measured using IP/LC-MS/MS technology platform (Precivity AD assay, C2N)'}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slower cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid cascade in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment effects and disease state'}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Lecanemab treatment effects'}]"
1956,166,IA-Elc Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
623,166,Aβ42/Aβ38 ratio,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
2024,166,IP-MS-WashU Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
635,166,Aβ42EI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
620,166,Aβ42/40,"[{'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Low burden of Aβ pathology'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain Aβ pathology in early Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of abnormal brain Aβ status'}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease progression""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'High risk of future conversion to Aβ-PET positivity'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal brain Aβ burden in Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Accurate identification of abnormal brain Aβ burden in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
643,166,Aβ5-X,"[{'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibition'}]"
627,166,Aβ42/Aβ40 ratios,"[{'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower risk of dementia'}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1458,167,"Encoding, Storage and Recuperation (ESR) word list","[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Memory assessment in Alzheimer's Disease""}]"
4570,167,total semantic units,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
4317,167,n-gram features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2479,167,N-gram features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]"
295,167,Acoustic features,"[{'article': 'PMC9171270.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3046,167,Recognition Accuracy (Recog),"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4501,167,speech-based classifiers,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive deficits in Alzheimer's Disease""}]"
2804,167,Part-Of-Speech cross-entropy,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4562,167,temporal speech features,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive deficits in Alzheimer's Disease""}]"
2287,167,MLU (Mean Length of Utterance),"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]"
1734,168,Gap duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4073,168,completion time,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3042,168,Reaction Times,"[{'article': 'PMC3581819.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk of falls in Alzheimer's Disease patients""}]"
3880,168,active minutes,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2113,168,Interpausal unit duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3043,168,Reaction time (RT),"[{'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]"
3065,168,Rest durations,"[{'article': 'PMC8500065.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
4102,168,dwell time,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
303,168,Active durations,"[{'article': 'PMC8500065.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
3648,168,Turn duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3371,168,T1 relaxation time,"[{'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2201,169,Left MTG,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor performance in naming verbs'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2155,169,L MTG,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2337,169,MTG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2338,169,MTHFR,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated homocysteine levels'}]"
2339,169,MTL density and volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict conversion from mild cognitive impairment to AD'}]"
2340,169,MTL network flexibility,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2341,169,MTL subregions (DG/CA1),"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology""}]"
2343,169,MTP,"[{'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Aerobic fitness in Alzheimer's Disease""}]"
2984,170,QoL-AD,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased QoL-AD scores are associated with improved quality of life in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Quality of life in Alzheimer's Disease""}]"
117,170,AD-GRS,"[{'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Dementia prediction in Non-Hispanic populations'}]"
141,170,ADCOMS,"[{'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
119,170,AD8,"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence""}]"
120,170,AD8-slefd,"[{'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}]"
696,170,BEHAVE-AD,"[{'article': 'PMC4764002.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral Pathology in Alzheimer's Disease""}]"
114,170,AD,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Gait characteristics in the same way as MD'}]"
154,170,ADRD,"[{'article': 'PMC7031904.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Related Dementias""}]"
2979,170,QOL-AD,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC4324943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Quality of life in Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Quality of life in Alzheimer's Disease""}, {'article': 'PMC7168967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease patients""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2206,172,Left frontal parietal network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
1638,172,Frontostriatal circuit functional connectivity,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's disease""}]"
1639,172,Frontostriatal circuit structural integrity,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's disease""}]"
3099,172,Right frontal parietal network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
4148,172,frontostriatal structural connectivity,"[{'article': 'PMC9972804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Verbal episode memory improvements in APP mutation carriers'}]"
2755,173,PLD3,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease susceptibility""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}]"
2870,173,PlGF,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ42/T-tau ratio'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2754,173,PLAS,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
2240,173,Lp-PLA2,"[{'article': 'PMC5209404.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5209404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5209404.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK2647544 treatment'}, {'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain Lp-PLA2 inhibition'}, {'article': 'PMC5209404.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2871,173,PlGF and Tie-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Intranasal insulin treatment'}]"
2248,173,MAG:PLP1,"[{'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2249,173,MAG:PLP1 ratio,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral hypoperfusion in Alzheimer's Disease""}]"
1366,174,Discourse difficulties,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2967,174,Psychoaffective Factors,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to early cognitive deficits and subsequent dementia'}]"
1855,174,Hallucinations,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1368,174,Disinhibition,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1327,174,Delusions,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3716,174,Verbal Intrusions,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
944,174,CONSCIENTIOUSNESS,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels linked to increased Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
1650,175,Functional connectivity (FC) in the temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}]"
1651,175,Functional connectivity (FC-values),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1649,175,Functional connectivity (FC) in the precuneus and temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Acupuncture combined with Donepezil intervention'}]"
1648,175,Functional connectivity (FC) in the left precuneus,"[{'article': 'PMC9309357.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}]"
1647,175,Functional connectivity (FC),"[{'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Subjective Cognitive Decline and mild cognitive impairment related to Alzheimer's Disease""}]"
1646,175,Functional connectivity,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
1643,175,Functional Connectivity (FC),"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4149,175,functional connectivity,"[{'article': 'PMC4846650.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Pre-AD'}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in older adults with mild cognitive impairment'}]"
4150,175,functional connectivity (FC),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1652,175,Functional connectivity (PLV),"[{'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
1642,175,Functional Connectivity,"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain Plasticity and Cognitive Training Response'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher cognitive performance'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower cognitive function'}, {'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
248,176,AT,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotection against Aβ42-induced toxicity in Alzheimer's Disease""}]"
254,176,ATF4,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
253,176,ATF3,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
250,176,AT8,"[{'article': 'PMC3978916.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
249,176,AT profile,"[{'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2011,177,IL1B,"[{'article': 'PMC3213220.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory response inhibiting ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2014,177,IL1α,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2056,177,Il1a,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2057,177,Il1b,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1997,177,IL-1α,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2013,177,IL1B rs16944,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
2012,177,IL1B rs1143627,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
3661,178,UPDRS III,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Motor function in Alzheimer's Disease""}]"
3662,178,UPDRS assessments,"[{'article': 'PMC7364345.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Parkinsonian symptoms in Alzheimer's Disease""}]"
3663,178,UPSA,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}]"
1874,179,Hesitation Ratio,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3548,179,Th1/Th2 ratio,"[{'article': 'PMC9290489.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improved immune recovery through MBSR/MBCT/MBCR'}]"
1498,179,F/B ratio,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1585,179,Firmicutes/Bacteroidetes (F/B) ratio,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}]"
3671,179,VAT/SAT ratio,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3561,179,Theta/Beta ratio (TBR),"[{'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mind wandering and reduced attention'}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improvements in attention and cognitive function'}]"
3407,179,THFs/THE ratio,"[{'article': 'PMC5301048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Liver 11β-HSD1 inhibition'}]"
4316,179,n-6/n-3 ratio,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3846,180,[18F]-FDG,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3871,180,[18F]ox-ROStrace,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3863,180,[18F]THK-5351,"[{'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3862,180,[18F]ROStrace,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3861,180,[18F]RO948,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]"
3850,180,[18F]AZD4694,"[{'article': 'PMC8043944.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta burden assessment'}]"
3860,180,[18F]MK-6240,"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Assessment of therapeutic interventions'}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease pathophysiology""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring during Alzheimer's Disease treatment""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3859,180,[18F]GTP1 tau PET,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3851,180,[18F]BR-351,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3852,180,[18F]BR-420,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3858,180,[18F]GTP1 SUVR,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8638526.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Clinical decline in cognitive assessments'}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in prodromal, mild, or moderate AD'}]"
3857,180,[18F]GTP1,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Identifying individuals at risk for rapid clinical progression in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]"
3856,180,[18F]GSK2647544,"[{'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3854,180,[18F]FDG,"[{'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Glucose metabolic rate in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral glucose consumption in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Liraglutide treatment in Alzheimer's Disease patients""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3853,180,[18F]FBAT,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3849,180,[18F]2B-SRF101,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1443,181,Early AD markers,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Clinical disease onset'}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of conversion to mild cognitive impairment or dementia'}]"
4177,181,graphic markers,"[{'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4592,181,vocal markers,"[{'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2807,181,Passive Digital Marker (PDM),"[{'article': 'PMC9552361.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease and Related Dementia (ADRD)""}]"
3888,182,amygdala,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]"
3889,182,amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1893,182,Hippocampal and amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
371,182,Amygdala volume,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4175156.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""emotional memory in patients with Alzheimer's Disease""}]"
373,182,Amygdale atrophy,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aberrant motor behaviour, anxiety, and irritability'}]"
372,182,Amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}]"
370,182,Amygdala,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor sleep quality in AD spectrum patients with ID'}]"
692,183,BDNF/TrkB,"[{'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
3641,183,TrkB,"[{'article': 'PMC2765081.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Synaptic plasticity'}]"
2753,183,PKB,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
3118,183,SAPK/JNK,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Abnormal tau phosphorylation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory response in Alzheimer's Disease""}]"
3205,183,SYK,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Modulation of Aβ phagocytosis and cognitive deficits in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Development of DAM and Aβ deposition in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Rescued microglia activation.'}]"
1057,184,Cerebral atrophy,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive aging'}]"
3964,184,brain atrophy,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3965,184,brain atrophy profiles,"[{'article': 'PMC3389343.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3966,184,brain atrophy rate,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
791,184,Brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia and Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1047,184,Cerebral Atrophy,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1212,184,Cortical atrophy,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Poor clinical response in Alzheimer's Disease""}]"
783,184,Brain Atrophy,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4076,184,cortical and limbic atrophy,"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
790,184,Brain atrophy,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
3587,184,Total brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment response in clinical trials'}]"
3331,184,Subcortical atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}]"
2939,184,Prefrontal cortex atrophy,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Dementia onset'}]"
3057,184,Regional brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Interventions to reduce post-stroke secondary degeneration'}]"
1632,184,Frontal Cortex Atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for cognitive decline or dementia'}]"
510,184,Atrophy in Temporal and Parietal Cortices,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reflects progression of Alzheimer's Disease pathology""}]"
2549,185,Naming Disorders,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2637,185,Object naming test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Language deficits in Alzheimer's Disease""}]"
777,185,Boston Naming Test,"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Naming Impairment in Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal fluency in Alzheimer's Disease""}]"
778,185,Boston Naming Test (BNT),"[{'article': 'PMC8615710.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reflect treatment response in bilingual speakers with PPA'}]"
284,186,Acetic acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}]"
283,186,Acetate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}]"
2478,186,N-acetylaspartate (NAA),"[{'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3129,186,"SCFAs (butyrate, acetate, propionate)","[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3127,186,SCFA (Short Chain Fatty Acids),"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased Aβ plaque deposition in Alzheimer's Disease""}]"
2953,186,Propionibacterium acnes (P. acnes),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2955,186,Propionyl-CoA carboxylase,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
991,187,CX3CR1,"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1613,187,Fornix,"[{'article': 'PMC6126036.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting TMS treatment based on functional connectivity with the fornix for cognitive dysfunction in Alzheimer's Disease""}]"
1238,187,Cx43,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
917,187,CGI-I,"[{'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Clinical improvement in Alzheimer's Disease""}]"
916,187,CGDS-SF,"[{'article': 'PMC9871821.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced depressive symptoms after tPBM treatment'}]"
4478,187,sCTX,"[{'article': 'PMC4396171.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to AZD0530 treatment'}, {'article': 'PMC4396171.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Marker of Src family kinase target inhibition'}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
918,187,CGIC,"[{'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Clinical Global Impression of Change'}, {'article': 'PMC4712287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Clinical improvement in Alzheimer's Disease""}]"
992,187,CXCL10,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2726,188,PER2,"[{'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Autophagy regulation in Alzheimer's Disease""}]"
2725,188,PER1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]"
2727,188,PER2 C111G,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in executive function, language, and visual–spatial ability in patients progressing to mild cognitive impairment'}, {'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Progression to mild cognitive impairment (MCI)'}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Worsening of cognitive functions in SCD patients'}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Association with cognitive reserve mechanisms'}]"
2728,188,PER2 C111G polymorphism,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better language performance in SCD patients'}, {'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater worsening of executive function, visual-spatial ability, and language composite scores in MCI patients'}]"
2729,188,PER2 G allele,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in language, executive function, and visual–spatial ability in patients with cognitive impairment'}]"
2730,188,PER2 genotype,"[{'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2812,188,Per1,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Memory-related signaling'}]"
2813,188,Per2 G,"[{'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in mild cognitive impairment patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher conversion rate to AD'}]"
1660,188,G Allele,"[{'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
483,189,Apolipoprotein C 2 (APOC2),"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3935,189,apolipoprotein E epsilon 4 allele,"[{'article': 'PMC5389824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3934,189,apolipoprotein E (ApoE) genotype,"[{'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'dementia'}]"
3925,189,apo B lipoproteins,"[{'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
491,189,Apolipoprotein E ε4 (APOE4),"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
3933,189,apolipoprotein B (apo B),"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta peptides (Aβ) in brain parenchyma'}]"
484,189,Apolipoprotein E (APOE),"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
485,189,Apolipoprotein E (APOE) ε4,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Faster memory decline'}, {'article': 'PMC4519341.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Faster cognitive decline in memory'}]"
482,189,Apolipoprotein 4,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
490,189,Apolipoprotein E genotyping,"[{'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
486,189,Apolipoprotein E (APOE) ε4 allele,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater accumulation of Aβ plaques and earlier age of onset of dementia'}]"
487,189,Apolipoprotein E (ApoE) ε4,"[{'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
488,189,Apolipoprotein E (ApoE) ε4 allele,"[{'article': 'PMC3849204.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}]"
489,189,Apolipoprotein E genotype,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through brain structural changes""}]"
3182,190,SRSS,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Sleep Disturbances in Alzheimer's Disease""}]"
3183,190,SRT,"[{'article': 'PMC4637414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3185,190,SRT latency,"[{'article': 'PMC4374455.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3294,190,Src,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3184,190,SRT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]"
1120,191,Cholinergic neurons,"[{'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1121,191,Cholinergic system,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Vascular Cognitive Impairment'}]"
1118,191,Choline acetyltransferase (ChAT),"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1119,191,Cholinergic activity,"[{'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
4059,191,cholinesterase inhibitors,"[{'article': 'PMC3481364.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Symptom relief in AD'}]"
4058,191,cholinergic pathways,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic evaluation""}]"
3592,191,Total cholinesterase (TChE),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3922,191,anticholinergic burden,"[{'article': 'PMC5442667.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1623,191,Fractional anisotropy (FA) in cholinergic pathways,"[{'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in VCI'}]"
1122,191,Cholinesterase activity,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3940,192,bFGF,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
726,192,Basic fibroblast growth factor [BFGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1542,192,FGF-2,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]"
1543,192,FGF9,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better cognitive performance in AD mice'}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduction in Alzheimer's Disease""}]"
838,193,CAA,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1271,193,DELAPAGTGVSREAVSG,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': ""Biomarker for Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'APLP1 cleavage'}]"
1025,193,Cav1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Transcellular transport across the BBB'}]"
848,193,CAVIRE,"[{'article': 'PMC8650134.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}]"
1001,193,CaV1.2,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""L-VSCC activity in Alzheimer's Disease""}]"
849,193,CAW,"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}]"
1002,193,CaV1.3,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""L-VSCC activity in Alzheimer's Disease""}]"
1000,193,Ca2+,"[{'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Intracellular Ca2+ changes in postsynaptic neuron during tDCS'}]"
880,194,CD59,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
879,194,CD47,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
873,194,CD4,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe dementia in Alzheimer's Disease""}]"
870,194,CD39,"[{'article': 'PMC6584558.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2127,194,Itgax (CD11c),"[{'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Microglial phagocytosis during treatment of Alzheimer's Disease""}]"
869,194,CD33,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of amyloid plaques and improvement of cognitive function in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Clinical trials for AD treatment (AL003)'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Blocked CD33 expression promoted Aβ phagocytosis and clearance; decreased neuroinflammatory.'}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6158742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Advanced Cognitive Decline and Alzheimer's Disease""}]"
868,194,CD31,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
864,194,CD163,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease, particularly in frontal and occipital cortex regions""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaques'}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased levels linked to worse prognosis in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Linked to immune response and microglial activation in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
862,194,CD11c,"[{'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Microglial activation and treatment response in Alzheimer's Disease""}]"
861,194,CD11b,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Microglia activation in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
860,194,CD-11b,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
882,194,CD68,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Phagocytic properties of CD163 immunoreactive microglia'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Phagocytic phenotype in microglia in Alzheimer's Disease""}]"
883,194,CD8,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe dementia in Alzheimer's Disease""}]"
881,194,CD63,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1027,194,Cd14,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1028,194,Cd44,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1029,194,Cd9,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}]"
1335,195,Di-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Protection against cell death, excitotoxic and hypoxic damage in rat cortical neurons'}]"
2454,195,Mono- and di-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}]"
952,195,CQAs,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Protection against Aβ-induced cytotoxicity'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Nrf2 gene expression'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased mitochondrial respiration in neuroblastoma cells'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved cognition in the 5xFAD mouse model of AD'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Metabolites in plasma'}]"
2455,195,Mono-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Protection against glutamate excitotoxicity in mice'}]"
1123,196,Cingulum bundle,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Hippocampal formation disruption in Alzheimer's Disease""}]"
1125,196,Cingulum_Mid_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1124,196,Cingulum bundle disruption,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Memory decline in Alzheimer's Disease""}]"
1126,196,Cingulum_Mid_R (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
4560,197,temporal meta-regions of interest (ROI) cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2932,197,Precuneus cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
4081,197,cortical thickness in temporal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2090,197,Insular cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]"
3536,197,Temporal meta-ROI cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Decline in cortical thickness associated with cognitive decline'}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1633,197,Frontal Cortical Thickness,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes in Alzheimer's Disease""}]"
4146,197,frontal cortical thickness,"[{'article': 'PMC6167961.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Change in SDMT and exercise load'}]"
2931,197,Precuneus cortex thickness,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2817,197,Pericalcarine cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]"
4079,197,cortical thickness in medial temporal lobe (MTL),"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2933,197,Precuneus thickness,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4080,197,cortical thickness in parietal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4078,197,cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1209,197,Cortical Thickness,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1210,197,Cortical Thickness (CT),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]"
1216,197,Cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict disease progression in AD'}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1217,197,Cortical thickness in early regions,"[{'article': 'PMC6167961.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
2156,198,L-VSCC,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2160,198,L-type voltage sensitive Ca2+ channels (L-VSCCs),"[{'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased activity in hippocampal CA1 neurons'}]"
2158,198,L-VSCCs,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Synaptic plasticity and cognitive function in Alzheimer's Disease""}]"
2157,198,L-VSCC activity,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced activity in XPro1595-treated rats'}]"
3392,199,TDP-43,"[{'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP)'}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protein homeostasis and neurodegeneration'}, {'article': 'PMC5382945.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with AT101, Chloroquine, Spautin-1, and MHY1485'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Overexpression in patient cells treated with MHY1485'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: AD and FTD/ALS'}, {'article': 'PMC6110931.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Hippocampal sclerosis and cerebral atrophy in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection and prognosis'}, {'article': 'PMC6966425.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Greater brain atrophy and cognitive impairment in Alzheimer's Disease""}]"
3393,199,TDP-43 (Transactive response DNA-binding protein 43 kDa),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1809,199,Growth associated protein 43,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3395,199,TDP-43-A,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pathological features in nfvPPA'}]"
3394,199,TDP-43 pathology biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4130,200,fasting insulin,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1574,200,Fasting plasma glucose,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1572,200,Fasting insulin,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1575,200,Fasting plasma glucose (FPG),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]"
1571,200,Fasting glucose,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1573,200,Fasting insulin levels,"[{'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
1569,200,Fasting Insulin Levels,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in patients with non-dementia vascular cognitive impairment'}]"
1568,200,Fasting Glucose,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1570,200,Fasting blood glucose,"[{'article': 'PMC8857690.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]"
3399,201,TG,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Plasma lipid levels in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4530,201,tPA,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3417,201,TMEM119,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3375,201,T4,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3373,201,T3,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3416,201,TMAO,"[{'article': 'PMC6353871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s disease'}]"
3571,201,Tmem66,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4219,202,insulin/IGF signaling,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
507,202,Astrocytic insulin signalling,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive performance and synaptic integrity in AD'}]"
506,202,Astrocytic insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Selection: Targeting astrocytes for AD therapy'}]"
2100,202,Insulin receptor signaling pathway (IRSP) genes,"[{'article': 'PMC6211704.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Normalization of compromised IRSP functions in AD with anti-diabetic treatments'}]"
2102,202,Insulin signaling,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced premature mortality associated with Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2558,203,Nerve Growth Factor (NGF),"[{'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2873,203,Placental growth factor [PIGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2872,203,Placental growth factor,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2559,203,Nerve growth factor (NGF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]"
3134,204,SDST,"[{'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Information processing speed deficits in Alzheimer's Disease""}]"
711,204,BPSD,"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavioral and psychological symptoms in Alzheimer's Disease""}]"
3135,204,SDT,"[{'article': 'PMC4637414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3132,204,SDI,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7083107.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Sleep disturbances in institutionalized dementia patients'}, {'article': 'PMC7083107.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Identifying patients for sleep interventions and mapping underlying causes of sleep problems'}]"
3022,204,RMSSD,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
3594,205,Total glutathione (GSH),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]"
3579,205,Total Glutathione (GSH),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}]"
1780,205,Glutathione (GSH),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
1700,205,GSH-peroxidase,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]"
1782,205,Glutathione peroxidase activity,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]"
1781,205,Glutathione peroxidase (GSH-Px),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
1779,205,Glutathione,"[{'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Recovered basal content in the presence of oleanolic acid and combined biomolecules'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]"
2707,206,PC1,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Learning performance and cognitive flexibility in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Learning and cognitive flexibility improvements'}, {'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Spatial learning and memory deficits in Ts65Dn mice'}]"
2781,206,PSEN2,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}]"
2772,206,PS1,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2775,206,PS2,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
2784,206,PSQI,"[{'article': 'PMC10439779.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Poor Sleep Quality in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence: Sleep disturbances in Alzheimer's Disease""}]"
2777,206,PSEN,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}]"
2778,206,PSEN1,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased Aβ42 levels and Aβ plaques'}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased Aβ42/Aβ40 ratio and amyloidogenic plaques'}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}]"
2776,206,PSD95,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased expression in the hippocampus associated with exercise-induced protection against reduction of synaptic proteins after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Synaptic loss in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive Improvement'}]"
748,207,Bielschowsky silver stain,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
752,207,Bilophila,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]"
700,207,BI,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Impairment in activities of daily living in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of functional performance in AD'}]"
747,207,Bielschowsky silver,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
746,207,Bielschowsky,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2969,208,Pupil dilation,"[{'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}]"
1735,208,Gaze direction,"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Social engagement in patients with dementia'}]"
1496,208,Eye Movement,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}]"
4455,208,pupil dilation,"[{'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1497,208,Eye gaze detection test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Eye gaze detection deficits in Alzheimer's Disease""}]"
294,209,Acid phosphatase,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Autophagy-lysosomal cascade functionality'}]"
2835,209,Phospholipase A2 (PLA2) activity,"[{'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2653,209,Oxidative phosphorylation,"[{'article': 'PMC2432467.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Energy metabolism and cellular stress'}]"
492,209,Apoptosis regulation,"[{'article': 'PMC2432467.txt', 'relationship': 'RELATED_TO', 'object': 'Cellular response to stress and inflammation'}]"
3879,209,activation of mitochondrial apoptosis,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]"
3560,210,Theta power,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment risk'}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive function improvements in VR intervention group'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Significant decrease in the parietal and temporal areas'}]"
3559,210,Theta oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Theta-tDCS'}]"
4147,210,frontal-posterior theta coherence,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioral improvements after cognitive training'}]"
3558,210,Theta frequency band,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3557,210,Theta band power,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]"
3556,210,Theta band oscillations,"[{'article': 'PMC6561937.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
3555,210,Theta Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]"
4566,210,theta rhythm,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4295,210,midline frontal theta power,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioral improvements after cognitive training'}]"
2071,210,Increased theta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3151,211,SLAB51 probiotic formulation,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
2946,211,Probiotics,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reversal of ampicillin-induced cognitive and behavioral abnormalities'}]"
367,211,Ampicillin,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased anxiety-like behavior and memory impairment'}]"
458,211,Antibiotics,"[{'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of neuroinflammation and cognitive improvement in AD'}]"
929,212,CMAI,"[{'article': 'PMC9116897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Agitation'}]"
930,212,CMAI score,"[{'article': 'PMC8496617.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8496617.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
931,212,CMB,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
932,212,CMBs,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'All-cause dementia risk'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology'}]"
933,212,CMMSE,"[{'article': 'PMC4380493.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}]"
935,212,CMRgl,"[{'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6646979.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Effect of AZD0530 treatment on 52-week reductions in relative CMRgl'}, {'article': 'PMC6646979.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC7489025.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cerebral metabolic rate for glucose in brain regions affected by AD'}]"
936,212,CMRglc,"[{'article': 'PMC4877513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease progression""}]"
937,212,CMV pp65 response,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2799,212,Parietal CMBs,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cerebral Aβ burden'}]"
4525,213,t-tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in t-tau concentration in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via increased levels""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD dementia'}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease neuropathologic changes""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with poor outcomes in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant treatment effect observed'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No treatment effect'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No change during treatment'}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects neuronal injury and Aβ-induced tau secretion in AD'}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower levels in APOE ε2/ε4 genotype compared to APOE ε3/ε4 genotype'}, {'article': 'PMC9716660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Changes in levels over time during intervention'}]"
3504,213,Tau PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4522,213,t-Tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in African Americans'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (increased levels considered pathological)""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4551,213,tau-PET,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis and tracking of disease progression in Alzheimer's Disease""}]"
2736,213,PET-quantified tau,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3499,213,Tau,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuroinflammation and AD progression'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau-related pathology progression in Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cortical amyloid load and cerebral hypometabolism'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'ApoE4-related GABAergic interneuron impairment'}, {'article': 'PMC3534053.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease pathogenesis""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neural loss in Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slight increase in cerebrospinal fluid levels during the study'}, {'article': 'PMC4095696.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying therapies in Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Impaired intracellular Aβ1-42 clearance and increased plaque deposition'}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ1-42 clearance'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ1-42 clearance and extracellular plaque deposition'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster progression of Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology'}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and AD pathogenesis in mice'}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz gamma oscillation therapy'}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Non-pathological cerebral spinal fluid profiles'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurodegenerative cerebral spinal fluid profiles'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC4267230.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Predicts AD dementia'}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increases in P‐tau, YKL‐40, and NFL levels over 2 years'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Nerve cell dysfunction in Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Correlation with synaptic loss and cognitive decline'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Targeted in combination therapies for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of treatment: LMTM'}, {'article': 'PMC7223540.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for anti-tau therapies in Alzheimer's Disease trials""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Biological outcome in Phase 2 studies for Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Associated with prognosis in Alzheimer's Disease and tauopathies""}, {'article': 'PMC7223540.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides selection of participants in basket trials for Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of TEMT treatment to disaggregate toxic oligomers'}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Anti-tau therapies in Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment to major neurocognitive disorder'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Alleviates tau hyperphosphorylation'}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced tau hyperphosphorylation levels and improved spatial learning and memory impairment'}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4579,213,t‐tau,"[{'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Incident neurodegeneration in Alzheimer's Disease""}]"
3384,213,TAUup,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3500,213,Tau (MAPT),"[{'article': 'PMC3389343.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3383,213,TAUdown,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3370,213,T-tau,"[{'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ pathology changes in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential dementia diagnosis'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4557,213,taurine levels,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'astrocytic activity'}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3525,213,Tau-PET,"[{'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of tau pathology in Alzheimer's Disease""}]"
4538,213,tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'MAPTRx treatment'}, {'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to AADvac1 vaccine treatment'}, {'article': 'PMC4255368.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of AADvac1 vaccine'}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline and memory impairment in Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""White-matter (WM) degeneration in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease using tau PET imaging""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in mild cognitive impairment'}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher tau levels correlated with increased mean diffusivity (MD) in brain pathways'}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ' Tau deposition patterns in brain regions for diagnostic purposes'}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'tau pathology in spatially selective pathways'}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'WM degeneration associated with tau deposition'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and diagnosis of cognitive impairment'}, {'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4471648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased cognitive impairment'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'posterior cortical flortaucipir SUVr'}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC5516350.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""treatment of Alzheimer's Disease by targeting pathological tau phosphorylation and aggregation""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Anti-tau therapies for Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cerebrospinal fluid tau biomarkers'}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment due to AD or mild AD dementia'}, {'article': 'PMC9327167.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Clinical trials of anti-amyloid monoclonal antibody'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early stages of tau deposition and cognitive decline in AD'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3528,213,Taurine,"[{'article': 'PMC4847010.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Inverse correlation with Aβ levels and GFAP in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}]"
3368,213,T-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4145,213,foetal tau,"[{'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
4477,214,sAPPβ,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decline in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]"
4476,214,sAPPα,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in cerebral spinal fluid levels compared to placebo'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with atabecestat'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]"
4475,214,sAPP-β,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4474,214,sAPP-α,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3117,214,SAP102,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
4473,214,sAPP,"[{'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related APP cleavage""}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Atabecestat'}]"
3116,214,SAP,"[{'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
3596,214,Total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4569,214,total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]"
4602,214,α-sAPP,"[{'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4623,214,β-sAPP,"[{'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
712,215,BPSD (Behavioral and Psychological Symptoms of Dementia),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3334,215,Subjective Cognitive Decline (SCD),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""First symptomatic manifestation of Alzheimer's Disease""}]"
733,215,Behavioural and Psychological Symptoms of dementia (BPSD),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Predicts more severe diagnosis of Alzheimer's Disease""}]"
3124,215,SCD (Subjective Cognitive Decline),"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease (did not predict in this sample)""}]"
3361,217,Syntactic components,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3360,217,Syntactic complexity,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3052,217,Reduced syntactic complexity,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2219,217,Lexical features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]"
2225,217,Linguistic features,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Probable Alzheimer's Disease""}, {'article': 'PMC9171270.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2218,217,Lexical components,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3362,217,Syntactic features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]"
278,218,Aberrant motor activity,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4426,218,physiological micro tremors (7–8 Hz amplitude),"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Male sex in the context of Alzheimer's Disease""}]"
1358,218,Digital biomarkers (micro hand gestures from accelerometer data),"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9203627.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
1357,218,"Digital biomarkers (e.g., Neuro-Motor Index (NMI))","[{'article': 'PMC9203627.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]"
4492,218,sensor-based Frailty Measurement (FM),"[{'article': 'PMC7996628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}]"
4253,219,mTORC1,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neurodegenerative Disorders'}]"
847,219,CASS4,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with AD pathogenesis and pathological features'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
2471,219,Mtss1L,"[{'article': 'PMC6609409.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6609409.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6609409.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3386,219,TBC1D4,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
988,219,CTNNB1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2999,219,RAP1B,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2306,219,MRC1,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CD163 immunoreactive perivascular macrophages'}]"
3227,220,Sensory impairment,"[{'article': 'PMC6004911.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Delayed diagnosis of Alzheimer's Disease""}]"
515,220,Auditory cortex,"[{'article': 'PMC10439779.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in verbal memory in AD spectrum with ID patients'}]"
516,220,Auditory network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
2067,220,Impaired sound perception and recognition,"[{'article': 'PMC6950055.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2066,220,Impaired Auditory and Written Comprehension,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2391,221,Memory—Delayed Recognition,"[{'article': 'PMC6052695.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]"
1318,221,Delayed memory,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
1317,221,Delayed Verbal and Visual Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
1316,221,Delayed Recall (DR),"[{'article': 'PMC5226952.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2390,221,Memory—Delayed Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1315,221,Delayed Recall,"[{'article': 'PMC4380493.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]"
1320,221,Delayed recall,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]"
1314,221,Delayed Memory Recall (MDR),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
3003,221,RAVLT delayed recall,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2064,221,Immediate memory,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
2063,221,Immediate Recall (IR),"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Decline in Alzheimer's Disease""}]"
2062,221,Immediate Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
2061,221,Immediate Memory Recall (MIR),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
2392,221,Memory—Immediate Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
172,222,ALZ-801,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Inhibition of Aβ oligomers'}]"
319,222,Affitope AD02,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II clinical investigation'}]"
105,222,ACC,"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Item memory gains'}]"
94,222,AAB-003,"[{'article': 'PMC4772335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Completed Phase I trials'}]"
95,222,AAB-003 levels,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Treatment response'}]"
106,222,ACC-001,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II trials due to autoimmune response'}]"
97,222,AADvac1,"[{'article': 'PMC6201586.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Active immunotherapy for Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Slower brain atrophy and less cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Patients with higher antibody titres'}]"
96,222,AADvac-1,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
4223,223,k3,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2151,223,Kir6.2,"[{'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Development of Alzheimer's Disease""}]"
2150,223,Ki-67,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proliferating cells in the dentate gyrus (DG)'}]"
2144,223,KU complex (Ku70 and Ku80),"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aging-associated autoimmunity'}]"
2926,223,Potassium,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
522,224,Axial Diffusivity (AxD),"[{'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
115,224,AD (Axial Diffusivity),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3040,224,Radial Diffusivity (DR),"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}]"
520,224,AxD (axial diffusivity),"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Axonal integrity damage in hippocampus-PCC tract'}]"
3041,224,Radial Diffusivity (RD),"[{'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
521,224,Axial Diffusivity (AD),"[{'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decreased AD in motor and somatosensory ROIs after TPS stimulation'}]"
523,224,Axial diffusivity (AD),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved axonal status in the sensorimotor network'}]"
332,225,All-trans-retinoic acid (RA),"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
3083,225,Retinol,"[{'article': 'PMC4922661.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Adequacy of energy intake in Alzheimer's Disease patients""}]"
3082,225,Retinoids,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Memory deficits'}]"
3081,225,Retinoic acid receptors (RARs),"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
3080,225,Retinoic Acid (RA),"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Maintenance of olfactory function, potentially preventive for Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic potential for neurodegenerative disorders, including Alzheimer's Disease""}]"
14,225,13-cis-retinoic acid,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
1709,226,GSSH,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]"
1701,226,GSH/GSSH,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]"
1699,226,GSH-Px,"[{'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher GSH-Px levels in intervention groups'}]"
1698,226,GSH-PX,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}]"
1697,226,GSH,"[{'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Oxidative stress management in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Antioxidant response in Alzheimer's Disease""}]"
4218,227,insulin-like growth factor-1 (IGF-1),"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2103,227,Insulin-like Growth Factor 1 (IGF1),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]"
1973,227,IGF-1,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Protection of neurons from Aβ oligomers'}, {'article': 'PMC3110111.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease: Brain function improvement through exercise""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal differentiation and hippocampal neurogenesis'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Neuroprotection and cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition'}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved executive function (Stroop performance)'}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive function improvement in mild cognitive impairment'}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced Aβ toxicity and enhanced Aβ phagocytosis'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic intervention in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Neuroprotective effects in traumatic brain injury'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protective effect on astrocytes and prevention of glutamate excitotoxicity in Alzheimer's Disease""}]"
1974,227,IGF-1 receptor,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved health and increased lifespan'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
1976,227,IGF1,"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Changes in brain health and cognition related to Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2097,227,Insulin growth factor 1 (IGF-1),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]"
1977,227,IGF1R,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1975,227,IGF-I,"[{'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protection against neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4217,227,insulin-like growth factor 1 (IGF-1),"[{'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}]"
3761,228,WM diffusion metrics,"[{'article': 'PMC8364310.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Monitor or predict tau propagation in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]"
1301,228,DTI measures,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]"
1299,228,DTI,"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'White matter structural integrity'}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Structural and functional features of frontostriatal and hippocampus-PCC neural circuits'}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'White matter structural integrity changes in mild cognitive impairment and AD'}]"
1300,228,DTI and GM volume measures,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment with improved accuracy'}]"
1346,228,Diffusion tensor imaging (DTI),"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in Familial Alzheimer’s disease'}]"
4404,229,parahippocampal gyrus,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1888,229,Hippocampal Synaptic Immunoreactivity,"[{'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}]"
4188,229,hippocampal binding memory task,"[{'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Evaluate the effect of levetiracetam on cognitive function in Alzheimer's Disease""}]"
1654,229,Functional connectivity of hippocampus,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pre-AD'}]"
4191,229,hippocampal-sparing AD,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better response to cholinergic treatment'}]"
1921,229,Hippocampus_L (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
1920,229,Hippocampus_L,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1910,229,Hippocampus,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Memory consolidation circuits in sleep and cognitive improvement'}, {'article': 'PMC6126036.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting TMS treatment based on functional connectivity with the hippocampus for cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease subtypes""}, {'article': 'PMC7203806.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: NGF treatment response in Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Longitudinal atrophy rates in Alzheimer's Disease subtypes""}, {'article': 'PMC7489025.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Brain region affected by Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Episodic memory performance'}]"
4193,229,hippocampus,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC5619554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4196,229,"hippocampus, ventro-medial prefrontal, fronto-insular, and lateral temporal cortex","[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]"
1887,229,Hippocampal Occupancy (HOC),"[{'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1891,229,Hippocampal activation,"[{'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Reduced activation during episodic encoding in ε3/4 heterozygotes'}]"
1900,229,Hippocampal size,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Fornix stimulation'}]"
4246,229,mALFF values in the left hippocampus,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive performance'}]"
1892,229,Hippocampal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early memory decline in Alzheimer's Disease""}]"
1886,229,Hippocampal GM density,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and progression of Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
47,230,24HC,"[{'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'CYP46A1 activation in early Alzheimer’s disease'}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Efavirenz treatment in Alzheimer's Disease""}]"
2874,230,Plasma 24HC,"[{'article': 'PMC9797897.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Treatment Eligibility: CYP46A1 activation in Alzheimer's Disease""}]"
3832,230,ZDHHC21 p.T209S mutation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and AD-related pathological changes'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Aβ levels'}]"
3831,230,ZDHHC21,"[{'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s Disease'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive Impairment and Synaptic Dysfunction'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease Progression""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]"
653,231,B Vitamins,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'brain atrophy'}]"
655,231,B1 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
656,231,B12,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reversible causes of cognitive impairment'}]"
657,231,B1N1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3738,231,Vitamin B-12,"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
654,231,B cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'chronic neuroinflammation and dementia'}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]"
3739,231,Vitamin B12,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2915,231,Plasma vitamin B12,"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3347,232,Sweating level,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]"
2657,232,Oxygen blood level,"[{'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}]"
4204,232,hyperproduction of reactive oxygen species,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]"
3989,232,cellular oxygen consumption rate (OCR),"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3044,232,Reactive Oxygen Species,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
830,233,C5,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ aggregates and neurotoxic effects'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1030,233,Cdh5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]"
2510,233,NIC5-15,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II clinical trials for Alzheimer's Disease""}]"
887,233,CDK5,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment mechanism""}]"
2021,233,INPP5D,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1563,233,Fabp5,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1549,233,FNDC5,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
178,233,ANAPC5,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3660,233,UNC5C,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
801,234,Brain-derived neurotrophic factor,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
784,234,Brain Derived Neurotrophic Factor (BDNF),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]"
2591,234,Neurotropic factors,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intervention response in Alzheimer's Disease""}]"
3972,234,brain-derived neurotrophic factor,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection in Alzheimer's Disease""}]"
3973,234,brain-derived neurotrophic factor (BDNF),"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3967,234,brain derived neurotrophic factor (BDNF),"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
802,234,Brain-derived neurotrophic factor (BDNF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved neurogenesis and neuronal survival'}, {'article': 'PMC5105117.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
2589,234,Neurotrophic Factors,"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
239,235,AR object placement fast Fourier transform (FFT),"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
237,235,AR global telemetry variance,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
238,235,AR object place and find telemetry variance,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
792,236,Brain free fraction (fND),"[{'article': 'PMC5209404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Brain penetration'}]"
1656,236,Fusiform (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3806,236,Whole brain (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1911,236,Hippocampus (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
710,236,BPF (Brain Parenchymal Fraction),"[{'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1023,237,Caudate and putamen volume,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1022,237,Caudate Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1024,237,Caudate volume loss,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
1021,237,Caudate,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1430,238,EQ-5D-3L,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1432,238,EQ-5D-5L,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1431,238,EQ-5D-3L proxy,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2893,239,Plasma N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
4363,239,p-tau181 (plasma),"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2894,239,Plasma N-terminal p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}]"
2913,239,Plasma tau,"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]"
2896,239,Plasma P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease""}]"
2908,239,Plasma p-tau181,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from non-AD dementia'}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4436,239,plasma p-tau231,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4435,239,plasma p-tau217,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4438,239,plasma tau,"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decline of MMSE score'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High baseline ADAS-cog and accelerated increase'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Large baseline ventricular volume and accelerated increase'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decrease of hippocampal volume'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decline of FDG-PET'}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor cognition at baseline and accelerated worsening of cognition'}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Accelerated worsening of cognition, large ventricular volumes at baseline and accelerated atrophy, and accelerated decrease in cortical glucose metabolism'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau associated with low cerebral spinal fluid Aβ42'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau associated with high cerebral spinal fluid T-tau and P-tau'}]"
4434,239,plasma p-tau181,"[{'article': 'PMC9289357.txt', 'relationship': 'PREDICTS_COGNITIVE_DECLINE', 'object': ""Cognitive decline in preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease pathology""}]"
4430,239,plasma P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early preclinical Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'PREDICTS', 'object': 'Higher future increase in tau-PET signal in the entorhinal ROI'}, {'article': 'PMC7653537.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Drug responses in clinical trials including individuals with preclinical AD'}]"
2909,239,Plasma p-tau217,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}]"
4437,239,plasma p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Preclinical AD'}]"
2910,239,Plasma p-tau231,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}]"
1930,240,Homer-1,"[{'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""BDNF Signaling in Alzheimer's Disease""}]"
2630,240,ODI,"[{'article': 'PMC8336239.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Sleep-disordered breathing in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}]"
2273,240,METs,"[{'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Aerobic fitness in Alzheimer's Disease""}]"
1929,240,Homer 1,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}]"
1952,241,Hypocretin-1,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
729,241,Beclin-1,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Autophagy activation and amyloid clearance in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of mitochondrial dynamics and weakening of apoptosis'}]"
4205,241,hypocretin-1,"[{'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early detection of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stage Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain accumulation of β-amyloid peptides in Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Biomarker Dynamics: Monitoring during treatment of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy Choice: Alzheimer's Disease""}]"
4085,241,cyclin D1,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3276,242,Somatostatin,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3277,242,Somatostatin (SOM),"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42'}]"
1460,242,Endostatin,"[{'article': 'PMC8645072.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]"
4116,242,endostatin,"[{'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}]"
2027,243,IR,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognition and mood regulation in Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1655,243,Functional near-infrared spectroscopy (fNIRS),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}]"
4129,243,fNIRS,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]"
2028,243,IR index,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Metformin'}]"
1202,244,Copper,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
345,244,Aluminum (Al) concentration,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
347,244,Aluminum levels,"[{'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}]"
344,244,Aluminum,"[{'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]"
346,244,Aluminum concentration,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4380,245,p53,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal apoptosis in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'LEVELS_DIMINISHED_UPON', 'object': 'SLAB51 treatment in AD mice'}]"
3410,245,THK5351,"[{'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cortical atrophy in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cortical volume changes in Alzheimer's Disease""}]"
3409,245,THK-5351 uptake,"[{'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'CORRELATED_WITH', 'object': ""Cortical atrophy in Alzheimer's Disease""}]"
3408,245,THK-5351 PET,"[{'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cortical atrophy and tau aggregates in Alzheimer's Disease""}]"
3159,245,SMB53,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less AD pathology'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}]"
3318,246,Stride width variability,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'No significant associations with hippocampal or somatosensory cortex volumes'}]"
3317,246,Stride variability,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3314,246,Stride time variability,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI) associated with Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Larger temporal horns and middle portions of ventricular bodies'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced grey matter volume in the right parietal lobe'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Larger hippocampal volume'}]"
3313,246,Stride time,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4509,246,stride width,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'global silent infarct presence'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}]"
2370,246,Mean stride time,"[{'article': 'PMC3156726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4510,246,stride width variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced mean diffusivity (MD) in white matter lesions'}]"
4507,246,stride length variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'increased mean diffusivity (MD) in normal appearing white matter'}]"
3312,246,Stride length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity in brainstem, projection, association, limbic and callosal tracts'}]"
4508,246,stride time variability,"[{'article': 'PMC4197903.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Episodic memory deficits in mild cognitive impairment'}]"
3310,246,Stride Length,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4506,246,stride length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'white matter lesions (WML) in the right centrum semiovale'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduction in white matter volume'}]"
3543,247,Texas Red-Dextran-70kD,"[{'article': 'PMC10917684.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Extravasation and clearance in Alzheimer's Disease""}]"
1605,247,Fluorescein-conjugated dextran,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3544,247,Texas Red–dextran,"[{'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3705,248,Vascular endothelial growth factor [VEGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3704,248,Vascular endothelial growth factor (VEGF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]"
3700,248,Vascular Endothelial Growth Factor (VEGF),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]"
1461,248,Endothelial function,"[{'article': 'PMC7934383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Exercise intervention in Alzheimer's Disease""}]"
4600,249,α-Tocopherol (AT),"[{'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}]"
2641,249,Olive oil,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4134,249,flavonoids,"[{'article': 'PMC6616509.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved mood in participants, which may relate to Alzheimer's Disease outcomes""}]"
3743,249,Vitamin E (α-tocopherol),"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Slowed progression of AD at doses of 2000 IU per day'}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased all-cause mortality at doses higher than 400 IU per day'}]"
3744,249,"Vitamin E, selenium","[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decreased levels in mild cognitive impairment and Alzheimer's Disease""}]"
3072,249,Resveratrol,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]"
2500,250,NEK6,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2499,250,NEFA,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular dysfunction in Alzheimer's Disease""}]"
2557,250,Neprilysin (NPE),"[{'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2562,250,NeuN,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal loss in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mature neuronal cells in Alzheimer's Disease""}, {'article': 'PMC5520675.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neuronal density in stimulated brain regions'}]"
2556,250,Neprilysin,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ load'}]"
3321,251,Stroop Color-Word Interference Test,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3322,251,Stroop Color-Word Test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}]"
3323,251,Stroop Color-Word test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
3324,251,Stroop incongruent words test,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]"
3325,251,Stroop test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}]"
3326,251,Stroop test performance,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety and Depression in Alzheimer's Disease""}]"
3327,251,Stroop trial 3,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3936,252,arterial stiffness,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced arterial stiffness is associated with improved brain health and cognitive function in older adults with Alzheimer's Disease.""}]"
3706,252,"Vascular risk factors (e.g., smoking, obesity, diabetes)","[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
498,252,Arterial Spin Labelling (ASL),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
497,252,Arterial Pulsatility,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
287,253,Acetylcholine (Ach) level,"[{'article': 'PMC4159858.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant alteration in AD-like mice'}]"
286,253,Acetylcholine (ACh),"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive function improvement in Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine)'}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
285,253,Acetylcholine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Reduced levels in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cortical activation and maintenance of wakefulness'}]"
291,253,Acetylcholinesterase ([11C]PMP) PET,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cholinergic deficit associated with Alzheimer's Disease""}]"
290,253,Acetylcholinesterase (AChE) activity,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
288,253,Acetylcholine level,"[{'article': 'PMC9011335.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nucleus basalis of Meynert (NBM) deep brain stimulation (DBS)'}]"
3877,253,acetylcholinesterase,"[{'article': 'PMC5372260.txt', 'relationship': 'INHIBITS', 'object': 'acetylcholinesterase'}]"
289,253,Acetylcholinesterase (AChE),"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
292,253,Acetylcholinesterase inhibitors,"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
4125,254,errors in language production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3179,254,SPMSQ >= 4 errors,"[{'article': 'PMC1914346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nursing home admission'}]"
4520,254,syntactic errors,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
3554,255,Thalamus,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3553,255,Thalamic dysfunction,"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Clinical impairments post-stroke'}]"
3562,255,Thigmotactic behavior,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3563,255,Thigmotaxis,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased thigmotactic behavior in untreated Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety-related behavior in Alzheimer's models""}]"
2679,256,P2X7 receptor,"[{'article': 'PMC11274940.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Therapy: Inflammation reduction'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2970,256,Purinergic P2X7 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
2678,256,P2X7,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""M1 microglial phenotype in Alzheimer's Disease""}]"
2677,256,P2X4,"[{'article': 'PMC3835777.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2680,256,P2X7R,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated amyloid pathology and promoted behavioral alterations.'}]"
3960,257,blood-based biomarkers,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8549374.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC8549374.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]"
3958,257,blood biomarkers,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differential diagnosis of Alzheimer’s disease vs frontotemporal dementia'}]"
4256,257,markers of angiogenesis,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3983,257,cardiovascular biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]"
2899,257,Plasma biomarkers,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection: Alzheimer's Disease""}]"
4586,257,various other experimental biomarkers,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improvements on various other experimental biomarkers'}]"
753,257,Biomarkers,"[{'article': 'PMC8507171.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predict incident dementia in individuals with subjective cognitive decline'}]"
1356,257,Digital biomarkers,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
762,257,Blood biomarkers,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease risk""}]"
2875,257,Plasma AD biomarkers,"[{'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4094,257,digital biomarkers,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early-onset Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease stages including mild cognitive impairment and dementia""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease in different clinical stages""}]"
2610,257,Nongenetic biomarkers,"[{'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathological processes leading to Alzheimer's Disease""}]"
2948,257,Prognostic biomarkers,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of AD pathology'}]"
770,257,Blood-based biomarkers,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2120,257,Iron metabolism biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3702,257,Vascular biomarkers,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
2513,258,NLRP3 inflammasome,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: IL-1β maturation and release'}]"
4244,258,lvPPA,"[{'article': 'PMC8615710.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2182,258,LRP-1,"[{'article': 'PMC9321013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Suppression of microglial activation and Alzheimer's Disease progression""}]"
4481,258,sLRP1,"[{'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Blood-brain barrier (BBB) integrity in Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in AD'}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiate AD from mixed dementia phenotypes'}]"
2183,258,LRP1,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ efflux and degradation in Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2512,258,NLRP3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated Aβ pathology and improved cognitive deficits.'}, {'article': 'PMC11274940.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: JC124'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduced inflammation and enhanced motor function recovery in Alzheimer's Disease""}]"
1577,259,Fatty Acids,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in elderly subjects'}]"
4432,259,plasma n-3 fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive responses to exercise treatment among patients with AD'}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS', 'object': 'cognitive responses to aerobic exercise interventions in AD'}, {'article': 'PMC5223628.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'recommendations for n-3 supplementation to enhance pro-cognitive effects of exercise'}]"
4314,259,n-3 Polyunsaturated Fatty Acids (n-3 PUFA),"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cerebral Small Vessel Disease'}, {'article': 'PMC6521224.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Cognitive Decline Prevention'}]"
4315,259,n-3 fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_RESPONSE_TO', 'object': ""Response to aerobic exercise treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive response to exercise treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Favourable changes in cognition at 12 months'}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}]"
1627,259,Free-fatty acids (FFA),"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}]"
2903,259,Plasma fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3212,259,Saturated fatty acids (14:0 and 16:0),"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
3213,259,"Saturated fatty acids (14:0, 16:0)","[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]"
1495,260,Exercise,"[{'article': 'PMC8873004.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Low Intensity Exercise to Reduce Postoperative Cognitive Dysfunction'}]"
3215,260,Sedentary lifestyle,"[{'article': 'PMC9501541.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]"
2223,260,Lifestyle activities,"[{'article': 'PMC5016950.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive outcomes in Alzheimer's Disease""}]"
2852,260,Physical activity,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive performance'}, {'article': 'PMC5123349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Tracking adherence in Alzheimer's Disease""}, {'article': 'PMC9501541.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Decline in Alzheimer's Disease""}]"
2853,260,Physical activity (PA),"[{'article': 'PMC5504954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Reduced risk of developing dementia'}]"
2854,260,Physical activity levels,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of mild Alzheimer's dementia associated with apathy and more daytime napping""}]"
2850,260,Physical Activity Scale for the Elderly (PASE),"[{'article': 'PMC4153626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Physical activity levels'}]"
318,260,Aerobic exercise,"[{'article': 'PMC5504954.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Larger hippocampal regions and increased gray and white matter volume'}]"
3216,261,Sele,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflamed BBB endothelium'}]"
3218,261,Semagacestat,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed Phase III clinical trials due to worsening symptoms'}]"
3136,261,SE,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3137,261,SEMA4D,"[{'article': 'PMC4966508.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VX15/2503 treatment'}]"
2761,262,PPAR delta,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]"
2768,262,PPQSA,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2766,262,PPARGC1A,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2764,262,PPAR-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced amyloid pathology and decreased gliosis activation.'}, {'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]"
2767,262,PPARγ,"[{'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}]"
2762,262,PPAR gamma,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]"
2760,262,PPAR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2759,262,PP2A,"[{'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Tau hyperphosphorylation and Alzheimer's Disease progression""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2721,263,PE,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2810,263,Pe (Error Positivity),"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1865,263,Health Utility Index (HUI),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]"
1426,263,EPA,"[{'article': 'PMC3335851.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment with n-3 FAs'}, {'article': 'PMC3335851.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to n-3 FA treatment'}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}, {'article': 'PMC6521224.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment compliance and biological activity'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}]"
3238,264,Serum triglyceride (TG),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]"
3633,264,Triglycerides,"[{'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cardiovascular risk in bexarotene-treated patients'}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Dyslipidemia in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Lipid profiles in Alzheimer's Disease patients""}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3632,264,Triglyceride,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]"
3634,264,Triglycerides (TG),"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3635,264,Triglycerides levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2379,264,Medium Chain Triglycerides (MCTs),"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
3239,264,Serum triglycerides,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower triglyceride levels in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
4576,264,triglycerides,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
999,265,CYP46A1 rs754203,"[{'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
998,265,CYP46A1,"[{'article': 'PMC3712995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved spatial memory retention in aged mice with Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Brain cholesterol metabolism in Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Activation by low-dose EFV'}, {'article': 'PMC9797897.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Low-dose EFV for Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of Efavirenz treatment for Alzheimer's Disease""}]"
996,265,CYP3A5,"[{'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]"
994,265,"CYP2D6, CYP3A4, CYP3A5","[{'article': 'PMC3764973.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guiding selection of acetylcholinesterase inhibitors based on genetic alleles'}]"
993,265,CYP2D6,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]"
997,265,CYP450,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Drug metabolism in Alzheimer's Disease treatment""}]"
995,265,CYP3A4,"[{'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]"
3079,266,Retinal thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
3074,266,Retinal Nerve Fiber Layer (RNFL) Thinning,"[{'article': 'PMC6445433.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Pathology: Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3076,266,Retinal Vessel Density,"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3075,266,Retinal Nerve Fiber Layer (RNFL) thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
3078,266,Retinal nerve fiber layer thickness,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early diagnosis of dementia'}]"
4401,267,pan-tyrosine phosphorylated Abl,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib administration'}]"
2829,267,Phospho-Abl (pan-tyrosine),"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}]"
3650,267,Tyrosine Hydroxylase Enzyme,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2648,267,Ornithine transcarbamylase (OTC),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4497,268,solanezumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Passive immunotherapy targeting soluble monomeric Aβ'}]"
3943,268,bapineuzumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Passive immunotherapy targeting Aβ'}]"
719,268,Bapineuzumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Terminated in Phase III trials due to lack of efficacy'}]"
3270,268,Solanezumab,"[{'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed to meet primary endpoint in Phase III trial'}]"
1104,269,Ch4a-i,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better executive function'}]"
1270,269,DDIT4,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
950,269,CPNE4,"[{'article': 'PMC6154782.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1373,269,Dll4,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]"
919,269,CHL1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
829,269,C4d,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposition and inflammation'}]"
1106,269,Ch4p,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better language function'}, {'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better navigation function'}]"
3329,270,Subclinical Depression,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of developing Alzheimer's clinical syndrome""}]"
459,270,Anxiety,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
460,270,Anxious-Depressive-Like Behavior,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early signs of Alzheimer's Disease""}]"
1742,270,Generalized Anxiety Disorder (GAD-7),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]"
1332,270,Depressive symptoms,"[{'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
728,270,Beck Depression Inventory (BDI),"[{'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}]"
2353,270,Major depression,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden associated with Alzheimer's Disease""}]"
4096,272,donepezil,"[{'article': 'PMC3481364.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2129,272,J147 + Donepezil,"[{'article': 'PMC3706879.txt', 'relationship': 'SYNERGISTIC_EFFECT', 'object': 'Improved hippocampal-dependent associative memory'}]"
1374,272,Donepezil,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC3706879.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reversal of scopolamine-induced cognitive impairment'}, {'article': 'PMC4743597.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}, {'article': 'PMC9340683.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
2128,272,J147,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Better prognosis in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid toxicity in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Memory improvements in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory enhancements in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Spatial learning and memory in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD mice'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Improvement in spatial navigational memory'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction in disinhibition phenotype'}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in short-term working memory and spatial memory in scopolamine-induced memory impairment model'}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reversal of memory deficits in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved spatial memory and hippocampal-dependent associative learning'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of soluble Aβ levels'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2792,273,Palmitic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Production of Aβ peptides and amyloid plaques in Alzheimer's Disease""}]"
2793,273,Palmitoleic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1562,273,FYN palmitoylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
228,273,APP palmitoylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3737,274,Visuospatial/constructional domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in visuospatial/constructional functions in suspected mild cognitive impairment'}]"
3736,274,Visuospatial/Constructional score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
3734,274,Visuospatial Function,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
3733,274,Visuospatial,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
3732,274,Visuoconstructional/Executive function,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Slower speech rate and shorter turns'}]"
3735,274,Visuospatial Processing,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance'}]"
4627,275,β2−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
4621,275,β-catenin,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4613,275,β-actin,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4612,275,β-Sitosterol (BS),"[{'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}]"
4625,275,β-wrapin AS69,"[{'article': 'PMC4857621.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
4610,275,β-NGF,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4611,275,β-OHB,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved paragraph recall with MCT administration'}]"
4626,275,β1−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
1628,276,Frequency magnitudes,"[{'article': 'PMC9203627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
368,276,Amplitude Low Frequency Fluctuation (ALFF),"[{'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1388,276,Dynamic cross-frequency coupling (CFC) patterns,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Early detection of Alzheimer's Disease progression""}, {'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: High classification accuracy (95%) for early diagnosis'}]"
3625,276,Treg Frequencies,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2502,277,NF-L,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive impairment and survival time in Alzheimer's Disease patients""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection and prognosis in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]"
2790,277,PWF,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
2600,277,Nfh,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}]"
2741,277,PHF,"[{'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2594,277,NfH,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in NfH levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
2751,277,PIGF,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2347,278,"Macrophage-derived chemokine [MDC, CCL22]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2458,278,"Monocyte chemoattractant protein-1 [MCP-1, CCL2]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2459,278,"Monocyte chemoattractant protein-4 [MCP-4, CCL13]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2346,278,Macrophage-derived chemokine,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Placebo group'}]"
3566,278,"Thymus and activation-regulated chemokine [TARC, CCL17]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4408,280,perilesional areas,"[{'article': 'PMC5253356.txt', 'relationship': 'PREDICTS_TREATMENT_RESPONSE', 'object': 'treatment response in chronic aphasia'}]"
3947,280,basal nucleus of Meynert,"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Clinical features of Alzheimer's Disease""}]"
2971,280,Purkinje cell layer cellularity,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Improved by T3D-959 treatment'}]"
1615,280,Foveal Avascular Zones (FAZ),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]"
3976,280,c-Fos-stained neurons,"[{'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2332,280,MRglc in posterior cingulate region,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]"
45,281,200 kDa neurofilament,"[{'article': 'PMC3978916.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal damage in Alzheimer's Disease""}]"
2581,281,Neuropeptide Y (NPY),"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Total-Tau (T-Tau) and Phosphorylated-Tau (P-Tau)'}]"
2580,281,Neuron Specific Enolase (NSE),"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}]"
2577,281,Neurofilament proteins,"[{'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2590,281,Neurotrophin concentration,"[{'article': 'PMC6893800.txt', 'relationship': 'RESPONDED_TO', 'object': 'Dark chocolate intake'}]"
1176,282,Cohen-Mansfield Agitation Inventory,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Agitation and aggressiveness in Alzheimer's Disease""}]"
3885,282,agitation,"[{'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in agitation levels after exercise intervention'}]"
324,282,Agitation,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4493,283,sleep disturbances,"[{'article': 'PMC8317398.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Bright Light Therapy (BLT)'}]"
3015,283,REM sleep changes,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mood changes'}]"
732,283,"Behaviors (e.g., getting out of bed at odd hours, going to bed earlier)","[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3014,283,REM sleep behavior disorder,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia with Lewy Bodies (DLB), which is often misdiagnosed as Alzheimer's Disease""}]"
2783,283,PSG confirmation of REM sleep without atonia,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
2605,283,Night behavioral disturbances,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3250,283,Sleep Disorder Inventory (SDI),"[{'article': 'PMC7083107.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Sleep disturbances in Alzheimer's Disease""}]"
3252,283,Sleep Patterns,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3255,283,Sleep activity,"[{'article': 'PMC5123349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Tracking adherence in Alzheimer's Disease""}]"
4231,284,left inferior temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Acupuncture combined with Donepezil treatment'}]"
4230,284,left inferior parietal gyrus,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4235,284,left superior temporal gyrus (STG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2421,284,Middle Frontal Gyrus (MFG),"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4232,284,left inferior temporal gyrus (ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
751,284,Bilateral anterior inferior temporal gyrus (ITG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]"
3342,284,Superior temporal gyrus (STG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]"
4468,284,right inferior temporal gyrus fALFF,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3097,284,Right Superior Temporal Gyrus (R STG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]"
750,284,Bilateral anterior fusiform gyrus (FG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]"
3341,284,Superior temporal gyrus,"[{'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3095,284,Right Inferior Temporal Gyrus (R ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Longer gap durations in Alzheimer's Disease""}]"
4294,284,middle and inferior frontal gyri,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2200,284,Left Inferior Temporal Gyrus (L ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]"
2199,284,Left Inferior Frontal Gyrus (L IFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]"
2209,284,Left posterior temporal gyrus atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]"
2211,284,Left supramarginal gyrus (SMG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]"
4229,284,left inferior frontal gyrus (IFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2208,284,Left inferior frontal gyrus (IFG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (nfvPPA variant)""}]"
2763,285,PPAR-β/δ,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]"
4631,285,δ−α2,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
2765,285,PPAR-δ agonist,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2757,285,PLVβ2 → γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
2758,285,PLVθ → β1,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
2365,286,Mean atrophy,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]"
1103,286,Ch4 subfield atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive and spatial navigation deficits in Alzheimer's Disease""}]"
4441,286,precuneus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RESPONDED_TO', 'object': 'NGF treatment in hippocampal-sparing AD'}]"
509,286,Atrophy (global and local),"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict disease course in AD and MCI'}]"
2930,286,Precuneus atrophy rate,"[{'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease subtypes""}]"
512,286,Atrophy progression,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive decline in SCD-clinic group'}]"
2661,287,P-tau,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'INNOTEST ELISAs'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ38'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Significant association with MMSE score change'}, {'article': 'PMC8901176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Adjustment in models for prognosis'}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive and motor progression in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2665,287,P-tau217 levels,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with worse prognosis in Alzheimer's Disease""}]"
2508,288,NFκB,"[{'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4320,288,network failure quotient (NFQ),"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2503,288,NF-κB,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2563,288,Neural Flexibility Quotient (NFQ),"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2082,289,"Inflammatory markers (e.g., Map3k7, Map2k4, C1qa, C1qb, C3, C4a, Flt1)","[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
2077,289,Inflammation biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2081,289,Inflammatory markers,"[{'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
4212,289,inflammatory biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]"
2076,289,Inflammation,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased inflammation in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2080,289,Inflammatory factors,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intervention response in Alzheimer's Disease""}]"
3363,289,Systemic immune-inflammation index,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]"
4060,289,chronic inflammatory mechanisms,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4214,289,inflammatory markers,"[{'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower levels of inflammatory markers are associated with improved physical fitness and function in older adults with dementia.'}]"
1510,290,FBB,"[{'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
1511,290,FBB PET,"[{'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ deposition in Alzheimer's Disease""}]"
2633,290,OLB,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Advanced dementia and cognitive decline in AD'}]"
1396,290,EB,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Blood-Brain Barrier Integrity'}]"
2993,290,R-WAB AQ,"[{'article': 'PMC4283612.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Higher scores are associated with more improvement in therapy tasks.'}, {'article': 'PMC4283612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Language impairment in Alzheimer's Disease""}]"
3017,290,RHOB,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3411,290,TIB,"[{'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Later age at onset of Subjective Cognitive Decline'}]"
1545,290,FJB,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal degeneration'}]"
1589,291,Flanker test,"[{'article': 'PMC10475546.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improvements in inhibitory control of attention'}]"
2122,291,Isaac’s set test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal fluency deficits in Alzheimer's Disease""}]"
59,291,30-second chair stand test (CST),"[{'article': 'PMC4431827.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in lower limb strength and function after exercise'}]"
2851,291,Physical Performance Test (PPT),"[{'article': 'PMC4497726.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Functional health'}]"
2928,291,Praxis test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Praxis deficits in Alzheimer's Disease""}]"
720,291,Barcelona Test-Revised (TBR),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Language ability in Alzheimer's Disease""}]"
1402,293,EDN1,"[{'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]"
312,293,Adamts1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]"
121,293,ADAM10,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
1403,293,EDNRA,"[{'article': 'PMC4835514.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]"
1404,293,EDVGSNK,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': ""Biomarker for Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Amyloid-beta production'}]"
3657,293,UGT8,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3652,293,UBE2V1,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3177,294,SPECT scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3176,294,SPECT imaging,"[{'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3175,294,SPECT,"[{'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5642413.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3178,294,SPECT-DaTscan®,"[{'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}]"
1306,294,DaTscan®,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
2443,295,Mitochondrial enzymes,"[{'article': 'PMC8868383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
2444,295,Mitochondrial function,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Improved mitochondrial function in Alzheimer's Disease""}]"
2445,295,Mitochondrial quality control markers,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Prognosis: Alzheimer's Disease""}]"
4302,295,mitochondrial function,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved mitochondrial function'}]"
4301,295,mitochondrial dysfunctions,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]"
4300,295,mitochondrial dysfunction,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4298,295,mitochondrial biogenesis,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired mitochondrial biogenesis in Alzheimer's Disease""}]"
4297,295,mitochondrial bioenergetics,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial function and neuroprotection in Alzheimer's Disease""}]"
2440,295,Mitochondrial Function,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
2441,295,Mitochondrial biogenesis-related protein,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Mitochondrial deficits and Alzheimer's Disease progression""}]"
2442,295,Mitochondrial dysfunction,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4303,295,mitochondrial quality control,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial quality control after exercise training in Alzheimer's Disease""}]"
4299,295,mitochondrial complex I–III activity,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2924,296,Posterior cingulate island sign on FDG-PET imaging,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
3050,296,Reduced occipital activity on FDG-PET imaging,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
2312,296,MRI and FDG-PET measures,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment within 48 months'}]"
2313,296,MRI and PET scans,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
1520,296,FDG PET scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2922,296,Posterior cingulate FDG-PET,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]"
1558,296,FTM-PET visual read,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1530,296,FDG-PET imaging,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2732,296,PET imaging,"[{'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2323,296,MRI or 18F-FDG PET,"[{'article': 'PMC7477392.txt', 'relationship': 'PREDICTS', 'object': 'Future cognitive decline'}]"
1341,297,Diastolic BP,"[{'article': 'PMC8000213.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MBSR intervention'}]"
3365,297,Systolic blood pressure,"[{'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Stress reduction efforts and category changes in Alzheimer's Disease risk reduction""}]"
767,297,Blood pressure,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and amyloid-β accumulation'}]"
761,297,Blood Pressure (BP),"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1950,297,Hypertension,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC5389824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive deterioration'}]"
3364,297,Systolic BP,"[{'article': 'PMC8000213.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MBSR intervention'}]"
3197,298,SV2A,"[{'article': 'PMC8325256.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid precursor protein (APP)'}]"
3198,298,SVD features,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and dementia'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive dysfunction'}]"
3201,298,SVLT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Verbal Memory Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
3200,298,SVD-associated features,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive aging'}]"
3199,298,SVD score,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}]"
1054,298,Cerebral SVD,"[{'article': 'PMC7477392.txt', 'relationship': 'MAY_BE_A_CAUSE_OF', 'object': 'Cognitive impairment in AD'}, {'article': 'PMC7477392.txt', 'relationship': 'PROMOTES', 'object': 'Aβ accumulation and neuronal damage'}]"
4126,299,estradiol to follicle-stimulating hormone ratio,"[{'article': 'PMC8060832.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of improved cognitive function in women with Alzheimer's Disease""}]"
1485,299,Estrogen levels,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'GABAergic interneurons in the hippocampus'}]"
1483,299,Estradiol levels,"[{'article': 'PMC8060832.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change with benzoate treatment'}]"
1482,299,Estradiol,"[{'article': 'PMC8060832.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in women with Alzheimer's Disease""}]"
1484,299,Estradiol to FSH ratio,"[{'article': 'PMC8060832.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in women with later-phase dementia'}, {'article': 'PMC8060832.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in women with later-phase dementia'}]"
259,301,AV-45,"[{'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical amyloid load in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral amyloid load in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early, pre-demential diagnosis of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Memory performance decline in prodromal AD patients'}, {'article': 'PMC3733998.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid load correlating with memory decline'}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques associated with Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Therapy Choice: PET template-based quantification for clinical diagnosis'}]"
1592,301,Florbetapir (AV-45),"[{'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
262,301,AV45-PET SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Aβ burden in Alzheimer's Disease""}]"
260,301,AV-45 Uptake,"[{'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid Pathology in Alzheimer's Disease""}]"
261,301,AV45-PET,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}, {'article': 'PMC4506984.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
263,301,AV45-SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in splenium and body of corpus callosum'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ deposition'}]"
1593,301,Florbetapir (AV45),"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1133,302,Clic5a,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Upregulated in 40Hz stimulation'}]"
1129,302,Cldn5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]"
928,302,CLU,"[{'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease inflammation""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Brain atrophy and disease severity in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
926,302,CLOX1 clock-drawing task,"[{'article': 'PMC3088375.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]"
925,302,CLOX1,"[{'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Executive function deficits in older adults'}]"
924,302,CLEC7A,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Rescue of microglia activation and attenuation of Aβ burden in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Microglia activation in AD'}]"
1132,302,Clec7a,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Microglial Neurodegenerative Phenotype (MGnD) in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Enhanced Aβ clearance in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4462,303,rCBF,"[{'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduction in rCBF in Tg mice during ON periods'}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring Alzheimer's Disease progression""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]"
3016,303,RFFT,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4463,303,rCBF in IPL,"[{'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3011,303,RCFT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Visuospatial Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
98,304,AB,"[{'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
99,304,AB 42/40 ratio,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
277,304,Ab42/40 ratio,"[{'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
275,304,Ab274,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]"
274,304,Ab,"[{'article': 'PMC4487699.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
276,304,Ab42,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}]"
3300,305,Step Length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3301,305,Step Length (SL),"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4504,305,step count,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3302,305,Step Width,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3266,305,Smart-vest steps,"[{'article': 'PMC9395831.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease progression""}]"
3303,305,Step frequency,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in metabolic rates of glucose uptake in the prefrontal, posterior cingulate, and parietal cortices'}]"
3304,305,Step length (SL) before turning,"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
3306,305,Step width,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced fractional anisotropy in the left corticospinal tract'}]"
3305,305,Step length variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity within the hippocampus and anterior cingulate cortex'}]"
4505,305,step length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in hippocampus'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in prefrontal cortex'}]"
525,308,Axon Peptide 108,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2045,308,IgG against Axon Peptide 108,"[{'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
818,308,C-peptide (ICP),"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Correction of brain functions in DM and MS'}]"
3699,309,Valine,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Mild Cognitive Impairment'}]"
3864,309,[18F]dihydromethidine,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4585,309,valproate,"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}, {'article': 'PMC7831739.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of agitation in dementia'}]"
2104,309,Intepirdine,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
1923,309,Histamine,"[{'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cortical activation and maintenance of wakefulness'}]"
736,309,Berberine,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Aβ-induced inflammatory responses in Alzheimer's Disease""}]"
1863,309,Hcy,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular inflammation and oxidative stress'}]"
2216,309,Levetiracetam,"[{'article': 'PMC8325256.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
2123,309,Isoleucine,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiation between mild cognitive impairment due to AD and healthy controls'}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GV-971 treatment'}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
2473,310,Music therapy (MT),"[{'article': 'PMC9246122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Improved cognitive function in AD patients'}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in AD patients'}]"
1730,310,Gamma sensory stimulation therapy effect on sleep,"[{'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Therapeutic response in mild to moderate Alzheimer's Disease""}]"
1196,310,Constant Therapy performance,"[{'article': 'PMC9513684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to cognitive training'}, {'article': 'PMC9513684.txt', 'relationship': 'RESPONDED_TO', 'object': 'Cognitive training intervention'}]"
4529,310,tDCS stimulation,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
769,311,Blood-Brain Barrier (BBB) Permeability,"[{'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2417,311,Microvasculature genes,"[{'article': 'PMC6211704.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Normalization of compromised microvascular functions in AD with anti-diabetic treatments'}]"
1397,311,EB extravasation,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Blood-Brain Barrier Disruption (BBBD)'}]"
1069,311,Cerebral microbleeds,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1899,311,Hippocampal perfusion,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Loss of spatial memory in older individuals'}]"
1070,311,Cerebral microbleeds (CMBs),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3997,311,cerebral perfusion,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
699,312,BHB levels,"[{'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of ketosis in Alzheimer's Disease patients""}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive performance improvement in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Correlation with improvement in ADAS-Cog score in E4(-) subjects'}]"
707,312,BMS,"[{'article': 'PMC10475546.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Exercise training for older adults with cognitive decline'}]"
757,312,Blautia,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau (higher levels reflect greater neurofibrillary tangle pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau/Aβ42 ratio (higher values imply greater AD pathology)'}]"
693,312,BDS,"[{'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive dysfunction in Alzheimer's Disease""}]"
685,312,BDI-II,"[{'article': 'PMC4468784.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Depression in Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depression in Alzheimer's Disease patients""}]"
698,312,BHB,"[{'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with AC-1202'}, {'article': 'PMC2731764.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Ketone body levels post-dosing'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Cognitive improvement in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Serum BHB levels during treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Changes in serum β-hydroxybutyrate levels in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Promotes mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance in Alzheimer's Disease""}]"
91,312,A2m,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Amyloid-β clearance'}]"
876,313,CD4+CD25+Foxp3+ regulatory T cells (Tregs),"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta (Aβ) deposition'}, {'article': 'PMC5342482.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic approach for Alzheimer's Disease""}]"
3059,313,Regulatory T cells (Tregs),"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Impaired systemic immunosuppression in Alzheimer's Disease""}]"
3447,313,TREM2 mutation,"[{'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'More extensive brain atrophy in AD patients'}]"
3626,313,Treg cells,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Immune system homeostasis in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Reduction of disease progression in Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD progression'}]"
3631,313,Triggering receptor expressed on myeloid cells 2 (TREM2),"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
2646,314,Orexin,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid-β (Aβ) pathology in Alzheimer’s disease'}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ deposition in the brain'}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ deposition'}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2616,314,Notch,"[{'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Inhibition of Notch cleavage linked to gastrointestinal symptoms'}]"
171,314,ALT,"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver enzyme levels during atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Liver enzyme elevations in Alzheimer's Disease treatment""}]"
2304,314,MNA,"[{'article': 'PMC7505369.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive stage and bone health status'}]"
2350,314,Maff,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Neurogenesis'}]"
2281,314,MHIS,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1834,314,HMOX,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]"
2625,314,Nuts,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
966,315,CSDD Behavioral disturbance,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Behavioral disturbances in dementia'}]"
964,315,CS metric,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
967,315,CSDD Mood-related signs,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Mood-related depression in dementia'}]"
968,315,CSDD total,"[{'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Depression in dementia patients'}]"
965,315,CSDD,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction in depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Comorbid depression in Alzheimer's Disease""}, {'article': 'PMC9116897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Depressive symptoms'}]"
1251,316,D1-like receptors,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1618,316,Fractalkine receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
3381,316,TAM receptor,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Developed fewer dense-core plaques.'}]"
1178,316,Colony-stimulating factor 1 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
1252,316,D2-like receptors,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1250,316,D1 receptor,"[{'article': 'PMC8048550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}]"
1009,316,Cannabinoid-2 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
2902,317,Plasma eicosapentaenoic acid (EPA),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
1451,317,Eicosanoids,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Vascular dynamics in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1450,317,"Eicosanoid metabolites (e.g., DHA, 9-HETE, 8-iso-15-keto PGF2β, 11- and 13-HDoHEs, 9- and 13-HODEs)","[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
1449,317,Eicosanoid metabolites,"[{'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}]"
2639,317,Oleanolic Acid (OA),"[{'article': 'PMC6921051.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction of inflammatory cytokines in BV-2 cells'}, {'article': 'PMC9321013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of oxidative stress and inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4112,317,eicosapentaenoic acid (EPA),"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]"
3455,318,TSPO expression in thalamus,"[{'article': 'PMC9349172.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3453,318,TSPO (18 kDa translocator protein),"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Neuroinflammation in Alzheimer’s Disease'}]"
3567,318,Thyroid-Stimulating Hormone (TSH),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3454,318,TSPO expression in hypothalamus,"[{'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2797,318,Parathyroid hormone (PTH),"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assess cognitive benefits and treatment response in Alzheimer's Disease""}]"
2394,319,Meningioma,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3537,319,Temporoparietal hypometabolism,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1951,319,Hypoalbuminemia,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in women with Alzheimer's Disease""}]"
3025,319,RMTG hypometabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3112,320,S100β,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebrovascular inflammation in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain-to-blood leakage'}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Blood-Brain Barrier (BBB) leakage in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and dystrophic neurites'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ formation and neuronal damage'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3113,320,S24-7,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3111,320,S100b,"[{'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reactive astrocytes in Alzheimer's Disease""}]"
3164,320,SNX17,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3110,320,S100B,"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuronal and glial death in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3109,320,S100A12,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}]"
4628,321,γ-glutamyl amino acids,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Impaired GSH homeostasis in Alzheimer's Disease""}]"
1775,321,Glutamate,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuronal death and AD pathogenesis'}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Decreased brain glutamate levels in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through excitotoxicity and neuronal damage""}]"
1776,321,Glutamine,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1777,321,Glutamine synthetase,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced levels in AD brains'}]"
1778,321,Glutamine synthetase (GS),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1732,321,Gamma-Glutamyl Transferase (GGT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4172,321,glutamate,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
677,322,BBS,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in balance under Wii-Fit treatment'}]"
2239,322,Lower BBS scores,"[{'article': 'PMC4431827.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicted improvement in 30-second chair stand test after intervention'}]"
676,322,BBB disruption,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]"
517,323,Automated parcellation,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Assess atrophy and predict conversion from MCI to AD'}]"
3282,323,Spatial navigation,"[{'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Progression to mild cognitive impairment'}]"
2815,323,Performance-Oriented Assessment of Mobility (POMA),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mobility performance in Alzheimer's Disease""}]"
2068,323,"In-home activity data (computer use, walking speed, time out of house)","[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early changes in Mild Cognitive Impairment'}]"
2354,324,Malformation of venous development,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3701,324,Vascular abnormalities,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3245,324,Single cavernous malformation,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2978,325,QEEG,"[{'article': 'PMC6130053.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1504,325,FAB,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Predicts fall risk reduction in older adults with Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}]"
2973,325,Q,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Q values are associated with community structure in brain networks of Alzheimer's Disease patients""}]"
1506,325,FAK,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2405,326,Mfn2,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
2276,326,MFG1,"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Item memory gains'}]"
2275,326,MFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2269,326,MEF2C,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
2279,326,MFN2,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of MFN2 enhances mitochondrial fusion in Alzheimer's Disease""}]"
2278,326,MFN1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of MFN1 enhances mitochondrial fusion in Alzheimer's Disease""}]"
2404,326,Mfn1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
758,327,Blessed ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
760,327,Blessed score ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
759,327,Blessed Test,"[{'article': 'PMC3978714.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
1565,328,Facial gender recognition test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Gender recognition deficits in Alzheimer's Disease""}]"
4113,328,emotional arousal,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]"
1505,328,FACIAL EMOTION RECOGNITION,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
1564,328,Facial emotion recognition test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Facial emotion recognition deficits in Alzheimer's Disease""}]"
1420,328,EFEs (Emotional Facial Expressions),"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Emotional and social engagement in patients with dementia'}]"
1645,329,Functional MRI (fMRI),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
786,329,"Brain MRI findings (widening of sulci in fronto-insular, occipital, and olfactory sulci)","[{'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4153,329,functional magnetic resonance imaging (fMRI),"[{'article': 'PMC8795741.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Changes in functional brain networks in people with mild cognitive impairment or early-stage dementia'}]"
3067,329,Resting State Functional MRI (rsfMRI),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4128,329,fMRI,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased activation and functional connectivity in brain regions specific for mnestic functions'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Default mode network connectivity predictive of clinical progression to dementia'}]"
3142,330,SG performance data,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Delay cognitive and motor decline in the elderly'}]"
2947,330,Processing speed,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3204,330,SWM performance,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Worse performance in Alzheimer's Disease compared to healthy controls""}]"
1509,330,FAST,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Disease progression in Alzheimer's Disease""}]"
300,331,Actinobacteria,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
717,331,Bacteroidetes,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Exacerbation of AD pathology through inflammation'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Greater Alzheimer's Disease pathology""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
716,331,Bacteroides (enterotype I),"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
715,331,Bacteroides,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau (higher levels reflect greater neurofibrillary tangle pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau/Aβ42 ratio (higher values imply greater AD pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Greater Alzheimer's Disease pathology""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive Impairment: Mild Cognitive Impairment in Alzheimer's Disease""}]"
1487,331,Eubacterium rectale,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less amyloid deposition'}]"
749,331,Bifidobacterium,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Less Alzheimer's Disease pathology""}]"
1481,331,Escherichia/Shigella,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Amyloid deposition on PET imaging'}]"
2638,331,Odoribacter,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]"
3307,331,Streptococcus,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment and memory dysfunction'}]"
1566,331,Faecalibacterium,"[{'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3647,331,Turicibacter,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}]"
1173,332,"Cognitive tasks (visual oddball, flanker, n-back, delayed match-to-sample)","[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Track cognitive ageing and progression of Alzheimer's Disease""}]"
3498,332,Task Activation Responses,"[{'article': 'PMC6538045.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Monitor changes in brain blood flow during treatment'}]"
2822,332,Perspective-taking tests,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Perspective-taking deficits in Alzheimer's Disease""}]"
4466,332,"references to objects, subjects and actions","[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
3268,332,"Social cognition tests (e.g., facial recognition, perspective taking)","[{'article': 'PMC4200223.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Risk of developing BPSD'}]"
731,332,Behavioral observations,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]"
1702,333,GSK-3B,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1707,333,GSK3β,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Tau hyperphosphorylation in Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4412,333,phospho-GSK-3 beta S9 (S9-GSK-3β),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
1706,333,GSK3B,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1705,333,GSK3,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1703,333,GSK-3β,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through tau phosphorylation""}]"
1554,334,FRAP assay,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decreased levels in mild cognitive impairment and Alzheimer's Disease""}]"
735,334,Benton Visual Retention Test (BVRT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3642,334,Trypan blue dye exclusion assay,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]"
3676,336,VDRL,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3696,336,VWF,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3695,336,VSRAD,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4583,336,vMRI,"[{'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]"
3688,336,VLDL,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Dyslipidemia in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]"
3686,336,VL,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Quality of Life in severe dementia'}]"
2222,337,Life-space characteristics,"[{'article': 'PMC9501541.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]"
1604,337,FluoSphere beads,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lymphatic clearance in Alzheimer's Disease""}]"
1261,337,DAMPs,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
805,338,BrdU,"[{'article': 'PMC4159858.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Enhanced neurogenesis in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cell proliferation in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Impaired brain cell genesis'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Neurogenesis in Alzheimer's Disease""}]"
709,338,BORB,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
850,338,CB2R,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3066,338,Resting CBF,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
851,338,CBF,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
90,339,A2 astrocyte phenotype,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
89,339,A1 astrocyte phenotype,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4337,339,oligodendrocytes,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
505,339,Astrocytes,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3938,339,astrocytes,"[{'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Astrocytes respond to NBM stimulation and play a role in synaptic plasticity, which may be associated with better outcomes.'}]"
3192,340,SUVR in putamen,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]"
3191,340,SUVR in globus pallidus,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]"
3190,340,SUVR in caudate,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]"
3193,340,SUVR in thalamus,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]"
858,341,CCO (Cytochrome C Oxidase),"[{'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1241,341,Cyclooxygenase,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
1244,341,Cytochrome c,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1245,341,Cytochrome c oxidase (COX),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]"
1038,342,Centiloids,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1037,342,Centiloid value,"[{'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta plaques'}]"
1036,342,Centiloid threshold values,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early amyloid accumulation in Alzheimer's Disease""}]"
1035,342,Centiloid scale assessments,"[{'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]"
1034,342,Centiloid method,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1033,342,Centiloid (CL),"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid burden in Alzheimer's Disease""}]"
1614,343,Fos,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3977,343,c-fos,"[{'article': 'PMC5520675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neural activation in the hippocampus'}, {'article': 'PMC5520675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal activation in the dentate gyrus after hippocampus stimulation'}]"
1555,343,FSH,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8060832.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility for benzoate treatment in women with Alzheimer's Disease""}]"
1559,343,FTO,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1556,343,FSH levels,"[{'article': 'PMC8060832.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change with benzoate treatment'}]"
1237,344,Curcumin,"[{'article': 'PMC3237323.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4084,344,curcumin,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Neuroprotection in AD'}]"
3539,344,Tenericutes,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3538,344,Tenascin-R,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1248,345,D-KEFS,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
815,345,C-DF,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1262,345,DAN alterations,"[{'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1249,345,D-serine,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive performance in Alzheimer's Disease""}]"
3248,346,Six-Item Screen (SIS),"[{'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive impairment in older adults'}, {'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]"
1192,346,Computer-based touchscreen cognitive task,"[{'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement due to Levetiracetam treatment'}]"
3604,346,Touch,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
2288,347,MME,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2303,347,MMSE-2:SV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Moderate Alzheimer's Disease""}]"
2301,347,MMSE-2:BV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}]"
2300,347,MMSE-2,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
2299,347,MMSE scores,"[{'article': 'PMC4396171.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive response to treatment in Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Slower progression in galantamine-treated patients'}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality: Lower rates in galantamine-treated patients'}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity""}]"
2302,347,MMSE-2:EV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2297,347,MMSE score,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC2880123.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2880123.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in CoV of stride time'}, {'article': 'PMC4335024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4335024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4335024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Disease progression in Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment severity in Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}]"
2141,347,K-MMSE,"[{'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2294,347,MMSE,"[{'article': 'PMC10092214.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurocognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC10092214.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Impairment in Neurocognitive Disorders'}, {'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Severity of Neurocognitive Disorders'}, {'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2194921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive changes in Alzheimer's Disease""}, {'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive state in Alzheimer's Disease""}, {'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower MMSE score associated with increased risk of AD'}, {'article': 'PMC3493328.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease patients""}, {'article': 'PMC3898226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4153626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC4153626.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Chronic recurring falls leading to injurious outcomes'}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognitive function in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Mini-Mental State Examination score criteria for study inclusion'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4353453.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4401690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4468784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis of: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Helps in prognosis of AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower MMSE scores in participants with dementia'}, {'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in men with Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Patient awareness of dementia'}, {'article': 'PMC8127192.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8305709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8316394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive Impairment'}, {'article': 'PMC8316394.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease based on cognitive impairment severity""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in Alzheimer’s Disease'}, {'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function assessment in Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC8957010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity and progression""}, {'article': 'PMC4712287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC4764002.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC5111338.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive response to galantamine treatment in memantine nonusers'}, {'article': 'PMC5111338.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive decline monitoring during treatment'}, {'article': 'PMC5122007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5122007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive Impairment Assessment'}, {'article': 'PMC5381339.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5403784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5434395.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment severity'}, {'article': 'PMC5546604.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better outcomes on the MMSE were associated with more ventral/caudal locations.'}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC6366025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Global cognitive function in mild cognitive impairment and AD'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of fall/injury in all groups including placebo'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Change in cognitive function related to Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC7662628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment and dementia conversion'}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess dysnomia in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Total ADL and IADL in Alzheimer's Disease patients""}, {'article': 'PMC7749592.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease patients""}, {'article': 'PMC7798342.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9092839.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Lower MMSE scores are associated with more severe Alzheimer's Disease stages.""}, {'article': 'PMC9361147.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9395831.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Used to diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive loss in prodromal Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease cognitive impairment""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
2293,347,MMQ,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2289,347,MMN,"[{'article': 'PMC6370863.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2298,347,MMSE score < 17,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Moderate or severe Alzheimer’s Disease'}]"
70,348,4SBT,"[{'article': 'PMC10475546.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Balance in older adults with cognitive decline'}]"
63,348,3MS,"[{'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognitive function in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
68,348,4G8,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Assessing Aβ levels in biopsy samples'}]"
2255,348,MB,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
76,348,6MWT,"[{'article': 'PMC6406356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global cognitive and physical function in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better brain health and cognition'}]"
156,349,AFF1,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]"
1416,349,EF,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
981,349,CSF1R,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related neuropathology""}]"
1964,349,ICVF,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
903,349,CELF1,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1805,350,Grey matter volume,"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower grey matter volume in SCD-community'}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}]"
11,350,129Xe signal in gray matter,"[{'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1796,350,Gray Matter Volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}]"
1798,350,Gray matter volume,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Brain health in dancers'}]"
3580,350,Total Gray Matter Volume,"[{'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1806,350,Grey matter volumes,"[{'article': 'PMC4506984.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicting conversion to dementia in mild cognitive impairment subjects'}]"
1802,350,Grey Matter Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1799,350,Grey Matter Density,"[{'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1797,350,Gray Matter Volume (GMV),"[{'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1795,350,Gray Matter (GM) volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]"
1099,351,Cerebrospinal fluid t-tau,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}]"
1098,351,Cerebrospinal fluid p-Tau,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}]"
1097,351,Cerebrospinal fluid T-tau/Aβ42,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
1096,351,Cerebrospinal fluid P-tau/Aβ42,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
1095,351,Cerebrospinal fluid Aβ42/40 ratio,"[{'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1094,351,Cerebrospinal fluid Aβ42/40,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
2528,352,NPI,"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia-related behaviors in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavioral disturbance in Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7745768.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7889418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""BPSD in Alzheimer's Disease patients""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in Neuropsychiatric Inventory scores at week 12'}, {'article': 'PMC7995588.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Neuropsychiatric symptoms in patients with Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
2539,352,NPID+A,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Changes in NPID+A scores reflect prognosis of mood and cognitive impairment in Alzheimer's Disease""}]"
2536,352,NPI-Q,"[{'article': 'PMC8386362.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}]"
2535,352,NPI-NH total,"[{'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuropsychiatric symptoms in dementia'}]"
2531,352,NPI-NH,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}]"
915,352,CGA-NPI,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}]"
2529,352,NPI scores,"[{'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral symptoms in Alzheimer's Disease""}]"
2530,352,NPI total score,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptom profiles in Alzheimer's Disease patients""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioural and psychological symptoms in Alzheimer’s Disease'}]"
1811,353,Gut Microbiota,"[{'article': 'PMC6520689.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1816,353,Gut microbiota composition,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1815,353,Gut microbiota,"[{'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic strategy for Alzheimer's Disease""}]"
1813,353,Gut microbiome,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease modulation""}]"
1814,353,Gut microbiome diversity,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4179,353,gut microbiota,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Therapeutic strategies for AD-related cognitive decline'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s Disease treatment'}, {'article': 'PMC7592675.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3292,354,Spindle Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]"
3166,354,SO/spindle coupling strength,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]"
3293,354,Spindle power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]"
2604,355,Nicotinic α7 receptors,"[{'article': 'PMC4890804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
4607,355,α7 nicotinic acetylcholine receptor (α7nAChR),"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2603,355,Nicotinic binding,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}]"
4608,355,α7 nicotinic acetylcholine receptors (α7 nAChRs),"[{'article': 'PMC4174765.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ oligomers binding and synaptic plasticity changes'}, {'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease progression""}]"
524,356,Axl,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Microglia recognition and phagocytosis of amyloid plaques in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pathogenesis of AD'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Microglial Neurodegenerative Phenotype (MGnD) in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}]"
526,356,Axona,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
271,356,AXL,"[{'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1528,357,FDG-PET glucose metabolism measures,"[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}]"
1527,357,FDG-PET cerebral metabolic rate of glucose,"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}]"
19,357,18F-FDG (glucose metabolism),"[{'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Glucose metabolism abnormalities in Alzheimer's Disease""}]"
1534,357,FDG-PET-derived metabolic measures,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]"
1771,357,Glucose metabolism (FDG-PET),"[{'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
326,358,Akt,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
162,358,AKT3,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}]"
160,358,AKT,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
161,358,AKT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
824,359,C3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ clearance'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Postoperative Cognitive Dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
825,359,C3 signaling,"[{'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Learning and memory dysfunction after surgery'}]"
828,359,C3b,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposition and inflammation'}]"
827,359,C3ar1,"[{'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
826,359,C3ar,"[{'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}]"
724,360,Basal forebrain volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to mild cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3944,360,basal forebrain,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3946,360,basal forebrain volume,"[{'article': 'PMC7203806.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Longitudinal atrophy rates'}]"
3945,360,basal forebrain atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'hippocampal atrophy in typical AD'}]"
723,360,Basal forebrain atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]"
3240,361,Serum β-hydroxybutyrate (BHB),"[{'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease cognitive outcomes""}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'AC-1202 treatment response'}]"
58,361,3-hydroxybutyrate,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function through ketogenesis'}]"
4622,361,β-hydroxybutyrate,"[{'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Therapeutic response to AC-1202 in Alzheimer's Disease patients""}, {'article': 'PMC3213220.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive performance changes in Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}]"
57,361,3-Hydroxybutyrate,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Mild Cognitive Impairment'}]"
1595,362,Florbetapir F-18 PET,"[{'article': 'PMC8502814.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Amyloid accumulation'}]"
1594,362,Florbetapir F 18 PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1597,362,Florbetapir PET SUVR,"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid burden in Alzheimer's Disease""}]"
4139,362,florbetapir PET,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid burden in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Change in brain amyloid burden'}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4140,362,florbetapir SUVr,"[{'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1598,362,Florbetapir-PET,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
34,362,18F-florbetaben PET,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ deposition'}]"
1591,362,Florbetapir,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid-beta (Aβ)'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4137,362,florbetapir,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in Dementia with Lewy Bodies (DLB)'}, {'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Treatment Eligibility: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Longitudinal cognitive deterioration'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β (Aβ) pathology in Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1596,362,Florbetapir PET,"[{'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid pathology in Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques'}]"
3229,363,Serum albumin,"[{'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in the NGF group compared to the AHF group (3.7 ± 0.6 vs. 4.0 ± 0.6, p = 0.045)'}, {'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pneumonia risk'}]"
331,363,Albuminemia,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in female Alzheimer's Disease patients""}]"
330,363,Albumin (ALB),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Antioxidant capacity in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
329,363,Albumin,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Semagacestat treatment'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduction in body mass in women with Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Used in plasma exchange to remove pathogenic Aβ elements'}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Plasma exchange with albumin replacement'}, {'article': 'PMC9606044.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of Plasma Exchange (PE) treatment with albumin replacement'}, {'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3886,363,albumin + IVIG,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'better treatment response in AD patients'}]"
1690,364,GP-Cog,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2429,364,Mini-Cog,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7031904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease and Related Dementias""}]"
945,364,COR,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women and men with Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Involuntary weight loss in AD patients'}]"
3406,365,TH17 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}]"
3547,365,Th1 cells,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-stage Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Decreased Th1 cells in Alzheimer's Disease mice treated with GV-971""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
3549,365,Th17,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3551,365,Th2 cells,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]"
3550,365,Th17 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]"
1538,366,FES,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""FES scores are related to balance confidence in Alzheimer's Disease patients""}]"
1537,366,FERMT2,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1539,366,FETZ-test,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reaction time, hand-eye quickness, and attention in Alzheimer's Disease patients""}]"
1578,366,Ferritin,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognostic biomarker for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Screening of preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Screening of preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]"
2119,366,Iron,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4132,366,ferritin,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'AD biomarker'}]"
3145,367,SIB,"[{'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Preserved abilities in severe AD'}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe impairment in Alzheimer's Disease""}, {'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvement in Alzheimer's Disease patients treated with donepezil 23 mg/day""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Change from baseline to week 24 in Severe Impairment Battery scores'}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in cognitive function in patients with Alzheimer's Disease""}]"
3146,367,SIB-L,"[{'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Language function improvement in Alzheimer's Disease patients treated with donepezil 23 mg/day""}, {'article': 'PMC3226311.txt', 'relationship': 'RESPONDED_TO', 'object': 'Donepezil 23 mg/day treatment'}]"
3147,367,SIB[lang],"[{'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in language abilities'}]"
3144,367,SI,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""SI scores are correlated with somatomotor network changes in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1619,368,Fractional Anisotropy,"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White Matter Integrity Changes with Cognitive Training'}]"
1620,368,Fractional Anisotropy (FA),"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1624,368,Fractional anisotropy (FA) of left uncinate fasciculus (UF),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'White matter integrity'}]"
1622,368,Fractional anisotropy (FA),"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'White matter damage in nfvPPA'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower gait velocity and shorter step length in Alzheimer's Disease""}]"
1621,368,Fractional anisotropy,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Cerebral spinal fluid p-tau'}]"
3843,369,[11C]dehydroascorbic acid,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3842,369,[11C]acetate,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3840,369,[11C]PK-11195,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ accumulation in patients with mild cognitive impairment and AD'}]"
3838,369,[11C]PBR28,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Microglial activation and Aβ deposition in patients with AD'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Microglial activation and tau deposition in patients with AD'}]"
3836,369,[11C]-l-deprenyl-D2,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3837,369,[11C]Ascorbic,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
0,369,11C-(R)-PK11195,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1,369,11C-DAA1106,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2,369,11C-DED,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytosis in early stages of Alzheimer's Disease""}]"
3,369,11C-PBR28,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2713,370,PD-1,"[{'article': 'PMC8258160.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment approaches""}]"
2715,370,PDE9,"[{'article': 'PMC6371616.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Alzheimer’s Disease'}]"
2720,370,PDM,"[{'article': 'PMC9552361.txt', 'relationship': 'PREDICTS', 'object': ""Alzheimer's Disease and Related Dementias (ADRD)""}]"
2714,370,PDE4B,"[{'article': 'PMC7089534.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
322,372,Age at diagnosis,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Survival time in Alzheimer's Disease""}]"
321,372,Age,"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]"
157,372,AGEs,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2146,373,Ketogenic diet,"[{'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved cognition in Alzheimer's Disease""}]"
2147,373,Ketones,"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Improved cognitive functioning in patients with Alzheimer's Disease or mild cognitive impairment""}]"
2148,373,Ketones (BHB),"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Improved cognitive functioning in Alzheimer's Disease patients""}]"
4601,373,α-ketoglutarate,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
3575,374,Total Antioxidant Capacity (TAC),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}]"
2914,374,Plasma total antioxidant capacity (TAC),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]"
3586,374,Total antioxidant capacity (TAC),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
2858,375,PiB SUVR,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1189,375,Composite SUVR,"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1188,375,Composite PET SUVR,"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1512,375,FBB SUVR,"[{'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta deposition in Alzheimer's Disease""}]"
3188,375,SUVR 18F-FBP,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via higher SUVR values""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher SUVR values associated with worse outcomes in Alzheimer's Disease""}]"
1513,375,FBP SUVR,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between CA1 volume and retroactive interference (RI)'}]"
3187,375,SUVR,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid burden'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher amyloid burden'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8005243.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Disease progression'}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early Aβ accumulation'}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta presence in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid Burden'}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}, {'article': 'PMC6937673.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guide treatment selection based on amyloid burden in Alzheimer's Disease""}]"
680,376,BCAA,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through increased oxidative stress and excitotoxicity""}]"
681,376,BCAAs,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improvement in mitochondrial function in Alzheimer's Disease""}]"
682,376,BCG,"[{'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Alzheimer's Disease risk in bladder cancer patients""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved overall survival and disease-specific survival in patients'}, {'article': 'PMC7074941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease'}, {'article': 'PMC7074941.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}]"
683,376,BCG therapy,"[{'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower incidence of Alzheimer’s disease'}]"
684,376,BCL2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
727,376,Bcl-2,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3581,377,Total Phonation Time,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2827,377,Phonation Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3623,377,Transformed Phonation Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2773,378,PS1 gene mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s disease'}]"
2780,378,PSEN1 mutations,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Earlier onset of dementia in Alzheimer's Disease""}]"
230,378,APP/PS1 mutation carriers,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
2782,378,PSEN2 mutations,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Older age of onset in Alzheimer's Disease""}]"
2779,378,PSEN1 mRNA,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2774,378,PS1 mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Compensatory effect on frontostriatal circuits'}]"
874,379,CD4+ T cells,"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
886,379,CD8+ TEMRA,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse cognitive function in AD'}]"
885,379,CD8+ T cells,"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
884,379,CD8 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
878,379,CD45high cells,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
877,379,CD4+CD25− T cells (Teffs),"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}]"
875,379,CD4+/CD8+ ratio,"[{'article': 'PMC9290489.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improved immune recovery through MBSR/MBCT/MBCR'}]"
3400,380,TGF-α,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}]"
3405,380,TGFβ,"[{'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3403,380,TGF-β2,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3401,380,TGF-β,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]"
3404,380,TGFα,"[{'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment Response in Alzheimer's Disease""}]"
3402,380,TGF-β1,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloidogenesis'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Anti-neuroinflammation activity in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2475,382,Myo-inositol,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4309,382,myo-inositol (mI),"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in preclinical Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4310,382,myo-inositol (mI)/creatine (Cr),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1294,383,DRS-2,"[{'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in patients with Alzheimer's Disease.""}]"
1293,383,DRS,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1291,383,DR,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Demyelination and axonal degeneration associated with Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}]"
1380,383,Dr,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2266,384,MDA lipid peroxidation marker,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2226,384,Lipid peroxidation,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2229,384,Lipopolysaccharides (LPS),"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain amyloid deposition in Alzheimer's Disease""}]"
2227,384,Lipid peroxides,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
2228,384,Lipid profiles,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Lipid metabolism in Alzheimer's Disease patients""}]"
4221,385,intermediate monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]"
4306,385,monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4064,385,classical monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]"
4334,385,non-classical monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]"
2460,385,Monocytes,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}]"
913,386,CFr,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""poorer cognitive performance in Alzheimer's Disease""}, {'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}]"
911,386,CFC,"[{'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
912,386,CFT,"[{'article': 'PMC9871821.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Biomarker Dynamics: Improved executive function after tPBM treatment'}]"
754,387,Blalock Alzheimer's Disease Up pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
755,387,Blalock Alzheimer’s Disease Down pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
756,387,Blalock Alzheimer’s Disease Up pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4890804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2153,388,L IFG orbitalis,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1967,388,IFB-2,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1968,388,IFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2197,388,Left IFG orbitalis,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts naming performance in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1971,388,IFNɣ,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]"
501,389,Asiaticoside,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}]"
500,389,Asiatic acid (AA),"[{'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica water extract treatment in cognitively impaired older adults'}]"
499,389,Asiatic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica treatment in cognitively impaired older adults'}]"
3937,389,asiatic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of asiaticoside'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with CAW'}]"
1339,390,Diabetes mellitus,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC5389824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive deterioration'}]"
1336,390,Diabetes,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]"
1337,390,Diabetes Management,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved diabetes management reduces Alzheimer's Disease risk""}]"
1338,390,Diabetes Mellitus,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1912,391,Hippocampus and precuneus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nerve growth factor (NGF) treatment response'}]"
1909,391,Hippocampal/parahippocampal atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4186,391,hippocampal atrophy,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Semantic memory deficits in svPPA'}]"
1894,391,Hippocampal atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1897,391,Hippocampal atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment response in clinical trials'}]"
1913,391,Hippocampus atrophy rate,"[{'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease subtypes""}]"
1884,391,Hippocampal Atrophy,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Brain volume changes in AD patients'}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of cognitive decline and dementia'}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease Progression""}]"
4194,391,hippocampus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RESPONDED_TO', 'object': 'NGF treatment in hippocampal-sparing AD'}]"
4403,391,parahippocampal atrophy,"[{'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]"
1901,391,Hippocampal subfield atrophy,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Verbal memory impairment'}]"
1898,391,Hippocampal formation atrophy,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4192,391,hippocampal-sparing atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better response to cholinergic treatment compared to AD patients'}]"
1895,391,Hippocampal atrophy in CA1 subfield region,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage dementia due to Alzheimer's Disease""}]"
1885,391,Hippocampal Atrophy Rate,"[{'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}]"
4187,391,hippocampal atrophy rate,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1183,392,Complement system components,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotective response in Alzheimer's Disease""}]"
1182,392,Complement proteins,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Complement-mediated synapse loss in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Synaptic pruning'}]"
1181,392,Complement C3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated C3b/CR3 complement activation, decreased inflammatory cytokines, promoted Aβ phagocytosis, and inhibited synapse loss.'}]"
1744,392,"Genes (complement receptor 1, CD33, TREM2)","[{'article': 'PMC6530014.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3855,393,[18F]Flutemetamol,"[{'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'β-amyloid neuritic plaques'}]"
3869,393,[18F]flutemetamol,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Fibrillar Aβ'}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Fibrillar Aβ burden in the brain'}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid-beta plaques in Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1609,393,Flutemetamol F 18 Injection,"[{'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4143,393,flutemetamol,"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1608,393,Flutemetamol F 18,"[{'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1607,393,Flutemetamol,"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3870,393,[18F]flutemetamol PET,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4144,393,flutemetamol (18F),"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3848,393,[18F]-flutemetamol,"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}]"
39,393,18F-flutemetamol PET,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1016,394,Category fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1017,394,Category fluency test,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1015,394,Category Fluency,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1018,394,Category fluency test scores,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease diagnosis""}]"
107,394,ACE category fluency,"[{'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Disease progression in amild cognitive impairment group'}]"
4528,395,t-α-synuclein,"[{'article': 'PMC7523311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4054,395,cerebral spinal fluid α-synuclein,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Stabilization of α-synuclein levels in PD'}]"
4605,395,α-synuclein,"[{'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for small molecule inhibitors to prevent amyloidogenesis'}, {'article': 'PMC4857621.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics and intra-molecular binding properties under treatment with inhibitors'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis from AD'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Lewy-related pathology in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Lewy body pathology among AD patients'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]"
4606,395,α-synuclein pathology biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
340,395,Alpha-synuclein,"[{'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
4568,395,total alpha-synuclein,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis between Alzheimer's Disease and Dementia with Lewy Bodies""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
194,396,APOE ε2 allele,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased Alzheimer's Disease pathology""}]"
215,396,APOEε4 allele,"[{'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of progressing to dementia'}]"
473,396,ApoE ε4 allele,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: No benefit from DHA supplementation in carriers'}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease Co-pathology""}]"
211,396,APOE4 allele,"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
478,396,ApoE4 allele,"[{'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
197,396,APOE ε4 allele,"[{'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Functional decline in the medial temporal lobe (MTL) in individuals with a family history of AD'}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased production of β-amyloid, reduced synaptic plasticity, and impaired hippocampus-dependent spatial memory'}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Greater longitudinal age-related decline in episodic memory functions in older ε4 carriers'}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced hippocampal activation during a novel-picture encoding task in ε3/4 heterozygotes'}, {'article': 'PMC2194921.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Modification of cognitive functioning and GM reduction in AD patients'}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased incidence of amyloid-related imaging abnormalities with edema or effusions (ARIA-E)'}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid-beta deposition and neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased anxiety and depression in ε4-positive group'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'cognitive function'}, {'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Clinical trials for Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Increased mortality risk in individuals with dementia'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of developing dementia'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression of sporadic Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of developing Alzheimer's Disease in individuals with Subjective Cognitive Decline (SCD)""}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}]"
188,396,APOE e4 allele,"[{'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
200,396,APOE ε4-allele,"[{'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4248,397,mALFF/mfALFF values in the precuneus,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4247,397,mALFF values in the precuneus,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Global cognition decline'}]"
4245,397,mALFF values,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
242,398,ARIA-H,"[{'article': 'PMC4772335.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC4822297.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Treatment efficacy in Alzheimer's Disease""}]"
240,398,ARIA,"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormality'}]"
241,398,ARIA-E,"[{'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Adverse outcome in Alzheimer's Disease treatment""}, {'article': 'PMC4772335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Incidence of ARIA-E as a treatment-related adverse event'}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-related imaging abnormalities'}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormalities with edema or effusions'}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-related imaging abnormalities in Alzheimer's Disease""}]"
888,399,CDK5 kinase,"[{'article': 'PMC7805132.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
4383,399,p70S6 kinase,"[{'article': 'PMC7805132.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC7805132.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to NNI-362 treatment in Alzheimer's Disease models""}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Improved memory function and increased adult-born neural cells'}, {'article': 'PMC7805132.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment with NNI-362""}]"
3651,399,Tyrosine kinase-2 [Tie-2],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4384,399,p70S6 kinase (p70S6K),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
2131,399,JAK kinases,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
1610,399,Fms-like tyrosine kinase 1 [FLT-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1659,399,Fyn kinase,"[{'article': 'PMC4396171.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment approach using AZD0530'}]"
2130,399,JAK inhibitors,"[{'article': 'PMC7884393.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
173,399,AMP-activated protein kinase,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Inflammation in Alzheimer's Disease""}]"
1242,400,Cys C,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and neurite outgrowth'}]"
1240,400,Cyanocobalamin,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1243,400,Cystatin C,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]"
1239,400,CyPA,"[{'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease vs. Subcortical Ischemic Vascular Dementia""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis between Alzheimer's Disease (AD) and Subcortical Ischemic Vascular Dementia (SIVD)""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Distinguish between AD and SIVD diagnosis'}]"
3740,400,Vitamin C,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3672,401,VBM,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Assess atrophy and predict conversion from MCI to AD'}, {'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cortical thickness changes'}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Brain regions associated with cognitive factors and brain atrophy'}]"
2497,401,NBM,"[{'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'NBM stimulation may serve to facilitate communication across intact networks and revitalize networks that have fallen out of phase.'}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of dementia'}]"
2553,401,NbM measurement,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic evaluation""}]"
2554,401,NbM volume,"[{'article': 'PMC5326769.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive impairment in subcortical VCIND'}]"
218,402,APP,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased Aβ Production'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ generation'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC2765081.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease'}, {'article': 'PMC3397527.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inhibition of γ-secretase cleavage of APP associated with adverse cognitive effects'}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Amyloid pathway manipulation for reducing AD incidence'}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic model""}, {'article': 'PMC4675859.txt', 'relationship': 'PROMOTES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in AD brain'}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased Aβ levels and Aβ42/Aβ40 ratio'}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4939696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6004911.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in Down Syndrome""}, {'article': 'PMC6004911.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposits in the brain'}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ production and synapse stability'}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques formation'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
224,402,APP levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
227,402,APP p.A673T,"[{'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protective effect in Alzheimer's Disease""}]"
229,402,APP-FL,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
233,402,APPsw,"[{'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved performance in Y-maze task with EMF treatment'}]"
221,402,APP fragments,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
232,402,APPSwe,"[{'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Synapse loss and reduced synapse stability'}]"
231,402,APP23,"[{'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
479,403,ApoE4 genotype,"[{'article': 'PMC4731943.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
476,403,ApoE-E4 genotype,"[{'article': 'PMC4846650.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Earlier emergence of clinical symptoms'}, {'article': 'PMC4846650.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Specific brain region atrophy'}]"
475,403,ApoE-E4 gene,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD'}]"
470,403,ApoE proteotype,"[{'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
469,403,ApoE genotyping,"[{'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
468,403,ApoE genotype,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
190,403,APOE genotype,"[{'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Risk assessment for Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance and Alzheimer's disease risk""}, {'article': 'PMC6004911.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age of dementia onset in individuals with Down Syndrome and Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive changes in response to physical activity'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Bexarotene treatment'}]"
3932,403,apoe4 genotype,"[{'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}]"
195,403,APOE ε3 genotype,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
199,403,APOE ε4 genotype,"[{'article': 'PMC10013957.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk in individuals with Subjective Cognitive Decline (SCD)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}]"
203,403,APOE-ɛ4 genotype,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's disease genetic risk""}]"
3926,403,apoE genotype,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
212,403,APOE4 genotype,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}]"
1066,404,Cerebral infarcts,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2072,404,Infarct presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1763,404,Global Microbleed and Infarct Presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2416,404,Microinfarcts,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive aging'}]"
2453,405,Molecular layer thickness,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Increased by T3D-959 treatment'}]"
3338,405,Substantia innominata (SI) thickness,"[{'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Nucleus basalis of Meynert (NbM) atrophy'}]"
1433,405,ERC thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]"
1012,405,Carotid Intima-Media Thickness (CCA-IMT),"[{'article': 'PMC6074058.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Progression of non-dementia vascular cognitive impairment'}]"
3645,406,Tumor necrosis factor alpha [TNF-α],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3643,406,Tumor Necrosis Factor (TNF),"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk for Alzheimer’s Disease'}]"
3644,406,Tumor necrosis factor alpha (TNFα),"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Alzheimer’s Disease'}]"
3646,406,Tumor necrosis factor beta [TNF-β],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
513,407,Attention,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Positive change in brain activity'}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3540,407,Test of Everyday Attention,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3542,407,Tests of Attention: Trails A and B,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}]"
3244,407,Simple Attention,"[{'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance'}]"
1185,407,Complex attention,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
343,408,Altoida Digital Neuro Signature (DNS),"[{'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts risk of developing mild cognitive impairment due to Alzheimer's Disease""}]"
342,408,Altoida DNS,"[{'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease 6–8 months prior to the event""}, {'article': 'PMC8225898.txt', 'relationship': 'MONITORS_DISEASE_PROGRESSION', 'object': ""Monitors disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Predicts disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_AS_CLINICAL_TRIAL_ENDPOINT', 'object': ""Used as a clinical trial endpoint for Alzheimer's Disease""}]"
1355,408,Digital Neuro Signature (DNS),"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and mild cognitive impairment""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Predicting conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Disease progression and treatment response in Alzheimer's Disease""}]"
2375,409,Medial temporal lobe volumes,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3060,409,Relative preservation of medial temporal lobe structures on CT/MRI,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
4263,409,medial temporal lobe volumes,"[{'article': 'PMC4750048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}]"
3918,409,anterior lobe structures,"[{'article': 'PMC5619554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4262,409,medial temporal lobe structures,"[{'article': 'PMC5619554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2803,409,Parietal lobe,"[{'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4261,409,medial temporal lobe network,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]"
2374,409,Medial temporal lobe volume,"[{'article': 'PMC4750048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Smaller medial temporal lobe volumes'}]"
2091,409,Insular lobe,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
4589,410,ventricular volume,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in ventricular volume in response to semagacestat treatment'}]"
4588,410,ventricles volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3710,410,Ventricular volume,"[{'article': 'PMC4283145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Greater ventricular expansion in high-dose treatment arm'}, {'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related to prognosis of Alzheimer's Disease""}]"
3709,410,Ventricles (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3006,411,RBANS scores,"[{'article': 'PMC9513684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Constant Therapy intervention'}, {'article': 'PMC9513684.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease patients""}]"
3005,411,RBANS Total Score,"[{'article': 'PMC7729136.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes due to MPH treatment in Alzheimer's Disease""}]"
3008,411,RBANS total scale index scores,"[{'article': 'PMC3832588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BCI-based intervention in elderly participants'}]"
3009,411,RBANS total score,"[{'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Improvement in cognitive functions in suspected mild cognitive impairment'}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
3004,411,RBANS,"[{'article': 'PMC3832588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3832588.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Cognitive decline in Alzheimer's Disease during BCI intervention""}, {'article': 'PMC3832588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8564643.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in social engagement and performance of ADLs'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Change in cognitive function related to Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and early signs of Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive improvement in memory functions'}, {'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3007,411,RBANS subtest scores,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3824,412,Y maze,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2465,412,Morris water maze,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2464,412,Morris Water Maze Performance,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Deficits in Alzheimer's Disease""}]"
1877,413,High Cholesterol,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2900,413,Plasma cholesterol,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3237,413,Serum total cholesterol,"[{'article': 'PMC8351379.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
3591,413,Total cholesterol (TC),"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1115,413,Cholesterol levels,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'White matter integrity preservation'}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1114,413,Cholesterol,"[{'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced parietal cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3590,413,Total cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]"
3577,413,Total Cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4056,413,cholesterol,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
2252,414,MAP-2,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Mature neuronal differentiation in Alzheimer's Disease""}]"
2254,414,MAPT mutations,"[{'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2253,414,MAPT,"[{'article': 'PMC5100351.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative diseases'}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inherited frontotemporal dementia and parkinsonism with Tau inclusions'}]"
4378,414,p38 MAPK,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2571,415,Neurofilament light,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment effect in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2572,415,Neurofilament light (NfL),"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2573,415,Neurofilament light chain,"[{'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2574,415,Neurofilament light chain (NFL),"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2575,415,Neurofilament light chain (NfL),"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2576,415,Neurofilament light chain (NfL) in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4324,415,neurofilament light,"[{'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4325,415,neurofilament light (NfL),"[{'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
4433,415,plasma neurofilament light chain,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4327,415,neurofilament light chain (NFL),"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
766,415,Blood neurofilament light (NfL),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2596,415,NfL (Neurofilament light chain),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2597,415,NfL (Neurofilament light),"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}]"
2598,415,NfL (Neurofilament-light chain),"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4326,415,neurofilament light chain,"[{'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
779,416,Bowel Movements,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1233,416,Crohn’s Disease,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3667,416,Ulcerative Colitis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2078,416,Inflammatory Bowel Disease,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3815,417,Word count in conversations,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
3813,417,Word Frequency,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4448,417,proportion of word counts,"[{'article': 'PMC4526336.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Mild Cognitive Impairment'}]"
2956,417,Proportion of spoken words during free conversation,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early signs of Alzheimer's Disease""}]"
2958,417,Proportion of words spoken by participants,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild cognitive impairment (MCI) related to Alzheimer's Disease""}]"
2957,417,Proportion of spoken words in conversation,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}]"
2649,418,Other bacteria (enterotype III),"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
1463,418,Enterotype I,"[{'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'higher prevalence of cerebral small vessel disease (SVD) components, such as white matter hypersensitivity (WMH)'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower global cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'higher voxel-based specific regional analysis system for Alzheimer’s Disease (VSRAD) scores'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
1464,418,Enterotype III,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Higher risk of Alzheimer's Disease""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower prevalence of cerebral SVD components, such as white matter hypersensitivity (WMH)'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower voxel-based specific regional analysis system for Alzheimer’s Disease (VSRAD) scores'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'increased global cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
306,419,Activities of Daily Living (ADLs),"[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
305,419,Activities of Daily Living (ADL) scale score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Dependence in daily living activities'}]"
66,419,4-item Instrumental Activities of Daily Living scale (IADL-PAQUID) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Disability in instrumental activities'}]"
2088,419,Instrumental Activities of Daily Living (IADLs),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Functional decline in Alzheimer's Disease""}]"
149,419,ADL (Activities of Daily Living),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1958,419,IADL (instrumental activities of daily living),"[{'article': 'PMC3382377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional status in Alzheimer's Disease""}]"
150,419,ADL (activities of daily living),"[{'article': 'PMC3382377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional status in Alzheimer's Disease""}]"
987,420,CTF-β,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
219,420,APP CTFs,"[{'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
986,420,CTF-α,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3263,421,Slow-wave sleep (SWS),"[{'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Deep NREM sleep'}]"
3261,421,Slow wave,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4495,421,slow waves,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""lower amyloid burden in older adults, which is associated with Alzheimer's Disease""}]"
3262,421,Slow wave latency,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
4240,421,lowSWA (low-frequency slow wave activity),"[{'article': 'PMC9053232.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Auditory slow wave stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Auditory slow wave stimulation'}]"
4210,421,induced second slow-wave peak,"[{'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ42/Aβ40 ratio improvement'}]"
3258,421,Slow Wave (SW) activity,"[{'article': 'PMC11493878.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}]"
3257,421,Slow Oscillations (SO),"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]"
923,422,CIBIS-plus,"[{'article': 'PMC3226311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global function in Alzheimer's Disease patients""}]"
922,422,CIBIC-plus,"[{'article': 'PMC9972756.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Clinical improvement in Alzheimer's Disease""}]"
921,422,CIBIC-Plus,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
920,422,CIBIC,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2244,423,M1 microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-stage Alzheimer's Disease""}]"
4291,423,microglia,"[{'article': 'PMC8258160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
2245,423,M1-type microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2246,423,M2 microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]"
2410,423,Microglia,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2411,423,Microglia activation,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
2412,423,Microglial activation,"[{'article': 'PMC3362564.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'XPro1595 treatment'}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'Microglial activation predicts AD progression via Aβ plaque load'}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease progression""}]"
4292,423,microglial activation,"[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced microglial activation in Alzheimer's Disease mice treated with GV-971""}]"
302,423,Activated microglia,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
1354,424,Digit-symbol substitution,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3349,424,Symbol Digit Modalities Test (SDMT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living (ADL) in Alzheimer's Disease""}]"
1349,424,Digit Symbol,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Disease Progression in Alzheimer's Disease""}]"
1489,426,Evans Blue (EB),"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Blood-Brain Barrier Disruption'}]"
2402,426,Methylene Blue,"[{'article': 'PMC3836814.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
773,426,"Bluish color temperature (4,440–9,325 K)","[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]"
2403,426,Methylene Blue (MB),"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Hypometabolism in the posterior cingulate/retrosplenial cortex'}, {'article': 'PMC3467226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Slowed progression of AD pathology and cognitive function decline'}, {'article': 'PMC3467226.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Neuroprotective strategies for Alzheimer's Disease""}]"
4114,427,endosome number,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4118,427,enlarged endosomes,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4115,427,endosome volume,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2364,427,Mean Endosome Volume (MEV),"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1459,427,Endosomal volume,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
3243,428,Similarities (WAIS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2026,428,IQ-CODE,"[{'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
3748,428,WAIS-IV Coding,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]"
2358,428,Matrices (WAIS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3780,428,Wechsler Adult Intelligence Scale (WAIS),"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2742,429,PHLPP-1,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2743,429,PHLPP-2,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1683,429,GLP-1 Analog,"[{'article': 'PMC4877513.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for treating Alzheimer's Disease""}]"
184,429,APLP1β17,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Semagacestat treatment'}]"
183,429,APLP1,"[{'article': 'PMC4780148.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1682,429,GLP-1,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive functioning in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'REDUCES_Aβ_LOAD_IN', 'object': ' Vivo and in cultured neuronal cells'}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}]"
481,429,Apold1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Endothelial cell signaling and BBB integrity'}]"
1344,430,Diffuse loss of brain volume,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
788,430,Brain Volume Loss,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Associated with future cognitive deterioration and conversion to dementia'}]"
2801,430,Parietal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
1043,430,Cerebellum and brain stem volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3534,430,Temporal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
1634,430,Frontal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
798,430,Brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1499,431,F2-IsoPs,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1500,431,F2-isoprostanes,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
78,431,"8,12-isoiPF(2alpha)-VI","[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating AD-MCA; biomarkers of AD progression'}]"
2124,431,Isoprostanes (F2-IsoPs),"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1691,432,GPX,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of GPX during adipogenesis in human MSCs'}]"
1692,432,GPx,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}]"
1783,432,Glx,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1693,432,GPx1,"[{'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}]"
1787,432,Gpb3,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1788,432,Gpnmb,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3915,433,animals/10s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3914,433,animals/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Dementia incidence'}, {'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia conversion'}]"
3916,433,animals/10 s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage dementia'}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]"
984,434,CT,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
985,434,CT scan,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2263,434,MD,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased step time variability (pace) and increased double support time (rhythm)'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Short stance time (rhythm)'}]"
3163,434,SNCA,"[{'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1807,435,Grip Strength,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1857,435,Hand Movement,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}]"
4181,435,hand movement analysis,"[{'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]"
1856,435,Hand Grip Strength,"[{'article': 'PMC7084863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
738,436,Berg Balance Scale (BBS),"[{'article': 'PMC4431827.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor functional balance and increased risk of falling in Alzheimer's Disease patients""}, {'article': 'PMC4431827.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Balance ability and functional outcomes in Alzheimer's Disease""}]"
737,436,Berg Balance Scale,"[{'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
678,436,BBS (Berg Balance Scale),"[{'article': 'PMC3382377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Balance improvements in Alzheimer's Disease""}]"
1039,437,Central Executive Network (CEN),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better cognitive performance in older adults'}]"
679,437,BC (Betweenness Centrality),"[{'article': 'PMC4545875.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increasing BC values in the lower alpha band in the anterior region with increasing disease severity'}]"
2232,437,Local efficiency in SMC and DMN,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased local efficiency in brain network architecture'}]"
1180,437,Community consistency in SMC,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased community consistency in the sensorimotor community'}]"
3731,437,Visual network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
1177,437,Collaborative network spontaneous activity,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Verbal memory improvement (AVLT-S changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'General cognitive improvement (MoCA score changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Episodic memory improvement (AVLT-L changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Sleep quality improvement (PSQI changes)'}]"
1275,438,DHA,"[{'article': 'PMC3335851.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment with n-3 FAs'}, {'article': 'PMC3335851.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to n-3 FA treatment'}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Slowing disease progression in Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced transport to cerebral spinal fluid in APOE ε4 carriers'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower levels in cerebral spinal fluid of participants with low Aβ42'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased cerebrospinal fluid DHA levels after supplementation'}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower levels in participants with lower Aβ42 tertiles'}, {'article': 'PMC4928349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Alzheimer's Disease treatment""}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RESPONDED_TO', 'object': ""Response to Treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}, {'article': 'PMC6521224.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment compliance and biological activity'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC9644639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive outcomes in Alzheimer's Disease""}]"
1276,438,DHA (22:6n-3),"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in the elderly'}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}]"
1277,438,DHEA-S,"[{'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1278,438,DHEA-s,"[{'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': '11β-HSD1 inhibition'}]"
2824,439,Phase locking of oscillations,"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Information transfer and learning'}]"
2756,439,PLI (Phase Lag Index),"[{'article': 'PMC4545875.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Decreasing functional connectivity with increasing disease severity in the lower alpha band in the posterior region'}]"
2823,439,Phase Locking Value (PLV),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates Presence: Alzheimer's Disease""}]"
2849,440,Photopic illuminance,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]"
1879,440,High illuminance (350–750 lux),"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]"
236,441,AQP4 polarization,"[{'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Glymphatic clearance and amyloid beta clearance in Alzheimer's Disease""}]"
235,441,AQP4,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glymphatic function and amyloid clearance in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Regulation of glymphatic clearance in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for AAV5-GFAP-EGFP-shAqp4 therapy'}, {'article': 'PMC10917684.txt', 'relationship': 'RESPONDED_TO', 'object': 'TGN020 modulation'}, {'article': 'PMC10917684.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy choice in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'shAQP4 strategy to attenuate AQP4 function'}, {'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Astrocytic endfeet polarization'}, {'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Impaired glymphatic clearance in Alzheimer's disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Impaired glymphatic clearance and amyloid-beta accumulation'}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Impaired glymphatic function contributes to Alzheimer's disease progression""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Loss of AQP4 polarization and reduced glymphatic clearance'}, {'article': 'PMC7698404.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired glymphatic function in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Decreased amyloid-beta clearance in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced glymphatic clearance in older individuals'}, {'article': 'PMC7698404.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Glymphatic activity and clearance'}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
234,441,AQ4,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Decreased Aβ clearance and cognitive impairment'}]"
3379,442,TACE activity,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3378,442,TACE,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3377,442,TAC,"[{'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3380,442,TAF15,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2166,443,LC3,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Muscle pathology and autophagy dysfunction'}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}]"
2172,443,LC3B,"[{'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagy'}]"
2170,443,LC3-II,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}, {'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Autophagy levels in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Autophagy activation in Alzheimer's Disease""}]"
2169,443,LC3-I/II,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]"
2168,443,LC3-I,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}]"
2167,443,LC3 (Atg8),"[{'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Autophagosome formation in Alzheimer's Disease""}]"
2171,443,LC3A,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Autophagy in Alzheimer's Disease""}]"
2372,444,Medial temporal atrophy,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4260,444,medial temporal lobe atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Poorer response to pharmacologic cholinergic treatment'}]"
3708,444,Ventral and lateral anterior temporal pole (ATP) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]"
3919,444,anterior temporal lobe atrophy,"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Semantic variant of primary progressive aphasia (svPPA)'}]"
3533,444,Temporal Lobe Atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for cognitive decline'}]"
2371,444,Medial Temporal Lobe Atrophy (MTA),"[{'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2373,444,Medial temporal lobe atrophy,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INTERACTS_WITH', 'object': 'WMHs in AD'}]"
3810,445,Within-domain IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Cognitive decline in Alzheimer's Disease""}]"
296,445,Across-domain IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Cognitive decline in Alzheimer's Disease""}]"
1383,446,Dual-task cost,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1384,446,Dual-task gait,"[{'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amnestic mild cognitive impairment (a-MCI)'}]"
1385,446,Dual-task gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI) associated with Alzheimer's Disease""}]"
1386,446,Dual-tasking impairment,"[{'article': 'PMC5434395.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4100,446,dual-task gait cost,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""aMCI (a subtype of Alzheimer's Disease)""}]"
3703,447,Vascular cell adhesion molecule-1 [VCAM-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
4480,447,sICAM-1 (Soluble intercellular adhesion molecule 1),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4487,447,sVCAM-1 (Soluble vascular cell adhesion molecule 1),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2105,447,Intercellular adhesion molecule-1 [ICAM-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3275,447,Soluble Intercellular Adhesion Molecule-1 (sICAM-1),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation'}]"
4442,448,precuneus/posterior cingulate cortex,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4439,448,posterior cingulate cortex,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
455,448,Anterior Cingulate Cortex (ACC),"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3917,448,anterior cingulate cortex,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]"
456,448,Anterior cingulate cortex,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety and Depression in Alzheimer's Disease""}]"
2480,449,N-methyl-D-aspartate (NMDA) receptor,"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2516,449,NMDA receptors,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2514,449,NMDA receptor,"[{'article': 'PMC5372260.txt', 'relationship': 'INHIBITS', 'object': 'NMDA receptor'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD-like cognitive decline'}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'NMDA receptor-associated neuroplastic changes underlying tDCS effects'}]"
4491,449,selective reduction of N-methyl-d-aspartate (NMDA) receptor NR2A density,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2515,449,NMDA receptor NR2A density,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety in Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""chronic anxiety in Alzheimer's Disease""}]"
519,450,Avagacestat,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II clinical trials due to adverse events'}]"
508,450,Atabecestat,"[{'article': 'PMC6106931.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3725,450,Verubecestat (MK-8931),"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Stopped in Phase III clinical trials due to lack of efficacy'}]"
1818,451,HDAC,"[{'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1819,451,HDL,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher HDL levels were associated with better outcomes in the r-IF group.'}]"
1821,451,HDL levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1824,451,HDoHes,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""DHA oxidation in Alzheimer's Disease""}]"
1822,451,HDL-C,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in elderly subjects'}, {'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1197,452,Contactin,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1198,452,Contactin 2,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1199,452,Contactin-2,"[{'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}]"
1745,453,Genetic Data,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates Presence: Increased Risk of Alzheimer's Disease""}]"
1746,453,Genetic data,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1748,453,Genetic status,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for clinical trials'}]"
1747,453,Genetic factors,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
3484,454,"TUGdt NA, number of animals","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3485,454,TUGdt naming animals (TUGdt NA),"[{'article': 'PMC7662628.txt', 'relationship': 'USED_TO', 'object': 'Predict dementia incidence among patients with SCI or mild cognitive impairment'}]"
3470,454,"TUGdt ""animals/10 s""","[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Predicts: Dementia incidence'}]"
3483,454,"TUGdt NA, animals/10 s","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3471,454,"TUGdt ""animals/10 s"" test","[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia (related to Alzheimer's Disease)""}]"
2619,454,Number of animals named during TUGdt,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates: Cognitive impairment in Alzheimer's Disease""}]"
3481,454,TUGdt NA number of animals,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]"
3480,454,TUGdt NA animals/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]"
2620,454,Number of animals named during TUGdt test,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
111,455,AChE,"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4936020.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cholinergic activity in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cholinergic Neuron Loss'}, {'article': 'PMC9202553.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]"
113,455,AChE protein levels,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
112,455,AChE activity,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1753,456,Giant component size,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased size of the giant component in brain networks'}]"
1752,456,Giant Component Size,"[{'article': 'PMC8795741.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}]"
1637,457,Frontostriatal and hippocampus-PCC circuits,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'General cognitive function and disease severity in FAD'}]"
1919,457,Hippocampus-PCC circuit structural connectivity,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's disease""}]"
4197,457,hippocampus-PCC circuit,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in FAD'}]"
4198,457,hippocampus-PCC structural connectivity,"[{'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1918,457,Hippocampus-PCC circuit,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in Familial Alzheimer’s disease'}]"
1502,457,FA of left hippocampus-PCC tract,"[{'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in APOEε4 group""}]"
2457,458,Monocaffeoylquinic acids,"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Centella asiatica treatment in cognitively impaired older adults'}]"
1342,458,Dicaffeoylquinic acids,"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Centella asiatica treatment in cognitively impaired older adults'}]"
1003,458,Caffeic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}]"
1004,458,Caffeic acid (CA),"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring of Centella asiatica water extract treatment in cognitively impaired older adults'}]"
1005,458,Caffeoylquinic acids (CQA),"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]"
1006,458,Caffeoylquinic acids (CQAs),"[{'article': 'PMC8868383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improved cognitive function in Alzheimer's Disease""}]"
3827,459,YKL‐40,"[{'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of cognitive function as measured by letter fluency'}]"
3826,459,YKL40,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Preclinical Alzheimer's Disease""}]"
3825,459,YKL-40,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in YKL-40 levels in cerebral spinal fluid'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neuroinflammation'}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""inflammation in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neuroinflammation or astrogliosis in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection and prognosis'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]"
1494,460,Executive functioning,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
1493,460,Executive function deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1307,460,Decline of executive functions,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1492,460,Executive function,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improvement in cognition in mild cognitive impairment patients'}, {'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts functional decline in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease cognitive decline""}]"
1491,460,Executive dysfunction,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in people with Down Syndrome""}]"
1490,460,Executive Functioning (EF),"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}]"
1417,460,EF and L (Executive Function and Learning),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3823,461,Xenon washout parameter,"[{'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4598,461,xenon washout parameter,"[{'article': 'PMC6023430.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Alzheimer's Disease""}]"
12,461,129Xe washout half-life,"[{'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4464,462,rMT,"[{'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severity of cognitive dysfunction in Alzheimer's Disease""}]"
3023,462,RMT,"[{'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3020,462,RMBPC,"[{'article': 'PMC4468784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral symptoms of Alzheimer's Disease""}]"
3024,462,RMTG,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with serious cognitive complaints, depression, and poor delayed recall performance'}, {'article': 'PMC8028241.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Indicates early marker for progression towards Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8028241.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Future cognitive deterioration in Alzheimer's Disease""}]"
1478,463,Episodic memory deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1479,463,Episodic memory performance,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Decline'}]"
3723,463,Verbal memory function,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
4590,463,verbal episodic memory performance,"[{'article': 'PMC4750048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}]"
3722,463,Verbal memory,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]"
2389,463,Memory/visuospatial predominant pattern,"[{'article': 'PMC4346122.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'PIB+ status'}]"
1477,463,Episodic memory,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2584,464,Neuroprotective biomarkers,"[{'article': 'PMC4095696.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
4331,464,neurotrophic biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]"
4332,464,neurotrophic blood-based biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced neurotrophic blood-based biomarkers are associated with improved cognitive function in individuals with dementia.'}]"
4257,464,markers of neurogenesis,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1026,465,Ccl12,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
857,465,CCL11,"[{'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""10-year delay in the age at onset of Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive function and neurogenesis in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Elevated levels leading to microglial activation and Aβ clearance'}]"
3988,465,ccl2,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
853,465,CCA-IMT,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor prognosis in Alzheimer's Disease""}]"
854,465,CCA-IMT progression,"[{'article': 'PMC6074058.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive function improvement'}]"
856,465,CCI,"[{'article': 'PMC8127192.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
2268,465,MDC (CCL22),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""increased risk of Alzheimer's Disease""}]"
4379,466,p3E,"[{'article': 'PMC4888851.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for Aβ immunotherapy'}]"
2684,466,P3,"[{'article': 'PMC4195286.txt', 'relationship': 'ASSOCIATED_WITH_COGNITIVE_DECLINE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2692,466,P3a,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2485,466,N1 component,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Attentional deficits in Alzheimer's Disease""}]"
2671,466,P1 component,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Attentional deficits in Alzheimer's Disease""}]"
2694,466,P3b,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2686,466,P3 component,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attentional network differences in Alzheimer's Disease""}]"
2432,467,Mini-Mental State Examination (MMS),"[{'article': 'PMC8436545.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Intervention effectiveness in Alzheimer's Disease patients""}]"
2295,467,MMSE (Mini Mental State Examination),"[{'article': 'PMC3382377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive status in Alzheimer's Disease""}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2436,467,Mini-mental State Examination (MMSE),"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2434,467,Mini-Mental State Examination (MMSE) score,"[{'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC4722852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2433,467,Mini-Mental State Examination (MMSE),"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Diagnosis of moderate stage Alzheimer's Disease""}, {'article': 'PMC4153626.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4922661.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Severity of dementia'}, {'article': 'PMC8436545.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of mild to moderately severe Alzheimer's Disease (MMSE score 11–26)""}, {'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876902.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognition in Alzheimer's Disease patients""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognition in Alzheimer's Disease""}, {'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment in Persons with Dementia (PwD)'}, {'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia severity'}, {'article': 'PMC9412195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assessing stabilization of global cognition in mild Alzheimer's disease""}]"
2438,467,Mini–Mental State Examination (MMSE),"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognitive functioning in Alzheimer's Disease""}]"
2296,467,MMSE (Mini-Mental State Examination),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline predicts functional decline'}]"
2431,467,Mini-Mental State Examination,"[{'article': 'PMC3804449.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3804449.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]"
2428,467,Mini Mental Status Examination (MMSE),"[{'article': 'PMC7313126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living (ADL) in Alzheimer's Disease""}]"
2427,467,Mini Mental State Examination (MMSE) score,"[{'article': 'PMC4820235.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
2437,467,Mini-mental state examination (MMSE) score,"[{'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function improvement in Alzheimer's Disease patients""}]"
2426,467,Mini Mental State Examination (MMSE),"[{'article': 'PMC4431827.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
2430,467,Mini-Mental State Exam (MMSE),"[{'article': 'PMC8615710.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment in neurodegenerative disorders'}, {'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive changes over time in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive function in Alzheimer's Disease""}]"
2435,467,Mini-Mental Status Examination score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease patients""}]"
2286,468,MIS-T screening instrument,"[{'article': 'PMC4066282.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia screening'}]"
2285,468,MIS-T,"[{'article': 'PMC7031904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease and Related Dementias""}]"
2284,468,MIS score,"[{'article': 'PMC3543284.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3543284.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Better cognitive function in Alzheimer's Disease""}, {'article': 'PMC3543284.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC3543284.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer cognitive outcomes in older participants with Alzheimer's Disease""}]"
2036,469,ITG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2198,469,Left ITG,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts naming performance in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Language severity in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2125,469,Itga5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]"
2154,469,L ITG,"[{'article': 'PMC6218435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2126,469,Itgax,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3181,470,SPPB (Short Physical Performance Battery),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Low scores predictive of ADL decline'}]"
3180,470,SPPB,"[{'article': 'PMC8564955.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Disability and all-cause mortality'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction of risk in functional capacity'}]"
2856,470,Physical performance (SPPB),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved physical performance in individuals with mild to moderate dementia'}]"
4088,472,cytoplasmic DNA,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aseptic inflammation and immune senescence'}]"
2618,472,Nucleic acid oxidative modifications,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
1286,472,DNA damage,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced DNA damage'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced DNA damage events and improved cognitive function'}]"
1288,472,DNAm age-acceleration,"[{'article': 'PMC5508035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5508035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease severity and progression'}]"
1287,472,DNA methylation,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Biological age and lifespan'}]"
3527,473,Tau:Aβ42 ratio,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Conversion from normal cognition to dementia in Alzheimer's Disease""}]"
4364,473,p-tau181/Aβ1-42 ratio,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
544,473,Aβ and tau oligomers,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Sleep dysfunction in Alzheimer's Disease""}]"
4555,473,tau/Aβ42 ratio,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Early AD pathology'}]"
581,473,Aβ/tau level ratios,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Decline to CDR>0 in normal individuals with CDR=0'}]"
595,473,Aβ1-42/t-tau ratio,"[{'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
628,473,Aβ42/P-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Lower ratios associated with higher risk of Alzheimer's Disease""}]"
4524,473,"t-Tau, Phospho-Tau, and Aβ42 combination","[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3526,473,Tau/Aβ42 ratio,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
572,473,"Aβ(1–42), total tau (t-tau), and phosphorylated tau (p-tau)","[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4527,473,t-tau/Aβ1-42 ratio,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
639,473,Aβ42IT/t-tauEI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
638,473,Aβ42IT/p-tauIT,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
632,473,Aβ42/tau ratio,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
631,473,Aβ42/t-tau ratio,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
630,473,Aβ42/t-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}]"
629,473,Aβ42/p-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}]"
2363,474,Mean Diffusivity (MD),"[{'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2367,474,Mean diffusivity (MD),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter damage in nfvPPA'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Poor white matter integrity and slower gait velocity in Alzheimer's Disease""}]"
2366,474,Mean diffusivity,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2569,475,Neurofibrillary tangles (NFTs),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""NFTs are associated with neuronal loss, disease severity, and clinical course in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of NFTs indicates Alzheimer's Disease progression and cognitive decline""}]"
2568,475,Neurofibrillary tangles,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8061233.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2567,475,Neurofibrillary Tangles (NTFs),"[{'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Targeting tau aggregation (TRx0237)'}]"
2448,476,MoCA scores,"[{'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive changes in Alzheimer's Disease""}]"
2305,476,MOCA,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment'}]"
2447,476,MoCA score,"[{'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2446,476,MoCA,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10475546.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive functioning and memory performance in Alzheimer's Disease""}, {'article': 'PMC10475546.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive function in older adults with mild-to-moderate cognitive decline'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring cognitive function over time in Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment and AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Mild cognitive impairment and AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis of: Early detection and diagnosis of AD'}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Helps differentiate between MCI and AD'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Symptoms of Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Global cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6538045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild to moderate Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment'}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive Impairment'}, {'article': 'PMC9513684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive impairment in Alzheimer's Disease""}]"
3622,477,Trails B,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Malingering behavior'}]"
3608,477,Trail Making B,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3606,477,Trail Making A,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3607,477,Trail Making A and B,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]"
3620,477,Trails A,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Malingering behavior'}]"
3621,477,Trails A and B,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
101,478,ABCA7 genotype,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance and Alzheimer's disease risk""}]"
100,478,ABCA7,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'RESPONDED_TO_TREATMENT', 'object': 'Exercise-induced cognitive benefits'}, {'article': 'PMC10710152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ accumulation in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease inflammation""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Late-Onset Alzheimer's Disease (LOAD)""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
102,478,ABCA7 rs3764650,"[{'article': 'PMC10710152.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease genetic risk factor""}]"
3253,479,Sleep Quality Index,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}]"
1480,479,Epworth Sleepiness scale,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}]"
3254,479,Sleep Quality Scores,"[{'article': 'PMC10439779.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved Sleep Quality Post-Treatment'}]"
3256,479,Sleep quality,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Efficient and successful aging and maintenance of high cognitive function'}]"
4494,479,sleep quality,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}]"
4461,479,quality of sleep,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]"
3251,479,Sleep Efficiency,"[{'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance in AD patients'}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
350,480,Alzheimer Disease Related Quality of Life (ADRQL),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease""}]"
2985,480,Quality of Life - Alzheimer's Disease (QoL-AD),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease""}]"
2986,480,Quality of Life in Late-Stage dementia Scale (QUALID),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Quality of life in late-stage dementia'}]"
2987,480,Quality of life (QOL-AD),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced quality of life in individuals with mild to moderate dementia'}]"
1329,480,Dementia Quality of Life Instrument (DQoL),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Quality of life in mild to moderate dementia'}]"
2980,480,QOL-AD (quality of life-Alzheimer's disease),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Quality of life improvements in Alzheimer's Disease""}]"
669,481,BACbche gene mRNA,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early biomarker for Alzheimer's Disease""}]"
668,481,BACbche gene gene,"[{'article': 'PMC7227237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
667,481,BACbche gene,"[{'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Amild cognitive impairment (aMCI) associated with Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Atabecestat'}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced BACbche gene expression and improved cognitive impairment in Aβ1-42-infused mouse model'}]"
2887,481,Plasma BACbche gene mRNA expression,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}]"
2888,481,Plasma BACbche gene mRNA levels,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3673,482,VCAM-1,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Vascular dysfunction in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Vascular pathology in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3675,482,VCP,"[{'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Autophagy modifiers for VCP disease myopathy'}, {'article': 'PMC9287862.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9287862.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor overall survival in breast carcinoma'}]"
3674,482,VCAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3707,482,Vcl,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]"
2270,483,MEG,"[{'article': 'PMC6370863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Theta band hypoconnectivity associated with early cognitive improvements in Alzheimer's Disease""}]"
2352,483,Magnetoencephalography (MEG),"[{'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1415,483,EEG/MEG,"[{'article': 'PMC6370863.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring network dysfunction in Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic approaches for Alzheimer's Disease""}]"
3882,484,acyl carnitines,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]"
2159,484,L-carnitine (CAR),"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]"
310,484,Acylcarnitines,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Mitochondrial β-oxidation defects in Alzheimer's Disease""}]"
357,485,Alzheimer’s Disease Assessment Scale-13 (ADAS-Cog 13),"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
358,485,Alzheimer’s Disease Assessment Scale-Cognitive Behavior section (ADAS-Cog),"[{'article': 'PMC3394709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
124,485,ADAS-Cog (Alzheimer's Disease Assessment Scale-Cognitive subscale),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline predicts functional decline'}]"
363,485,Alzheimer’s disease Assessment Scale-Cognition (ADAS-Cog),"[{'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}]"
354,485,Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog),"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
359,485,Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-cog),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
353,485,Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog),"[{'article': 'PMC9412195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Evaluating cognitive changes in mild Alzheimer's disease""}]"
352,485,Alzheimer's Disease Assessment Scale (ADAS-Cog),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
348,485,Alzheimer Disease Assessment Scale–Cognitive Subscale (ADAS-Cog),"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive change in Alzheimer's Disease""}]"
2242,486,LxR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3036,486,RXR,"[{'article': 'PMC4731943.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
3107,486,RxR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2941,487,Presenilin-1 mutation,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in carriers with mild cognitive impairment""}]"
1393,487,E280A Presenilin-1 mutation,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
2940,487,Presenilin genes,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}]"
4443,487,presenilin-1,"[{'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1653,489,Functional connectivity (left DLPFC to right IPL),"[{'article': 'PMC6961663.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved accuracy on 2-Back task'}]"
1281,489,DLPFC activity,"[{'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Cognitive functions in Alzheimer's Disease""}]"
1280,489,DLPFC,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Improved item memory performance in elderly populations'}]"
3397,490,TEMPau,"[{'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4451,490,ptau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}]"
2785,490,PTEN,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4393,490,pTau,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2968,490,Ptau,"[{'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease neuropathological changes""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1375,491,Dopamine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Impaired neuronal circuits in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased release of dopamine leading to cardiovascular effects'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
1378,491,Dopamine depletion,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1379,491,Dopamine transporter (DAT),"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Lewy Body Dementia (LBD) vs. AD'}]"
4097,491,dopamine receptors,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1376,491,Dopamine (DA),"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1377,491,Dopamine Transporter,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4344,492,p-NMDAR2A,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Spatial memory deficits in Alzheimer's Disease""}]"
2519,492,NMDAR2B,"[{'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}]"
2518,492,NMDAR1,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Spatial memory deficits in Alzheimer's Disease""}]"
2517,492,NMDAR,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Enhanced synaptic plasticity in Alzheimer's Disease""}]"
3473,493,TUGdt MB,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia disorder, mild cognitive impairment, SCI, and no cognitive impairment'}]"
3476,493,TUGdt MB time score,"[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3482,493,TUGdt NA time score,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}, {'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3479,493,TUGdt NA,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia disorder, mild cognitive impairment, SCI, and no cognitive impairment'}]"
3487,493,TUGdt time,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates: Presence of Alzheimer's Disease""}]"
3488,493,TUGst time score,"[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3469,493,TUGdt,"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Decline'}, {'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Progression from Mild Cognitive Impairment to Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia'}]"
315,494,Adjusted Flow Index (AFI),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
316,494,Adjusted flow index (AFI),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}]"
1847,495,HSP60,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}]"
1849,495,HSP90,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC8333062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
4201,495,hsCRP,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1850,495,HSP90α,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1848,495,HSP70,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}]"
1851,495,HSP90β,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1846,495,HSP40,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}]"
2936,497,Prefrontal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Compensatory mechanisms in Alzheimer's Disease""}]"
2937,497,Prefrontal cortex,"[{'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2938,497,Prefrontal cortex activity,"[{'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased prefrontal cortical activity'}, {'article': 'PMC7364345.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dopaminergic interventions for Alzheimer's Disease""}]"
2935,497,Prefrontal Activation,"[{'article': 'PMC6538045.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better training benefits in working memory'}]"
4151,498,functional connectivity (FC) of the caudate-rMFG tract,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early identification of preclinical Alzheimer’s disease'}]"
2210,498,Left putamen-rMFG tract fiber number,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APP group""}]"
2205,498,Left caudate-rMFG tract FC,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1514,498,FC of left caudate-rMFG tract,"[{'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in APOEε4 group'}]"
3098,498,Right caudate-rMFG tract AxD,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3755,499,WHO–UCLA AVLT score,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive function in Alzheimer's Disease""}]"
3753,499,WHO-UCLA AVLT,"[{'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS treatment in mild AD patients'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3756,499,WHO–UCLA AVLT scores,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2952,500,Propionate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4447,500,propionate,"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
339,501,Alpha-syn,"[{'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Correlation with tau levels and neurodegeneration'}]"
4603,501,α-syn,"[{'article': 'PMC4857621.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Absence of significant reactivity in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Low LED scores (<1000 mg/day)'}, {'article': 'PMC7171193.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Age (≥70 years)'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (significant differences in levels between AD and DLB groups)""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4599,501,α-Syn,"[{'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
4453,502,ptau181,"[{'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4400,502,pThr231,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4399,502,pThr217,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4398,502,pThr181,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2787,502,PTP1B,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: INI and ICP combination'}]"
2786,502,PTK2B,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
4397,502,pTau181,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4391,502,pSer202/pThr205,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3103,503,Rikenellaceae,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3106,503,Ruminococcaceae,"[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2185,503,Lachnospiraceae,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Good cognition behaviors and production of beneficial metabolites'}]"
1334,503,Desulfovibrionaceae,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]"
2942,503,Prevotella,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]"
2943,503,Prevotellaceae,"[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3677,504,VEGF,"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Progenitor cell proliferation and neuronal differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of neurogenesis and brain blood flow changes related to Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular survival and memory restoration in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}, {'article': 'PMC8789895.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'better performance on memory composite score'}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with enhanced migratory activity of MSCs in Alzheimer's Disease treatment""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment-induced changes in plasma levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Upregulates VEGF levels to promote angiogenesis'}]"
3678,504,VEGF-C,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3681,504,VEGFR1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
3679,504,VEGF-D,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3680,504,VEGFA,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1960,505,IATI index,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
1959,505,IAF peak,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early stages of Alzheimer's Disease""}]"
3108,505,S-IADL,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1957,505,IADL,"[{'article': 'PMC4468784.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor functional abilities in Alzheimer's Disease""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Instrumental functional impairment in Alzheimer’s Disease'}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Instrumental Activities of Daily Living assessment in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Activities of daily living in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Instrumental Activities of Daily Living in Alzheimer's Disease""}, {'article': 'PMC7745768.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional independence in Alzheimer's Disease""}, {'article': 'PMC9501541.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]"
369,505,Amsterdam IADL,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}]"
1984,506,IL-12P70,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]"
1983,506,IL-12P40,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]"
2009,506,IL12P70,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
1985,506,IL-12p70,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4381,507,p62,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Autophagy activation and reduced levels in Alzheimer's Disease""}]"
2488,507,N200,"[{'article': 'PMC4611062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4376,507,p11,"[{'article': 'PMC3835777.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4390,507,pNN50,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]"
4377,507,p27,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal apoptosis in Alzheimer's Disease""}]"
2697,507,P50,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2674,507,P200,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]"
2486,507,N100,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
2687,507,P300,"[{'article': 'PMC3923761.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Superior information processing'}, {'article': 'PMC3923761.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aging-related cognitive decline'}, {'article': 'PMC4611062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]"
687,508,BDNF ApoE,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
688,508,BDNF Met-allele,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive Decline in Episodic Memory and Executive Functions'}]"
689,508,BDNF levels,"[{'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive functions and delayed onset of Alzheimer's Disease symptoms""}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive improvement in Alzheimer's Disease models""}]"
690,508,BDNF plasma levels,"[{'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dance intervention effectiveness'}]"
691,508,BDNF-Val66Met polymorphism,"[{'article': 'PMC4487699.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
686,508,BDNF,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protection against neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Memory and long-term potentiation'}, {'article': 'PMC3110111.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease: Brain function improvement through exercise""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive enhancement and prevention of memory deficits in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved learning and memory in AD mice'}, {'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Function in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes and protection against cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4401690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Synaptic plasticity and memory improvement in Alzheimer's Disease""}, {'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INCREASES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved neurological outcomes in traumatic brain injury'}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal survival and differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through exercise-induced response""}, {'article': 'PMC8211849.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Exercise-induced neurotrophic responses'}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ' Promotion of mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance'}, {'article': 'PMC8470960.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cognitive functioning and neuroprotection in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Promotes mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower concentrations in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}, {'article': 'PMC8645072.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to tDCS treatment'}, {'article': 'PMC8645072.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Individual responses to tDCS stimulation'}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroplasticity and cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Neuroplasticity and cognitive function in elderly individuals'}, {'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroplasticity in aging human brain'}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Prevention of gray matter and cognitive decline in elderly'}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in AD models'}, {'article': 'PMC5504954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function and reduced risk of dementia'}, {'article': 'PMC6040685.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neuroplasticity in elderly'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased plasma BDNF levels after dancing'}, {'article': 'PMC6040685.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved brain volume and cognitive function'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of increased plasma BDNF levels after dance training'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6040685.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive benefit in mild cognitive impairment'}, {'article': 'PMC6225735.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to treatment in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Synaptic plasticity and neurogenesis'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition and reduced Aβ plaque formation in AD animal models'}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Elevated neurotrophin levels indicating improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease progression'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and functional abilities in Alzheimer’s disease'}, {'article': 'PMC6945614.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Aerobic exercise interventions'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neurogenesis and synaptic function in Alzheimer’s disease'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to aerobic training in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease outcomes""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to aerobic training in Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to exercise training in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise training response monitoring in Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic training'}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Aerobic training'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change in plasma BDNF levels in response to training interventions.'}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Amelioration of brain network deficiencies and delayed disease progression'}, {'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer Disease'}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Improved synaptic plasticity and cognitive function in Alzheimer Disease'}, {'article': 'PMC7930223.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS treatment'}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture upregulates BDNF expression, promoting neurogenesis.'}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhances brain-derived neurotrophic factor (BDNF)/tropomyosin-related kinase B'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Neurotrophic support in cognitive recovery'}, {'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of synaptic proteins and neuronal survival'}]"
2449,509,Modified Hachinski Ischemia Ratings,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease vs. vascular dementia""}]"
1854,509,Hachinski Ischemic Score (HIS),"[{'article': 'PMC5546604.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular risk factors in Alzheimer's Disease""}]"
2450,509,Modified Hachinski Ischemia Scale,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Vascular Dementia vs. Alzheimer's Disease""}]"
2451,509,Modified Hachinski score,"[{'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3778,510,Waist Circumference,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4593,510,waist circumference,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3056,511,Regional Cerebral Blood Flow (rCBF),"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive Decline in Alzheimer's Disease""}]"
3055,511,Regional Cerebral Blood Flow (CBF),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced brain function and structure'}]"
1060,511,Cerebral blood flow (CBF),"[{'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cerebral blood flow during physical exercise in Alzheimer's Disease""}]"
1059,511,Cerebral blood flow,"[{'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
852,511,CBF (Cerebral Blood Flow),"[{'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3992,511,cerebral blood flow (CBF),"[{'article': 'PMC3467226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""tACS treatment in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'tACS treatment effects'}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}]"
1051,511,Cerebral Blood Flow (CBF) in Default Mode Network (DMN),"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1052,511,Cerebral Blood Flow Velocity (CBFv),"[{'article': 'PMC6538045.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Assess neurovascular response to cognitive training'}]"
1050,511,Cerebral Blood Flow (CBF) in Central Executive Network (CEN),"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1049,511,Cerebral Blood Flow (CBF),"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Gains in Healthy Seniors'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved Cognitive Function in Aging Population'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher cognitive performance'}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cerebrovascular change'}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1048,511,Cerebral Blood Flow,"[{'article': 'PMC6538045.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring during cognitive training in Alzheimer’s Disease'}]"
2491,512,NAA,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2495,512,NAIP,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2493,512,NAC,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Inhibition of adipogenesis in mouse MSC cell line 10T1/2'}]"
2492,512,NAA/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal damage in Alzheimer's Disease""}]"
4559,513,telomeres,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Organismal aging and DNA damage response'}]"
3530,513,Telomerase activity,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}]"
3531,513,Telomere activity,"[{'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increased activity associated with MBSR/MBCT/MBCR'}]"
4558,513,telomerase,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Aging-related diseases and cancer'}]"
3070,514,Resting Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3069,514,Resting Treg subset,"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Decrease in resting Treg frequencies in Alzheimer's Disease""}]"
3068,514,Resting Treg Compartment,"[{'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2912,515,Plasma superoxide dismutase (SOD) activity,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mild cognitive impairment and Alzheimer's Disease progression""}]"
1236,515,Cu/Zn-superoxide dismutase (SOD),"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3343,515,Superoxide Dismutase,"[{'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
3344,515,Superoxide dismutase (SOD),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
3345,515,Superoxide dismutase (SOD) activity,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced oxidative stress'}]"
4070,516,cognitive impairment,"[{'article': 'PMC3978714.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
514,516,Attention deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2424,516,Mild cognitive impairment (MCI),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Prodromal stage of Alzheimer's Disease""}]"
1158,516,Cognitive behavioral deficits,"[{'article': 'PMC4707222.txt', 'relationship': 'RESPONDED_TO', 'object': ""Response: Improvement in cognitive behavioral deficits in Alzheimer's Disease""}]"
1165,516,Cognitive impairment,"[{'article': 'PMC1914346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nursing home admission'}, {'article': 'PMC4923754.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional impairment in Alzheimer's Disease""}, {'article': 'PMC4923754.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying treatments for Alzheimer's Disease""}]"
4068,516,cognitive deficits,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1160,516,Cognitive deficits,"[{'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improvement in cognitive deficits in AD patients'}]"
3822,516,Working memory deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4339,517,oxidative stress,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2656,517,Oxidative stress markers (4-hydroxynonenal and 8-hydroxy-2′-deoxyguanosine),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]"
2655,517,Oxidative stress biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2654,517,Oxidative stress,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau hyperphosphorylation in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'REDUCES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased oxidative stress in Alzheimer's Disease""}]"
2652,517,Oxidative markers,"[{'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
4258,517,markers of oxidative stress,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4340,517,oxidative stress markers,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in oxidative stress markers'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2901,518,Plasma docosahexaenoic acid (DHA),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
1360,518,Dihydroferulic acid (DHFA),"[{'article': 'PMC8868383.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to Centella asiatica water extract treatment in cognitively impaired older adults'}]"
2889,518,Plasma EPA and DHA levels,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
1359,518,Dihydrocaffeic acid (DHCA),"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Pharmacokinetic dynamics of Centella asiatica water extract in cognitively impaired older adults'}]"
2540,519,NPY,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'GABAergic interneurons in the hilus'}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Metabolic and cardiovascular diseases'}]"
2527,519,NPE,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ Degradation'}]"
2541,519,NPs,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2612,520,Norepinephrine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}]"
4335,520,norepinephrine,"[{'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2613,520,Norepinephrine (NE),"[{'article': 'PMC9340683.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4407,521,peak VO2,"[{'article': 'PMC5302785.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better memory performance and reduced hippocampal atrophy in early-stage Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Functional ability and cognitive decline in Alzheimer's Disease""}]"
3689,521,VO2 peak,"[{'article': 'PMC4497726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cardiorespiratory fitness'}, {'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved Visuospatial Processing'}, {'article': 'PMC4497726.txt', 'relationship': 'PREDICTS', 'object': 'Cognitive benefits'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}]"
3690,521,VO2max,"[{'article': 'PMC6406356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global cognitive and physical function in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Preserved brain volume'}]"
3691,521,VOR gain,"[{'article': 'PMC9344717.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3692,521,VOSP,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2811,521,Peak VO2,"[{'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1544,522,FGP,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]"
3092,522,RgpB,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
697,522,BGP,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive and functional characteristics'}]"
3090,523,Rey Figure reproduction,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Visual construction deficits in Alzheimer's Disease""}]"
3089,523,Rey Complex Figure Test,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive processes in Alzheimer's Disease""}]"
3091,523,Rey-O,"[{'article': 'PMC9871821.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved visual memory after tPBM treatment'}]"
2982,524,QTc interval,"[{'article': 'PMC4051660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'QT prolongation and risk of Torsade de pointes (TdP)'}, {'article': 'PMC4051660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Citalopram treatment in Alzheimer's disease patients""}, {'article': 'PMC4051660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to citalopram treatment in Alzheimer's Disease patients""}, {'article': 'PMC4051660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment with citalopram'}]"
2974,524,Q values,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Q values after dance intervention'}]"
2981,524,QTc,"[{'article': 'PMC4051660.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis: Arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased risk of arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased risk of arrhythmia and related complications'}]"
2413,525,Microhaemorrhage,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2414,525,Microhaemorrhages,"[{'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2415,525,Microhemorrhages,"[{'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Adverse outcome in Alzheimer's Disease treatment""}]"
2469,526,Motor test duration,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2468,526,Motor test drawing features,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2467,526,Motor performance profiles,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
1858,526,Hand-Motor Performance,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better motor function in Alzheimer's Disease""}]"
465,527,Apo A-I,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced HDL anti-inflammatory activity'}]"
466,527,ApoB,"[{'article': 'PMC10236460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
454,527,Anomia,"[{'article': 'PMC9171270.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
185,527,APO E,"[{'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3924,527,apo B,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebrovascular inflammation in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral microvascular leakage in Alzheimer's Disease""}]"
1880,528,High molecular weight adiponectin,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improvement in insulin sensitivity in Alzheimer's Disease patients""}]"
1835,528,HMW adiponectin,"[{'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved insulin sensitivity in Alzheimer's Disease patients""}]"
314,528,Adiponectin levels,"[{'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
1116,529,Choline,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1117,529,Choline (Cho),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4057,529,choline,"[{'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1664,530,GABAergic modulation,"[{'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1666,530,GABAergic transmission,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1665,530,GABAergic synaptic strength,"[{'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer Disease'}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Modulation of inhibitory/excitatory balance in Alzheimer Disease'}]"
129,531,ADAS-Cog scores,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
132,531,ADAS-Cog13 scores,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Change in cognitive decline over 12 months'}]"
135,531,ADAS-cog scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant differences in ADAS-cog scores between patients with minimal and moderate WMHs'}, {'article': 'PMC6130053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
127,531,ADAS-Cog 13-item total score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improvement in cognitive function in Alzheimer's Disease""}]"
128,531,ADAS-Cog score,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
972,532,CSF Aβ42,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
970,532,CSF Aβ,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
626,532,Aβ42/Aβ40 ratio in CSF,"[{'article': 'PMC7067750.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Nilvadipine treatment in Alzheimer's Disease""}]"
971,532,CSF Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2711,533,PCC/PCu rCBF and ALFF combination,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2710,533,PCC/PCu rCBF,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2709,533,PCC/PCu ALFF,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
167,533,ALFF combined with ASL in PCC/PCu,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]"
577,534,Aβ-immunoglobulin G (IgG),"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Immune response to CAD106 in Alzheimer's Disease""}]"
574,534,Aβ-IgG,"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
578,534,Aβ-specific IgG,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Antibody response to CAD106 treatment'}]"
579,534,Aβ-specific IgGs,"[{'article': 'PMC4410460.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to CAD106 treatment'}]"
270,535,AVLT-learning,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
269,535,AVLT-SDR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
268,535,AVLT-LDR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
267,535,AVLT-IR,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
266,535,AVLT-DR,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
265,535,AVLT scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
264,535,AVLT,"[{'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Memory function in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Memory impairment in Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related prognosis: Memory impairment in Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APP group""}]"
3208,536,Salivary melatonin,"[{'article': 'PMC8336239.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2380,536,Melatonin,"[{'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease by blocking tau hyperphosphorylation""}, {'article': 'PMC8317398.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of symptom improvement in Alzheimer's Disease patients undergoing BLT""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep-wake disorders in persons with Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in sleep-wake disturbances (SWDs)'}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive functioning and sleep maintenance in Alzheimer's Disease patients""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance and sleep efficiency in Alzheimer's Disease patients""}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved sleep quality in AD patients'}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Sleep maintenance improvements in AD patients'}, {'article': 'PMC9644639.txt', 'relationship': 'RESPONDED_TO', 'object': ""Alzheimer's Disease-related sleep disturbances""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Alzheimer's Disease treatment efficacy""}, {'article': 'PMC9666898.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive improvement in Alzheimer’s disease'}]"
4264,536,melatonin,"[{'article': 'PMC8336239.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Diurnal neuroendocrine activity'}]"
2700,537,PACC score,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict future decline in AD'}]"
2698,537,PAC,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI), a precursor to Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2701,537,PACC-like composite,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3388,538,TC,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Plasma lipid levels in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3390,538,TChE,"[{'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower TChE levels in intervention groups'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive function improvement in Alzheimer's Disease""}]"
3442,538,TR,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaque-associated microglia'}]"
3451,538,TSH,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Thyroid function during treatment with [124I]-PU-HZ151'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reversible causes of cognitive impairment'}]"
3452,538,TSPO,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Microglial activation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in women'}, {'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Microglial activation in Alzheimer's Disease""}]"
3456,538,TST,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7083107.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3366,538,T,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3529,538,Tcf-4,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1068,539,Cerebral metabolic rate of glucose (CMRgl),"[{'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduced CMRgl in MTL and cortical regions of AD patients and ε4 carriers'}]"
1914,539,Hippocampus glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2923,539,Posterior cingulate glucose metabolism,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Future cognitive decline'}]"
1362,539,Diminished Cerebral Glucose Metabolism (DCGM),"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]"
3968,539,brain glucose metabolism,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved synaptic function'}]"
794,539,Brain metabolic function,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to RF treatment in AD mice'}]"
3994,539,cerebral glucose metabolic rate,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]"
3995,539,cerebral glucose metabolism,"[{'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3993,539,cerebral glucose hypometabolism,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2802,539,Parietal cortex glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1062,539,Cerebral glucose metabolic rate,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1053,539,Cerebral Metabolic Rate of Glucose (CMRglc),"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring of treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MSDC-0160 treatment'}]"
1063,539,Cerebral glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment response to DBS in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment with GV-971""}]"
3996,539,cerebral metabolic rate of oxygen (CMRO2),"[{'article': 'PMC3467226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}]"
3535,539,Temporal cortex glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1067,539,Cerebral metabolic rate for glucose (CMRgl),"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
793,539,Brain glucose metabolism,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to MSDC-0160 treatment in Alzheimer's Disease""}]"
146,540,ADCS-CGIC,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
147,540,ADCS-IADL,"[{'article': 'PMC4353453.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Functional response in Alzheimer's Disease""}]"
143,540,ADCS-ADL,"[{'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4324943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Functional status in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8386362.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Daily living activities in Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess gait in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in activities of daily living in patients with Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Functional decline'}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease functional decline""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Functional decline in Alzheimer's Disease""}]"
148,540,ADL,"[{'article': 'PMC8316394.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Personal Independence in Alzheimer's Disease""}, {'article': 'PMC8316394.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Lower ADL Scores Indicate Poor Prognosis'}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Functional impairment in Alzheimer’s Disease'}, {'article': 'PMC7745768.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional independence in Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
151,540,ADL decline,"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]"
2087,540,Instrumental ADL performance,"[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
152,540,ADLs,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC9395831.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Functional decline in Alzheimer's Disease""}]"
1953,540,I-ADL,"[{'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional decline in Alzheimer's Disease""}]"
145,540,ADCS-ADL23,"[{'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional impairment in Alzheimer's Disease""}]"
1689,541,GMcerebral spinal fluid,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Levels reflect response to Transcranial Electromagnetic Treatment (TEMT)'}]"
1738,541,Gcerebral,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1739,541,Gcerebral spinal fluid,"[{'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor cognitive performance in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}]"
2176,542,LDL-C,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2178,542,LDR,"[{'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Enhanced amyloid deposition and reduced cognitive function in Alzheimer's Disease""}]"
1823,542,HDL/LDL,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2173,542,LDAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2175,542,LDL levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2977,542,QDRS,"[{'article': 'PMC9552361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease and Related Dementias (ADRD)""}]"
1312,543,Default-mode network (DMN),"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]"
1311,543,Default network dysregulation,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer memory performance in Alzheimer's Disease""}]"
1310,543,Default Mode Network (DMN),"[{'article': 'PMC8287201.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive brain health'}]"
1284,543,DMN disruptions,"[{'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1283,543,DMN connectivity changes,"[{'article': 'PMC4503593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
1313,543,Default-mode network (DMN) disruption,"[{'article': 'PMC9309357.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
3153,544,SLC24A4/RIN3,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
3154,544,SLC2A1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3152,544,SLC24A4,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3155,544,SLC2A4,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to anti-diabetic medications in Alzheimer's Disease""}]"
938,545,CNB-001,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Better prognosis in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of: Alzheimer's Disease""}]"
939,545,CNP520,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II/III clinical trials for Alzheimer's Disease""}]"
940,545,CNV,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
941,545,CNV amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attentional network differences in Alzheimer's Disease""}]"
74,545,6-CN-PiB,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2382,546,Memory,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter interpausal units and slower speech rate'}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}, {'article': 'PMC5016950.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts functional decline in Alzheimer's Disease""}]"
3222,546,Semantic memory,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2235,546,Logical Memory I (LMI) and II (LMII) from the Wechsler Memory Scale-Abbreviated (WMS-a),"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Memory Impairment in Alzheimer's Disease""}]"
2234,546,Logical Memory (WMS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2233,546,Logical Memory,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mild Cognitive Impairment to AD Conversion'}]"
2041,547,Icam1,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflamed BBB endothelium'}]"
1963,547,ICAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1962,547,ICAM-1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1345,548,Diffuse plaques (DPs),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
3225,548,Senile plaques,"[{'article': 'PMC8061233.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2564,548,Neuritic plaques,"[{'article': 'PMC5144753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline'}]"
2565,548,Neuritic plaques (NPs),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
4321,548,neuritic plaques,"[{'article': 'PMC9213384.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""presence of depression in Alzheimer's Disease""}]"
2309,549,MRI (Whole-brain volume percentage change),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Structural atrophy in Alzheimer's Disease""}]"
3808,549,Whole brain volume on volumetric MRI (vMRI),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2308,549,MRI (Hippocampi and ventricles volumes),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Structural atrophy in Alzheimer's Disease""}]"
3747,549,Voxel-based specific regional analysis system for Alzheimer's disease (VSRAD) scores,"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
3746,549,Volumetric MRI,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}]"
2317,549,MRI hippocampal volume,"[{'article': 'PMC6685277.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
2321,549,"MRI measures (hippocampus and ERC volumes, temporal lobe cerebral glucose metabolism)","[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Future conversion to mild cognitive impairment'}]"
797,549,Brain volume (MRI),"[{'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2325,549,MRI volumetric,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}]"
2676,550,P2RY12,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2681,550,P2Y12,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""M2 microglial phenotype in Alzheimer's Disease""}]"
2682,550,P2Y12 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
2683,550,P2ry12,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2886,551,Plasma Aβx–40 levels,"[{'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment'}]"
2885,551,Plasma Aβ42/40,"[{'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2884,551,Plasma Aβ42,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2883,551,Plasma Aβ40,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2882,551,Plasma Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2881,551,Plasma Aβ(1–40),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2880,551,Plasma Aβ(1-40),"[{'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2878,551,Plasma Aβ markers,"[{'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloidosis in Alzheimer's Disease""}]"
2877,551,Plasma Aβ,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in plasma Aβ peptides with semagacestat treatment'}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4428,551,plasma Aβ,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
3189,552,SUVR 18F-FDG,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via lower SUVR values""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Lower SUVR values associated with more severe Alzheimer's Disease""}]"
29,552,18F-PI-2620 SUVR in fusiform gyrus,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]"
28,552,18F-PI-2620 SUVR,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau load'}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tau positivity'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid t-tau'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduced hippocampal volume'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
27,552,18F-PI-2620,"[{'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau deposition in early Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early tau deposition in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau buildup in Alzheimer's Disease""}]"
17,552,18F-AV45 SUVR,"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
49,553,25-hydroxyvitamin D (25OHD),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]"
3741,553,Vitamin D,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease Treatment""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease and Related Dementia (ADRD)""}]"
3742,553,Vitamin D (25OHD),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive performance in Alzheimer's Disease patients""}, {'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved gait and functional abilities in Alzheimer's Disease patients""}]"
1828,554,HLA,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1829,554,HLA-DR,"[{'article': 'PMC6584558.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3757,554,WLA,"[{'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1830,554,HLA-DR expression,"[{'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
808,555,Bridging integrator 1 (BIN1),"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Proinflammatory activation and neurodegeneration in Alzheimer's Disease""}]"
704,555,BIN1 risk variant,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased tau loads in AD patients'}]"
703,555,BIN1,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
963,557,CS Imm,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]"
962,557,CS Del,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]"
772,557,Bluish BL with high CS level,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in depressive symptoms in Alzheimer's Disease patients""}]"
1876,557,High CS levels,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]"
982,557,CSS,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3047,558,Reduced DAT uptake in basal ganglia,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
725,558,Basal ganglia,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Gait in Alzheimer's Disease""}]"
722,558,Basal Ganglia Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2897,559,Plasma PUFA index,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
4311,559,n-3 PUFA,"[{'article': 'PMC6521224.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Cognitive decline'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline'}, {'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Better cognitive function'}]"
4313,559,"n-3 PUFAs (22:6n-3, total n-3)","[{'article': 'PMC4179179.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance in Alzheimer's Disease""}]"
4318,559,n3-PUFAs,"[{'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower incidence of Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Promotes amyloid-beta clearance in Alzheimer's Disease""}]"
4312,559,n-3 PUFAs,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in the elderly'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced cognitive decline'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive performance in Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}]"
2789,559,PUFAs,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]"
2642,559,Omega-3 PUFAs,"[{'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved glymphatic function and reduced amyloid-beta aggregation'}]"
279,560,Abeta,"[{'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Predicts AD dementia'}]"
280,560,Abeta-42,"[{'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}]"
104,560,ABeta42/40,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
103,560,ABeta42,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2290,561,MMP-9,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Resveratrol treatment in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2291,561,MMP10,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]"
2292,561,MMP9,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in cerebral spinal fluid levels reflects response to treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Resveratrol treatment response in Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid MMP9 levels after resveratrol treatment'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""T cell migration and neuro-inflammation in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in Subcortical Ischemic Vascular Dementia'}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Blood-brain barrier (BBB) integrity in Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in AD'}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD'}]"
159,561,AKAP9,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1256,561,DA9,"[{'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2739,562,PGE2,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4388,562,pGlu-CCL2,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2959,562,Prostaglandin E2 (PGE2),"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Indomethacin treatment response in Alzheimer's Disease""}]"
2738,562,PGC-1α,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial biogenesis and function through PGC-1α in Alzheimer's Disease""}]"
4389,562,pGluAB42,"[{'article': 'PMC8381483.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Development of Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3698,563,Valeric acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment'}]"
3697,563,Valeric Acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased Risk of Postoperative Cognitive Dysfunction'}]"
4584,563,valeric acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired learning and memory dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]"
3053,564,Reduced uptake on metaiodobenzylguanidine myocardial scintigraphy,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]"
8,564,123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia with Lewy Bodies (DLB), which is often misdiagnosed as Alzheimer's Disease""}]"
1766,565,Global efficiency,"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved brain network efficiency'}]"
4111,565,efficiency,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
1762,565,Global Efficiency (GE),"[{'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased GE in sensorimotor network after TPS stimulation'}]"
4169,565,global efficiency,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3346,566,Surface Area (SA),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]"
1214,566,Cortical surface area,"[{'article': 'PMC6547570.txt', 'relationship': 'USED_TO_DETECT', 'object': 'Brain structural alterations in individuals with Subjective Cognitive Decline (SCD)'}]"
1208,566,Cortical Surface Area,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]"
1410,567,EEG oscillatory activity,"[{'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Rotigotine treatment in Alzheimer's Disease""}]"
1409,567,EEG microstates,"[{'article': 'PMC10363100.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease severity""}]"
2989,567,Quantitative Electroencephalography (QEEG),"[{'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'NBM DBS treatment response'}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NBM DBS treatment response'}]"
1454,567,Electroencephalography (EEG),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'NBM DBS treatment response'}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NBM DBS treatment response'}]"
1406,567,EEG abnormalities,"[{'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1413,567,"EEG-based measures (ERPs, spectral band-power)","[{'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1412,567,EEG spectral parameters (fast frequency bands),"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
1411,567,EEG phase,"[{'article': 'PMC9053232.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Auditory stimulation timing'}]"
1408,567,EEG markers,"[{'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}]"
2988,567,Quantitative EEG analysis,"[{'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
1405,567,EEG,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to treatment in Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Predicting response to levetiracetam in Alzheimer's Disease patients""}, {'article': 'PMC8325256.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Levetiracetam treatment response in Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Predicts response to levetiracetam treatment in Alzheimer's Disease patients.""}, {'article': 'PMC8325256.txt', 'relationship': 'PREDICTS_OUTCOME', 'object': ""Correlated with outcomes for each participant at the study end in Alzheimer's Disease.""}, {'article': 'PMC8325256.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment response prediction""}, {'article': 'PMC8760674.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Alterations in SEP components specific to somatosensory processing'}, {'article': 'PMC6130053.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in cognitive function'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of mild cognitive impairment, which is associated with Alzheimer's Disease""}]"
1414,567,EEG/ERP tasks,"[{'article': 'PMC8281974.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]"
3260,567,Slow oscillatory brain activity,"[{'article': 'PMC3682121.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory consolidation during non-REM sleep'}]"
2224,568,Linguistic density,"[{'article': 'PMC4526336.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}]"
2927,568,Pragmatic Language Function,"[{'article': 'PMC5359367.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Assessment of dementia status (DMR Cognitive Scale)'}]"
3287,568,"Speech characteristics (sentence complexity, verbal fluency)","[{'article': 'PMC4526336.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive impairment'}]"
1603,568,Fluent but Empty Speech,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4502,568,speech/language alterations,"[{'article': 'PMC9171270.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis of Alzheimer's Disease""}]"
2191,568,Language severity,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Object and action naming impairments in PPA'}]"
4227,568,language production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3048,568,Reduced Sentences,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]"
4226,568,language comprehension,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2190,568,Language,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}]"
2052,569,IgG2,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2054,569,IgG4,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2050,569,IgG1,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2049,569,IgG titres,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive decline and hippocampal atrophy in AD patients'}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive benefit and disease severity in AD patients'}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Immune response to AADvac1 treatment'}, {'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to AADvac1 and need for re-vaccination'}]"
2048,569,IgG response,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]"
2043,569,IgG,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Blood-brain barrier disruption in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Blood-brain barrier disruption in Alzheimer's Disease""}]"
2053,569,IgG3,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1295,570,DSB,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1296,570,DSF,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1297,570,DSG2,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1298,570,DSM criteria,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1675,572,GDF-15,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Enhanced endogenous adult neurogenesis and synaptic activity'}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]"
708,572,BNDF,"[{'article': 'PMC8470960.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}]"
2863,572,Pigment epithelium-derived factor (PEDF),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]"
2723,572,PEDF,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and functional recovery after CNS disorders'}]"
2907,573,Plasma nitric oxide (NO),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]"
2607,573,Nitric oxide (NO),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
2608,573,Nitric oxide synthase,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
1265,574,DC25,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1269,574,DCX,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal differentiation and survival in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Newborn neurons in the dentate gyrus (DG)'}]"
1268,574,DCS,"[{'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia and Mild Cognitive Impairment'}, {'article': 'PMC9354045.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive outcomes in older adults'}]"
1264,574,DC11,"[{'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2335,575,MS4A6A,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Braak tangle and plaque in AD patients'}]"
2333,575,MS4A,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
2334,575,MS4A4A,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Detrimental effect on LOAD pathogenesis'}]"
3830,576,ZCWPW1,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with LOAD'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
3833,576,ZO-1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]"
3829,576,ZBI,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2643,576,Omni-z,"[{'article': 'PMC4407573.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1601,577,Flt-1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1547,577,FLT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1602,577,Flt1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]"
2771,578,PS,"[{'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}]"
2524,578,NO,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Aβ formation and neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced generation in the presence of β-sitosterol and oleanolic acid'}]"
2477,578,N,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1305,578,Da,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1254,578,DA,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and apathy in Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increase in DA levels'}]"
163,578,ALA,"[{'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}]"
1260,578,DAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
670,578,BAD,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1934,579,Hub location,"[{'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Shift from posterior to anterior regions'}]"
1935,579,Hub strength,"[{'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decrease in posterior regions'}]"
1169,580,Cognitive reserve change score (CRCS),"[{'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive reserve'}]"
1168,580,Cognitive reserve (CR),"[{'article': 'PMC4846650.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pre-AD'}]"
1157,580,Cognitive Reserve (CR),"[{'article': 'PMC6937673.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Medication Therapy Management (MTM) interventions'}]"
3413,581,TLR2/4,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3414,581,TLR3,"[{'article': 'PMC9666898.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Activation of anti-inflammatory cytokines and neuroprotective response'}]"
3415,581,TLR4,"[{'article': 'PMC4956742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Microglial detection of Aβ and neuro-inflammatory responses'}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3412,581,TLR2,"[{'article': 'PMC11274940.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: TLR2 inhibition'}]"
3570,581,Tlr2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3139,582,SFA,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3140,582,SFN,"[{'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease therapy""}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]"
3141,582,SFS,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}]"
2821,583,Perivascular spaces,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}]"
2820,583,Perivascular Spaces,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
179,584,ANGP-2,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular survival and memory restoration in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}]"
180,584,ANGPT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3062,584,Renin-angiotensin system,"[{'article': 'PMC4835514.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}]"
451,584,Angiopoietin,"[{'article': 'PMC5427593.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with enhanced migratory activity of MSCs in Alzheimer's Disease treatment""}]"
85,585,8-oxodG/8-oxoGuo,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress linked to Alzheimer's Disease""}]"
2635,585,OXPHOS complex levels,"[{'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
84,585,8-oxodG,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative DNA damage'}]"
83,585,8-oxoGuo,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative RNA damage'}]"
2659,585,Oxytocin,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}]"
1769,586,Glucose,"[{'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Metabolic changes in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lower levels of glucose during fasting lead to autophagy in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4170,586,glucose metabolism,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4171,586,glucose uptake,"[{'article': 'PMC3467226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'spatial memory deterioration'}]"
765,586,Blood glucose,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1774,586,Glucose uptake,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1773,586,Glucose metabolism rates,"[{'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
44,586,2-deoxy-D-glucose (2DG),"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
3339,586,Sugar intake,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the posterior cingulate gyrus in preclinical Alzheimer's Disease""}]"
1064,586,Cerebral glucose uptake,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced gait speed and reduced cadence'}]"
3959,586,blood glucose,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7407252.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Adherence to dietary intake reporting protocols'}]"
1772,586,Glucose metabolism levels,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Deep Brain Stimulation treatment'}]"
3058,586,Regional glucose metabolism,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1770,586,Glucose metabolism,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC5026133.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Deep brain stimulation (DBS) effects on brain regions affected by AD'}, {'article': 'PMC5026133.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Patients ≥65 years showed increased metabolism with DBS'}, {'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Younger patients (<65 years) showed decreased metabolism and greater cognitive decline'}, {'article': 'PMC5026133.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased glucose metabolism at 6 months in temporal and parietal regions'}, {'article': 'PMC5026133.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to DBS-f treatment'}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Fornix stimulation'}]"
1754,587,Gingipains,"[{'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Tau and ubiquitin pathology in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neurotoxic effects on tau'}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Small-molecule inhibitors reduce bacterial load and Aβ1–42 production'}]"
2667,587,P. gingivalis,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain DNA'}]"
4166,587,gingipains,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2668,587,P. gingivalis DNA,"[{'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1755,587,Gingko biloba,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
1756,587,Ginsenoside Rb1,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1757,587,Ginsenosides,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]"
2921,587,Porphyromonas gingivalis infection,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42 production'}]"
1046,588,Cerebelum_8_R (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
1045,588,Cerebelum_8_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1044,588,Cerebelum_8_L (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
2137,589,JNK1,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2133,589,JAK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
2145,589,Kcnk1,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytic response to 40Hz stimulation in Alzheimer's Disease""}]"
2138,589,Jag1,"[{'article': 'PMC4304279.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]"
2134,589,JAK3,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
2132,589,JAK1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
3774,590,WML load,"[{'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3772,590,WML,"[{'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'Automated segmentation using the LST toolbox implemented in SPM8'}]"
43,591,2'-deoxyguanosine,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through oxidative stress and cognitive decline""}]"
2401,591,Methoxy-X-O4,"[{'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Microglial Aβ phagocytosis'}]"
82,591,8-hydroxydeoxyguanosine (8-OHdG),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in AD'}]"
65,591,4-hydroxyhexenal (4HHE),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in AD'}]"
81,591,8-hydroxy-2′-deoxyguanosine (8-OHdG),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]"
168,592,ALFF/fALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease diagnosis and staging""}]"
166,592,ALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia of Alzheimer’s disease'}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia of Alzheimer’s disease'}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Alzheimer's Disease treatment""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
169,592,ALFF/fALFF levels,"[{'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
54,593,2DG uptake,"[{'article': 'PMC6015016.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain metabolism deficits in Alzheimer's Disease""}]"
21,593,18F-FDG uptake,"[{'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1522,593,FDG uptake,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Decreased glucose metabolism in the left cortex and temporoparietal regions'}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hypometabolism in Alzheimer's Disease""}]"
50,594,25OHD,"[{'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Hypovitaminosis D in Alzheimer's Disease Patients""}]"
48,594,24OH,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3712995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Better spatial memory retention in aged female mice, indicating potential for better prognosis in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}]"
79,594,8-OHDG,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
80,594,8-OHdG,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""DNA and RNA oxidation in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differentiating Alzheimer's Disease from healthy controls""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4471,595,rivastigmine,"[{'article': 'PMC5075013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3104,595,Rivastigmine,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5075013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5075013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dosing in patients with renal impairment'}, {'article': 'PMC5075013.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'No dose adjustment required in patients with renal impairment'}]"
4485,596,sTREM2,"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4483,596,sTNFR1,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""TACE activity in Alzheimer's Disease""}]"
4484,596,sTNFR2,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""TACE activity in Alzheimer's Disease""}]"
1438,597,ERP,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive deficits associated with Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with cholinesterase inhibitors'}]"
1439,597,ERP measures,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive deficits associated with Alzheimer's Disease""}]"
1436,597,ERN,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]"
2592,598,Neutrophil,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2593,598,Neutrophils,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Chronic inflammation in Alzheimer's Disease""}]"
4333,598,neutrophils,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2029,599,IRS,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC6211704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}]"
2030,599,IRS-1,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
2031,599,IRS-1/2,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced Aβ deposition and behavioural deficits'}]"
2033,599,IRS2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2034,599,IRSP,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]"
2032,599,IRS1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Anti-diabetic treatment in Alzheimer's Disease""}]"
2408,600,Microbleeds,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced gait velocity in Alzheimer's Disease""}]"
2407,600,Microbleed presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4290,600,microbleeds,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""lower Aβ42 levels in vascular dementia and higher tau levels in participants with subjective memory complaints, associated with Alzheimer's Disease""}]"
2359,601,Matrix metalloproteinases,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]"
2398,601,Metalloproteinases,"[{'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2180,602,LOC101929163,"[{'article': 'PMC6158742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
272,602,AZD0530,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Efficacy in Alzheimer's Disease treatment""}]"
1704,602,GSK2647544,"[{'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain exposure and penetration'}]"
1708,602,GSK933776,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed to show clinical benefit'}]"
2181,602,LOC399491,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2699,602,PAC001381_s,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive health and beneficial metabolite production'}]"
702,602,BI 409306,"[{'article': 'PMC6371616.txt', 'relationship': 'RESPONDED_TO', 'object': 'Alzheimer’s Disease treatment'}]"
2136,602,JNJ-54861911,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II/III clinical trials for Alzheimer's Disease""}]"
273,602,AZD3293,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase III clinical trials for Alzheimer's Disease""}]"
1845,602,HSD17B11,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3131,603,SCP VD (parafoveal),"[{'article': 'PMC6445433.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}]"
2795,603,Parafoveal SCP AFI,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}]"
2796,603,Parafoveal SCP VD,"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]"
834,604,CA1 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Memory impairment in Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between FBP SUVR and retroactive interference (RI)'}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between p-tau and retroactive interference (RI)'}, {'article': 'PMC10075195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Memory impairment in preclinical Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
836,604,CA3 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'RI (hippocampal-dependent memory process)'}]"
835,604,CA2+3 Volume,"[{'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease outcome""}]"
837,604,CA4 volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2189,605,Lacunes,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4224,605,lacunes,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD progression'}]"
1768,606,Glucocorticoid Production,"[{'article': 'PMC6520689.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2966,606,Psoriasis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1938,606,Hypercortisolism,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in men with Alzheimer's Disease""}]"
3093,606,Rheumatoid Arthritis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
452,606,Ankylosing Spondylitis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3242,608,Silent lacunar infarcts (SLIs),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
2188,608,Lacunar infarcts,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2186,608,Lacunar Infarcts,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to cognitive decline and increased risk of dementia'}]"
2187,608,Lacunar infarct,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
2750,609,PICALM SNP rs541458,"[{'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decreased levels of cerebral spinal fluid Aβ42'}]"
2749,609,PICALM SNP rs3851179,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Thickening of entorhinal cortex and hippocampal degeneration'}]"
1550,610,FOXF2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1617,610,Foxp3,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1616,610,FoxO,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
1750,611,Geriatric Depression Scale (GDS),"[{'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease""}]"
2425,611,Mini Geriatric Depression Scale,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1749,611,Geriatric Depression Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC8518196.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assess health outcomes in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Depression in Alzheimer's patients""}]"
297,612,Actigraphy,"[{'article': 'PMC8500065.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep disturbances in Alzheimer's Disease patients""}]"
298,612,Actigraphy measurements,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4413,613,phospho-JNK,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4415,613,phospho-PKA,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4416,613,phospho-PKCα,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4411,613,phospho-ERK,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4410,613,phospho-AKT,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4418,613,phospho-p38,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1840,614,HP 129Xe,"[{'article': 'PMC7554935.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Alzheimer’s Disease'}, {'article': 'PMC7554935.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral perfusion and blood–brain barrier permeability in Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain oxygenation mapping in Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain disease detection'}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
13,614,129Xe-GM,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cerebral perfusion changes in Alzheimer's Disease""}]"
9,614,129Xe,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Disease state and progression'}]"
947,615,COX-1,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation in microglia surrounding amyloid plaques'}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuroinflammation in Alzheimer's Disease""}]"
946,615,COX,"[{'article': 'PMC3978916.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mitochondrial dysfunction in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mitochondrial dysfunction in Alzheimer's Disease""}]"
949,615,COX2,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}]"
948,615,COX-2,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaque formation and cognitive impairment'}, {'article': 'PMC3741576.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]"
3354,616,Synaptic proteins,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic loss and cognitive decline'}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cognitive function in Alzheimer's Disease""}]"
4516,616,synaptic toxicity,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced synaptic toxicity'}]"
4515,616,synaptic proteins and BDNF,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive Dysfunctions'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved Cognitive Functions'}]"
4514,616,synaptic dysfunction,"[{'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]"
4513,616,synaptic density,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3353,616,Synaptic dysfunction biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
3355,616,Synaptic strength and plasticity measures,"[{'article': 'PMC3362564.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Hippocampal function in response to XPro1595'}]"
3358,616,Synaptosomal associated protein 25,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
662,617,BACE (β-secretase),"[{'article': 'PMC5516350.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
742,617,Beta secretase-I,"[{'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}]"
744,617,Beta-secretase activity,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3953,617,beta secretase I,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4624,617,β-secretase,"[{'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
3952,617,beta secretase 1 protein (BACE-1),"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4629,617,γ-secretase complex,"[{'article': 'PMC7389451.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
256,618,ATP content,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Increased ATP content in Alzheimer's Disease""}]"
255,618,ATP,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Synaptic alteration in Alzheimer's Disease""}]"
3209,619,Sarkosyl-insoluble Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Tau aggregation and conversion from soluble Tau'}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3210,619,Sarkosyl-insoluble tau,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3211,619,Sarkosyl-soluble Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Tau aggregation and conversion to insoluble Tau'}]"
2135,620,JAM-1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]"
3568,620,Tie-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ42/40 ratio'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1720,620,Gal-1,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and neural stem cell self-renewal'}]"
1839,620,HOP-1,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}]"
1671,620,GAS-10,"[{'article': 'PMC9871821.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced anxiety symptoms after tPBM treatment'}]"
1838,620,HOP,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3162,620,SNAP-25,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Patient selection'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]"
1279,620,DJ-1,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Treatment response in Alzheimer's Disease""}]"
4237,620,let-7,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4133,621,filled pauses,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
3949,621,be quiet,"[{'article': 'PMC5237556.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Probable Alzheimer's Disease""}]"
2070,621,Increased silent pauses,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3619,621,Trailing Off,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]"
2177,622,LDL-cholesterol,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2238,622,Low-density lipoprotein (LDL),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cholesterol levels in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2174,622,LDL cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in low-density lipoprotein cholesterol levels'}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]"
1881,622,High-density lipoprotein (HDL),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cholesterol levels in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3636,622,Triglycerides/HDL-cholesterol ratio,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1820,622,HDL cholesterol,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavior change and improved clinical outcomes in Alzheimer's Disease risk reduction""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improvement in HDL cholesterol levels'}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in HDL cholesterol levels'}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]"
3790,623,White blood cell count,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]"
1184,623,Complete Blood Count (CBC),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
763,623,Blood cell count,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
768,623,Blood samples,"[{'article': 'PMC3849204.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
771,623,Blood-markers,"[{'article': 'PMC7934383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function in Alzheimer's Disease""}]"
2121,624,Irritability,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2814,624,Perceived stress levels,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in perceived stress levels'}]"
2463,624,Mood,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved mood and quality of life'}, {'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2995,624,RAGE,"[{'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3308,624,Stress,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive dysfunction and increased risk of Alzheimer's Disease""}]"
1370,625,Dispersion-based methodology,"[{'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD phenotypic variation and cognitive health changes'}]"
1369,625,Dispersion,"[{'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION_EVENT', 'object': ""From mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_MONITOR', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2650,626,Overall Pathology,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2651,626,Overall pathology,"[{'article': 'PMC4003513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]"
1186,627,Compliance,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Memantine treatment adherence'}]"
2376,627,Medication Compliance,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1292,628,DRG1,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1833,628,HLA-DRB5/HLA-DRB1,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
1832,628,HLA-DRB1,"[{'article': 'PMC6158742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1382,628,Drp1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Excessive mitochondrial fragmentation in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Down-regulation of Drp1 expression improves mitochondrial function in Alzheimer's Disease""}]"
3431,629,TNF-alpha,"[{'article': 'PMC2241592.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Perispinal etanercept administration for Alzheimer's Disease""}, {'article': 'PMC2241592.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive improvement in Alzheimer's Disease patients""}, {'article': 'PMC2500042.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Perispinal etanercept for Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Improved verbal fluency, memory, and cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Etanercept treatment'}, {'article': 'PMC5410904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3440,629,TNFα,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to P. gingivalis brain infection treatment'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Inflammation related to Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3439,629,TNFSR1A,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
3438,629,TNFR2,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Significant decrease in TNFR2 with age in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Excitotoxic damage in Alzheimer's Disease""}]"
3437,629,TNFR1 signaling,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aged rats with improved Morris Water Maze performance'}]"
3436,629,TNFR1,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated protein levels in the hippocampus of aged rats'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased TNFR1/TNFR2 ratio during aging in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""XPro1595 treatment in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Apoptosis and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: XPro1595 for Alzheimer's Disease""}]"
3435,629,TNF-β,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3432,629,TNF-proteins,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3430,629,TNF-alfa,"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3429,629,TNF-a,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3428,629,TNF blocking agents,"[{'article': 'PMC7089534.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'treatment of inflammatory diseases'}]"
3427,629,TNF blockers,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for co-morbid Alzheimer's Disease in patients with rheumatoid arthritis""}]"
3426,629,TNF,"[{'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain aging and synaptic alterations'}, {'article': 'PMC3362564.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'XPro1595 therapy'}, {'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease synaptic strength and LTD induction""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation and synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive function and reduced neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease progression""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk for Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3572,629,Tnf,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
3433,629,TNF-α,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced neuroinflammation, decreased APP processing, Aβ plaque formation, and promoted cognitive function.'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: XENP345, Thalidomide'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposits and cognitive impairment'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ aggregates'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory processes in Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation in AD models'}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Targeted by drugs in AD treatment'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of oleanolic acid'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased neuroinflammation and cognitive impairment'}]"
1389,630,Dyslipidemia,"[{'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to Alzheimer's Disease in ApoE ε4 carriers""}]"
1939,630,Hyperlipidemia,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3367,631,T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'chronic neuroinflammation and dementia'}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]"
3398,631,TEMRA T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2388,631,Memory T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2552,631,Naïve T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3369,631,T-cells,"[{'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved immune response under MBSR/MBCT/MBCR intervention'}]"
4304,632,mitofusin-2,"[{'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of mitochondrial dynamics and weakening of apoptosis'}]"
1723,632,Galectin-1 (Gal-1),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]"
1721,632,Galactin-3,"[{'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]"
494,632,Aquaporin-4,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1722,632,Galantamine,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}]"
1724,632,Galectin-3,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protection against Aβ neurotoxicity'}]"
1231,633,Creatinine,"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Kidney function during indomethacin treatment'}, {'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Return to previous levels after treatment discontinuation'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Renal function in Alzheimer's Disease patients""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1229,633,Creatine kinase,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced levels in AD brains'}]"
1230,633,Creatine+Phosphocreatine,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2074,634,Inferior frontal lobe grey matter volume,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]"
1800,634,Grey Matter Density in Hippocampus,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
795,634,Brain structure (grey matter density and amygdala volume),"[{'article': 'PMC4526336.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Social network size and communication ability'}]"
1801,634,Grey Matter Density in Temporal Lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1804,634,Grey matter density in medial temporal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
2788,635,PU-HZ151,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain permeability and proteome dysfunction in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Proteome dysfunction in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
3844,635,[124I]-PU-HZ151,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2384,636,Memory Awareness Rating Scale-Memory Functioning (MARS-MF),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3337,636,Subjective Memory Complaints (SMCs),"[{'article': 'PMC5619332.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor quality of life and impaired activities of daily living (ADL)'}]"
3336,636,Subjective Memory Complaints (SMC),"[{'article': 'PMC5619332.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3335,636,Subjective Memory Complaint (SMC),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3295,636,Stages of Objective Memory Impairment (SOMI),"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]"
2385,636,Memory Complaints Scale (MCS),"[{'article': 'PMC5619332.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early screening and preventive or therapeutic interventions for Alzheimer's Disease""}]"
383,637,Amyloid PET SUVr,"[{'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid negativity and clinical decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation and clinical decline in Alzheimer's Disease""}]"
407,637,Amyloid burden (SUVR),"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
394,637,Amyloid SUVr,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
393,637,Amyloid SUVR,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3892,637,amyloid PET SUVr,"[{'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]"
4199,638,hmuY gene,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3948,638,bche gene,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]"
1741,638,Gene expression profiles,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Intermediate-stage Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Late-stage Alzheimer's Disease""}]"
61,638,390-gene co-expression module,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3693,638,VQIINK motif,"[{'article': 'PMC4294473.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Tau aggregation inhibition'}]"
4633,639,θ−β1,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
4632,639,θ−α2,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
4634,639,θ−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]"
2117,640,Ioflupane (123I),"[{'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of striatal dopaminergic deficit disorders (SDDDs)'}, {'article': 'PMC4091455.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of diseases with striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of a striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection for differentiating PD from ET, and DLB from AD'}, {'article': 'PMC4091455.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Correction to treatment following imaging results'}]"
4222,640,ioflupane (123I),"[{'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3150,641,SIRT1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin sensitivity in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive behavior and mitochondrial function in Alzheimer's Disease""}]"
3247,641,Sirt1,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1673,642,GBS,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia severity'}]"
1736,642,Gbp2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1672,642,GBA,"[{'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
1737,642,Gbp6,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2963,643,Proteobacteria,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1326,643,Deltaproteobacteria,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]"
164,644,ALB,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Involuntary weight loss in AD patients'}]"
165,644,ALCAR,"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive and neurodegenerative disorders in the elderly'}]"
170,644,ALK,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
2587,645,"Neuropsychiatric Inventory, 10-item total score","[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in neuropsychiatric symptoms of Alzheimer's Disease""}]"
2585,645,Neuropsychiatric Inventory,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in neuropsychiatric symptoms in participants with mild to moderate Alzheimer's disease""}]"
2586,645,Neuropsychiatric Inventory (NPI),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Behavioral abnormalities in Alzheimer's Disease""}, {'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric behaviors in Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Clinically significant neuropsychiatric symptoms'}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2566,645,Neuro-Psychiatric Inventory (NPI),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral disorders in Alzheimer's Disease""}]"
3311,646,Stride Time Variability (STV),"[{'article': 'PMC3156726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1154,646,Coefficient of Variation (CoV) of stride time,"[{'article': 'PMC3156726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to memantine treatment in Alzheimer's Disease patients""}, {'article': 'PMC3898226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Gait safety improvement in Alzheimer's Disease patients treated with memantine""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to anti-dementia treatment'}]"
3316,646,Stride time variability (CoV),"[{'article': 'PMC3156726.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]"
1153,646,CoV of stride time,"[{'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Memantine treatment'}]"
3315,646,Stride time variability (CVst),"[{'article': 'PMC4197903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]"
244,647,ASC,"[{'article': 'PMC11274940.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Amyloid burden'}]"
243,647,AS,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
245,647,AST,"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver enzyme levels during atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to atabecestat'}]"
1917,648,Hippocampus volumes,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1916,648,Hippocampus volume loss,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]"
1915,648,Hippocampus volume,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Mild cognitive impairment'}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Independent risk factor for AD and conversion to AD in mild cognitive impairment subjects'}, {'article': 'PMC4811920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in APOEε4 group'}]"
1889,648,Hippocampal Volume,"[{'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease neuropathology""}, {'article': 'PMC4563885.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4563885.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Exercise intervention in Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]"
1908,648,Hippocampal volumetry,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1890,648,Hippocampal Volume (HV),"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Impairment'}, {'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in stroke patients'}]"
2794,648,Para-hippocampal volume,"[{'article': 'PMC6167961.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]"
3061,648,Relative volume of left hippocampus,"[{'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in PS1 group'}]"
4189,648,hippocampal subfield morphometry and volumetry,"[{'article': 'PMC10710152.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
1904,648,Hippocampal volume (HV),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]"
4190,648,hippocampal volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'reduced atrophy and improved memory performance'}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No evidence of reverse relationship with exercise load'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter stride length and smaller hippocampal volume'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
2207,648,Left hippocampal volume,"[{'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor diet quality (high Western dietary factor scores, low prudent dietary factor scores)'}, {'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Good diet quality (high prudent dietary factor scores, low Western dietary factor scores)'}, {'article': 'PMC4563885.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Smaller left hippocampal volume associated with poorer diet quality and Alzheimer's Disease""}]"
1906,648,Hippocampal volume rate of change,"[{'article': 'PMC4283145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
1905,648,Hippocampal volume loss,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory deficits in Mild Cognitive Impairment'}]"
1903,648,Hippocampal volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild cognitive impairment conversion to Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}, {'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and smaller hippocampal volumes'}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Hippocampal volume increase in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neurodegeneration""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1902,648,Hippocampal subfield volume,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4467,648,right hippocampus volume,"[{'article': 'PMC4846650.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Advanced clinical symptoms of Pre-AD'}]"
4195,648,hippocampus volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'cognitive impairment'}]"
1907,648,Hippocampal volume reduction,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]"
3100,648,Right hippocampus volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to mild cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2505,649,NFKBIZ,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2504,649,NFKBIA,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
2601,649,Nfkb2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
3665,650,Ubiquitin-mediated proteolysis,"[{'article': 'PMC2432467.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proteostasis and stress response'}]"
4580,650,ubiquitin,"[{'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
3664,650,Ubiquitin,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protein homeostasis and neurodegeneration'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}]"
3666,650,Ubiquitinated proteins,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}]"
1058,651,Cerebral atrophy on MRI,"[{'article': 'PMC7477392.txt', 'relationship': 'REFLECTS', 'object': 'Cumulative loss and shrinkage of neuropil'}]"
2326,651,MRI-based atrophy measurements,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2322,651,MRI measures of cerebral atrophy,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline'}]"
2318,651,MRI markers (regional cerebral atrophy),"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Presence of delusions, apathy, depression, agitation, anxiety, and irritability in BPSD'}]"
2314,651,MRI atrophy rates,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]"
2311,651,MRI Temporal Atrophy,"[{'article': 'PMC3733998.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}]"
3939,651,atrophy rate measured from structural MRI,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
785,651,"Brain MRI (regional atrophy in frontal, parietal, temporal structures)","[{'article': 'PMC4200223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Specific BPSD symptoms (delusions, apathy, depressive symptoms)'}]"
1896,651,Hippocampal atrophy on MRI,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Clinically probable Alzheimer's Disease""}]"
511,651,Atrophy on MRI,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
2342,652,MTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4252,652,mTOR kinase,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
4251,652,mTOR,"[{'article': 'PMC4485995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for autophagy modulation in VCP disease'}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment pathway""}]"
4254,652,mTORC1 activation,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neuroprotection'}]"
2093,653,Insulin (INI),"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of cognitive and metabolic disorders in T2DM'}]"
2116,653,Intranasal insulin (INI),"[{'article': 'PMC10306194.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10306194.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognition in Alzheimer's Disease""}, {'article': 'PMC6483338.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Improvement in verbal fluency, motor performance, and functional health'}]"
2115,653,Intranasal Insulin (INI),"[{'article': 'PMC10306194.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved global cognition in Alzheimer's Disease patients""}]"
1353,654,Digit-span,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1352,654,Digit span test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]"
1351,654,Digit span forward test,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Short-term memory in Alzheimer's Disease""}]"
1350,654,Digit span forward,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1348,654,Digit Span,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]"
30,655,18F-PI-2620 SUVR in inferior temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]"
32,655,18F-PI-2620 SUVR in occipital cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]"
33,655,18F-PI-2620 SUVR in superior temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]"
31,655,18F-PI-2620 SUVR in mesial temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]"
2217,656,Lexical and semantic retrieval deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3223,656,Semantic word fluency,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function and language ability in Alzheimer's Disease patients""}]"
3220,656,Semantic Fluency,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Disease-Related Declines in Cognitive Abilities'}]"
3219,656,Semantic Deficits,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4211,657,inferior parietal lobule (IPL),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
2023,657,IP-10,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2025,657,IPL,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]"
2073,657,Inferior Parietal Lobule (IPL),"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]"
3784,658,White Blood Cell (WBC),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3785,658,White Blood Cells (WBC),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Inflammation in Alzheimer's Disease""}]"
3752,658,WBC count,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory response'}]"
3751,658,WBC,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3821,659,Working memory,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]"
3818,659,Working Memory/Attention,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter turns and shorter interpausal units'}]"
3819,659,Working Memory/Attention/Executive Control,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]"
3820,659,Working Memory/Attention/Executive Control (ExecCon),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]"
4386,660,p75NTR,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotrophin receptor activity in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2277,660,MFIp75NTR,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]"
4385,660,p75,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
109,661,ACTH,"[{'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': '11β-HSD1 inhibition'}]"
299,661,Actin,"[{'article': 'PMC8581408.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'BBB permeability and integrity'}]"
304,661,Activin A,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Enhanced endogenous adult neurogenesis and synaptic activity'}]"
3615,662,Trail Making Test B,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]"
1191,662,Comprehensive Trail Making Test (TMT),"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Executive Function Impairment in Alzheimer's Disease""}]"
3609,662,Trail Making B test,"[{'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Frontal lobe involvement in mild cognitive impairment groups'}]"
3618,662,Trail-Making Test-B,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3617,662,Trail Making Test part B,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]"
3616,662,Trail Making Test Part B,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function deficits in Alzheimer's Disease""}]"
3614,662,Trail Making Test A,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]"
3613,662,Trail Making Test (TMT) times,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3610,662,Trail Making Test,"[{'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Processing speed and mental flexibility in Alzheimer's Disease""}]"
3612,662,Trail Making Test (TMT) parts A and B score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline'}]"
3611,662,Trail Making Test (TMT) A and B,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1361,663,Dimensional Apathy Scale (DAS),"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]"
3950,663,behavioural markers of apathy,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Apathy in Alzheimer's Disease""}]"
2537,663,NPI-Q Apathy,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
461,663,Apathy,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
464,663,Apathy Scale (AS),"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]"
463,663,Apathy Inventory,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apathy in participants with dementia'}]"
462,663,Apathy (NPI),"[{'article': 'PMC4431827.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to exercise intervention in Alzheimer's Disease""}]"
3923,663,apathy,"[{'article': 'PMC4431827.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced apathy in nursing home residents with dementia'}, {'article': 'PMC4431827.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Apathy in nursing home residents with dementia'}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]"
1529,664,FDG-PET hypometabolism,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]"
1524,664,FDG-PET Hypometabolism,"[{'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1065,664,Cerebral hypometabolism on FDG PET,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]"
4124,665,epichaperome probes,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1475,665,Epichaperomes,"[{'article': 'PMC8333062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease-related processes and biological functions""}]"
2951,666,"Proinflammatory cytokines (IL-1, IL-6, TNF-alpha, TGF-beta)","[{'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2950,666,Proinflammatory cytokines,"[{'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease severity""}]"
4208,666,immune cytokines,"[{'article': 'PMC2241592.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2241592.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4086,666,cytokine levels,"[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced cytokine levels in Alzheimer's Disease mice treated with GV-971""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]"
4213,666,inflammatory cytokines,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]"
975,666,CSF cytokine levels,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]"
2079,666,Inflammatory cytokines,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]"
1247,666,Cytokines,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reversal of Cognitive Impairment'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to TEMT treatment in Alzheimer's Disease patients""}]"
4087,666,cytokines,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""neuroinflammation in Alzheimer's Disease""}]"
764,666,Blood cytokine levels,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}]"
2944,666,Pro-inflammatory cytokines,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammation and disease progression in Alzheimer's Disease""}]"
1246,666,Cytokine and chemokine signatures,"[{'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuro-inflammation'}]"
2945,666,"Pro-inflammatory cytokines (e.g., TNF-α)","[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
3638,667,Triterpenoid saponins (TT),"[{'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3637,667,Triterpenes (TT),"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]"
2355,668,Malondialdehyde (MDA),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced oxidative stress'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
2906,668,Plasma malondialdehyde (MDA),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]"
980,669,CSF tau,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
661,670,BACE,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through Aβ levels""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression based on BACE levels and activity'}, {'article': 'PMC4304279.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: BACE inhibitors for Alzheimer's Disease prevention and treatment""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: BACE inhibitor therapy in clinical trials for Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Slowing cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Verubecestat treatment for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Prognosis: Alzheimer's Disease""}]"
663,670,BACE activity,"[{'article': 'PMC6966425.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Alzheimer's Disease""}]"
666,670,BACE2,"[{'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
664,670,BACE enzyme,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
665,670,BACE1,"[{'article': 'PMC4304279.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: BACE1 inhibitor drugs for Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Clinical trials for Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]"
2538,672,NPI-Q Depression,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2534,672,NPI-NH Psychosis,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Psychosis in dementia patients'}]"
2533,672,NPI-NH Agitation,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Agitation in dementia patients'}]"
2532,672,NPI-NH Affective symptoms,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Affective symptoms in dementia'}]"
1662,673,GABAergic interneuron numbers,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1669,673,GAD67-positive interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Spatial learning deficits in female apoe4-KI mice'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related spatial learning deficits""}]"
1663,673,GABAergic interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
4185,673,hilar GABAergic interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Learning performance in female apoe4-KI mice'}]"
3278,673,Somatostatin-positive interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related spatial learning deficits""}]"
1272,674,DEMQOL,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1273,674,DEMQoL scale,"[{'article': 'PMC7413274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Health-related Quality of Life (QoL) in Persons with Dementia (PwD)'}]"
4535,675,tTau/Aβ42,"[{'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4534,675,tTau/Aβ1-42 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4533,675,tTau/Aβ1-42,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}]"
634,675,Aβ42/ttau ratio,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]"
633,675,Aβ42/ttau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with high sensitivity at 95% specificity""}]"
4396,675,pTau/Aβ42,"[{'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4395,675,pTau/Aβ1-42 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4452,675,ptau/Aβ1–42,"[{'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]"
174,676,AMPA,"[{'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related synaptic changes""}]"
175,676,AMPK,"[{'article': 'PMC4615808.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RESPONDED_TO', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4342,676,p-AMPK,"[{'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture increases p-AMPK levels in the hippocampus.'}]"
2934,677,Precuneus_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4440,677,precuneus,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]"
2929,677,Precuneus,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Reduced activity in early phases of Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease subtypes""}]"
4470,677,right precuneus,"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment response""}]"
3054,679,Reduction in blood flow in the posterior cingulate gyrus and/or precuneus,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3049,679,Reduced blood flow in posterior cingulate gyrus/precuneus,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
960,680,CRY1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]"
961,680,CRY2,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]"
1644,681,Functional Independence Measure,"[{'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4152,681,functional independence,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
6,682,11β-HSD1,"[{'article': 'PMC5301048.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: UE2343 (Xanamem™) for Alzheimer's Disease""}]"
7,682,11β‐HSD1,"[{'article': 'PMC5301048.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of cognitive impairment in early‐stage Alzheimer's Disease""}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive improvement in memory'}, {'article': 'PMC5301048.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapeutic strategy for Alzheimer's Disease""}]"
3835,683,[11C]-Pittsburgh Compound B PET (PiB-PET),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2865,683,Pittsburgh Compound-B (PiB) SUVR,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of amyloid presence in Alzheimer's Disease""}]"
2866,683,Pittsburgh compound B (PIB),"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid deposition associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Amyloid deposition levels in corticobasal syndrome patients'}]"
5,683,11C-Pittsburgh compound B (PiB) PET uptake,"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2733,683,PET with Pittsburgh Compound B (PIB),"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2867,683,Pittsburgh compound B (PiB),"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'AD-type dementia in healthy older individuals'}]"
1109,684,ChAT activity,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}]"
1108,684,ChAT,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory improvement'}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cholinergic neuron loss in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cholinergic neuron loss in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cholinergic activity in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Improved cognitive function and memory performance in AD rat model'}]"
4328,685,neurogranin,"[{'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in early Alzheimer's Disease continuum""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic toxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic toxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Visceral adipose tissue area'}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Visceral adipose tissue area'}]"
2578,685,Neurogranin,"[{'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Synaptic Degeneration'}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive decline'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Changes in neurogranin levels during treatment'}, {'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with Varoglutamstat'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: AD progression and cognitive decline'}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher neurogranin levels in ApoE4 carriers'}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to PQ912 treatment'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Disease progression in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease progression and patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to BAN2401 treatment in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2579,685,Neurogranin (in CSF),"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
4329,685,neurogranin levels,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced neurogranin levels'}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1136,686,Clinical Dementia Rating Scale (CDR),"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia severity in Alzheimer's Disease""}]"
1137,686,Clinical Dementia Rating Sum of Boxes (CDR-SB),"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}]"
1139,686,Clinical Dementia Rating scale-Sum of Boxes (CDR-SB),"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
1140,686,Clinical dementia Rating (CDR),"[{'article': 'PMC8336239.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]"
1141,686,Clinical dementia Rating–sum of boxes (CDR-SB),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]"
1134,686,Clinical Dementia Rating (CDR),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Severity of dementia'}]"
1135,686,Clinical Dementia Rating (CDR) scores,"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]"
293,687,Ach,"[{'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Ach release from NBM affects the neocortical environment, potentially guiding treatment for Alzheimer's Disease.""}]"
855,687,CCH,"[{'article': 'PMC7477392.txt', 'relationship': 'ACCELERATES', 'object': 'Cerebral Aβ deposition'}, {'article': 'PMC7477392.txt', 'relationship': 'PROMOTES', 'object': 'Cognitive impairment in combination with APP gene mutations'}, {'article': 'PMC7477392.txt', 'relationship': 'UPREGULATES', 'object': 'APP processing and β-secretase expression'}]"
110,687,ACh,"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher ACh levels in intervention groups'}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease through increased ACh levels""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Slowing of cognitive function loss'}, {'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Facilitating neuronal plasticity and cognitive functions in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved ACh concentration after tDCS therapy'}]"
72,688,5-HT6 receptor antagonist,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
3217,688,Selective serotonin reuptake inhibitors (SSRIs),"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]"
3228,688,Serotonin (5-HT),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]"
3867,689,[18F]florbetapir SUVR,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
3865,689,[18F]florbetaben,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
24,689,18F-Florbetaben SUVR,"[{'article': 'PMC8570037.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}]"
25,689,18F-Florbetapir,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3868,689,[18F]flortaucipir,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau accumulation in patients with mild cognitive impairment and AD'}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]"
35,689,18F-florbetapir,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid accumulation in Alzheimer’s disease'}]"
4138,689,florbetapir F 18,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
23,689,18F-Florbetaben,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
36,689,18F-flortaucipir,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Tau deposition in Alzheimer's Disease""}]"
26,689,18F-Flortaucipir (18F-AV1451),"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3866,689,[18F]florbetapir,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
3845,689,[18F] florbetapir,"[{'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2622,690,Number of medications (NMED),"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in women with Alzheimer's Disease""}]"
2621,690,Number of medications,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in female Alzheimer's Disease patients""}]"
2716,691,PDGF,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]"
2717,691,PDGFR,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]"
2719,691,PDGFRα,"[{'article': 'PMC4899632.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]"
2718,691,PDGFRB,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]"
16,692,18F-AV-1451 (tau),"[{'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}]"
15,692,18F-AV-1451,"[{'article': 'PMC4995360.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}, {'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau aggregates in Alzheimer's Disease""}, {'article': 'PMC5209394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
258,692,AV-1451 PET,"[{'article': 'PMC6204612.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Monitoring disease progression in Progressive Supranuclear Palsy (PSP)'}]"
257,692,AV-1451,"[{'article': 'PMC5209394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiate PSP patients from controls'}, {'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau pathology in Alzheimer's Disease""}]"
3289,693,Speech rate and pause characteristics,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2809,693,Pause Length,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]"
3296,693,Standard Pause Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
2236,693,Longer pause duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2265,694,MDA levels,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced oxidative stress and lipid peroxidation'}]"
2267,694,MDC,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuro-inflammation in Alzheimer's Disease""}]"
2264,694,MDA,"[{'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower MDA levels indicating reduced oxidative stress'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Oxidative stress in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating AD-MCA; biomarkers of AD progression'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased MDA levels in the n-IF group indicate oxidative stress, which is associated with Alzheimer's Disease presence.""}]"
73,695,5-LOX,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Reduced to control levels by J147'}]"
71,695,5 LOX,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of pro-inflammatory enzyme in AD mice'}]"
2348,696,Madecassic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica treatment in cognitively impaired older adults'}]"
2349,696,Madecassoside,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}]"
4255,696,madecassic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of madecassoside'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with CAW'}]"
3653,697,UBQLN1,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegenerative diseases'}]"
3654,697,UBQLN2,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegenerative diseases'}]"
1949,698,Hyperspectral (HS) score,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1948,698,Hyperspectral (HS) imaging,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]"
2998,699,RANTES/CCL5,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]"
2997,699,RANTES,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]"
2547,700,NSP subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1102,700,Ch3 subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1107,700,Ch4p subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1105,700,Ch4a-i subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1101,700,Ch1/2 subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
2522,701,NMED,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}]"
2521,701,NME8,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with cognitive decline and elevated tau levels'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]"
2387,702,Memory Impairment Screen (MIS-T),"[{'article': 'PMC4066282.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of Dementia'}]"
2386,702,Memory Impairment Screen (MIS),"[{'article': 'PMC4983010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
4159,703,gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amnestic mild cognitive impairment'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'silent infarcts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) burden'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) severity'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'ventricular enlargement, WMH volume, and brain infarcts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'corpus callosum volume at baseline'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'high total and periventricular white matter hyperintensities'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'amyloid beta peptides burden'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'large total WMH volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'total white matter volume and cerebral spinal fluid volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in frontal cortex'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in occipital cortex'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced hippocampal volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebellar atrophy'}]"
4157,703,gait speed,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta peptides burden'}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of falls'}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cognitive decline and adverse outcomes such as falls in Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression and outcomes""}, {'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""increased risk of falls and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of falls'}]"
3259,703,Slow gait speed,"[{'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of falls in Alzheimer's Disease patients""}]"
1713,703,Gait Speed,"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predictive of decline in activities of daily living (ADL) and instrumental ADL'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement with exercise reflects response to treatment'}]"
1714,703,Gait Velocity,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]"
1716,703,Gait speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher global white matter hyperintensity volume'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced total grey matter volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced metabolic rates of glucose uptake in the prefrontal, posterior cingulate, and parietal cortices'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher burden of white matter hyperintensities'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults'}]"
1718,703,Gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'More severe global age-related white matter changes'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity in brainstem, projection, association, limbic and callosal tracts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]"
1719,703,Gait-speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Gait abnormalities in Alzheimer's Disease""}]"
1831,704,HLA-DR surface expression,"[{'article': 'PMC6584558.txt', 'relationship': 'NOT_IMPAIRED_IN', 'object': ""Alzheimer's Disease patients""}]"
871,704,CD39 surface expression,"[{'article': 'PMC6584558.txt', 'relationship': 'NOT_IMPAIRED_IN', 'object': ""Alzheimer's Disease patients""}]"
